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ABSTRACT 
 
Listeria monocytogenes is an opportunistic Gram-positive pathogen and the 
cause of human listeriosis, a severe and often fatal foodborne disease that targets 
immunocompromised hosts. This pathogenicity results from the action of 
numerous virulence proteins, many of which are associated with the cell envelope. 
The cell wall of L. monocytogenes is densely decorated with wall teichoic acids 
(WTAs), a class of anionic glycopolymers known to play key roles in bacterial 
physiology, such as protection against antimicrobial peptides (AMPs) and control 
of autolysin activity. In other Gram-positive bacteria, WTA modification by amine-
containing groups such as D-alanine was largely correlated with increased 
resistance to AMPs and shown to influence autolytic levels. However, in 
L. monocytogenes, where WTA modification is achieved solely by glycosylation, 
WTA-dependent mechanisms of AMP resistance and autolytic regulation remain 
unknown. 
In this work, we show that the L. monocytogenes WTA L-rhamnosylation 
requires the rmlACBD locus, which encodes the biosynthetic pathway for L-
rhamnose, and the upstream-flanking gene rmlT, encoding a putative 
rhamnosyltransferase. We then demonstrate for the first time that this particular 
WTA tailoring mechanism promotes AMP resistance, sustains physiological levels 
of bacterial autolysis and supports virulence mechanisms. In particular, we show 
that L-rhamnosylated WTAs delay the crossing of the L. monocytogenes cell wall 
by AMPs and postpone their contact with the plasma membrane, through a 
decrease of the cell wall permeability to AMPs. Importantly, we reveal the 
contribution of this WTA decoration for L. monocytogenes survival and virulence in 
a mouse model of infection. In addition, we implicate L-rhamnosylated WTAs in the 
maintenance of optimal levels of autolytic activity and host cell invasion, through a 
previously unknown contribution to an efficient surface anchoring of representative 
members of the L. monocytogenes GW protein family. 
Altogether, these results demonstrate that WTA glycosylation mechanisms 
are also important for a variety of biological processes linked with bacterial 
physiology and pathogenesis. 
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RESUMO 
 
Listeria monocytogenes é uma bactéria Gram-positiva patogénica causadora 
da listeriose humana. Esta doença afecta sobretudo hospedeiros 
imunocomprometidos, onde pode evoluir até se tornar fatal. A patogenicidade de 
L. monocytogenes resulta da acção de inúmeros factores de virulência, muitos 
dos quais estão associados com o invólucro bacteriano. A parede celular desta 
bactéria é densamente decorada com ácidos teicoicos (ATs), uma família de 
glicopolímeros aniónicos conhecidos pelos seus variados papéis na biologia 
bacteriana, como por exemplo protecção contra péptidos antimicrobianos (PAMs) 
e controlo da actividade autolítica. Noutras bactérias Gram-positivas, a 
modificação dos ATs com grupos aminados (p.e. D-alanina) está intimamente 
relacionada com resistência à actividade de PAMs e influencia os níveis de 
autólise. No entanto, em L. monocytogenes – cujos ATs são apenas modificados 
com açúcares – os mecanismos de resistência a PAMs e de regulação da 
actividade autolítica dependentes de ATs permanecem desconhecidos.  
Neste trabalho, mostramos que a L-ramnosilação dos ATs de 
L. monocytogenes precisa dos genes rmlACBD, que codificam a via biosintética 
da L-ramnose, e do gene rmlT, que codifica para uma potencial 
ramnosiltransferase. Demonstramos pela primeira vez que este mecanismo 
particular de substituição de ATs promove a resistência a PAMs, sustenta níveis 
fisiológicos de autólise, e apoia mecanismos de virulência. Mostramos 
especificamente que os ATs ramnosilados atrasam a travessia da parede celular 
de L. monocytogenes pelos PAMs e adiam o contacto destes com a membrana, 
através de uma diminuição da permeabilidade da parede celular a estes péptidos. 
Revelamos também a importante contribuição desta decoração de ATs para a 
sobrevivência e virulência de L. monocytogenes in vivo, usando murganhos como 
modelo de infecção. Ainda, responsabilizamos os ATs ramnosilados pela 
manutenção de níveis óptimos de actividade autolítica e invasão celular, através 
da contribuição previamente desconhecida para a eficiente ancoragem à 
superfície de L. monocytogenes de membros representativos da família de 
proteínas com domínios GW. 
 14 
No seu conjunto, estes resultados demonstram que os mecanismo de 
glicosilação de ATs são igualmente importantes para uma variedade de processos 
biológicos associados com a fisiologia e patogénese bacteriana. 
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A. LISTERIA MONOCYTOGENES 
 
A.1. History 
 
Our knowledge about Listeria monocytogenes (Lm) goes back as far as 
1926, when the identification of this bacterium was first reported by Murray and 
colleagues, in the aftermath of an epidemic outbreak among rabbits and guinea 
pigs in their laboratory in Cambridge, England. They named the new species 
Bacterium monocytogenes due to the increased number of monocytes observed in 
the blood of animals infected with sub-lethal doses of this microorganism (Murray 
et al. 1926). The following year, Pirie unknowingly reported the isolation of the 
same species in South Africa, which he named Listerella hepatolytica, in honor of 
Lord Joseph Lister, the father of antiseptic surgery (Pirie 1927). Acknowledging 
Murray’s discovery, Pirie changed the species name to Listerella monocytogenes, 
but confronted with the prior use of Listerella for a genus of slime molds, he 
proposed its renaming in 1940 to the current form (Pirie 1940).  
Although human cases had already been reported (Nyfeldt 1929, Reiss et al. 
1951), they were highly sporadic and Lm infection was essentially regarded as a 
zoonosis. It was only in 1981 that Lm was recognized as a human food-borne 
pathogen, after a severe listeriosis outbreak in Canada related with consumption 
of contaminated food resulted in an elevated percentage of case deaths (Schlech 
et al. 1983). Further food-related outbreaks during the following two decades 
consolidated the status of Lm as a microorganism of public health concern 
(Swaminathan and Gerner-Smidt 2007a).  
 
A.2. Taxonomy, phylogeny and classification 
 
Listeria is one of two genera – the other is Brochothrix – of the Listeriaceae 
family, which in turn belongs to the order Bacillales, class Bacilli, and phylum 
Firmicutes of the domain Bacteria. Other genera closely related to Listeria include 
Bacillus and Staphylococcus. Since its discovery, Lm was for a long time the only 
species within its genus. However, in the second half of the 20th century, with the 
aid of biochemical and genetic typing tools, Seeliger and Rocourt were able to 
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distinguish and identify five novel species: L. innocua (Seeliger 1981), 
L. welshimeri, L. seeligeri (Rocourt and Grimont 1983), L. ivanovii (formerly 
L. bulgarica) (Seeliger et al. 1984) and L. grayi (Larsen and Seeliger 1966, 
Rocourt et al. 1992). Recently, the Listeria genus has undergone a major 
expansion, from six to seventeen species, with the identification of L. marthii and 
L. rocourtiae (Graves et al. 2010, Leclercq et al. 2010); L. fleischmannii and 
L. weihenstephanensis (Bertsch et al. 2013, Halter et al. 2013); and L. floridensis, 
L. aquatica, L. cornellensis, L. riparia and L. grandensis (den Bakker et al. 2014). 
Among these, Lm (infects humans and animals) and L. ivanovii (infects mainly 
livestock) are the only confirmed pathogenic species; the remaining live as 
apathogenic saprophytes in nature (Rocourt and Grimont 1983, Graves et al. 
2010, Leclercq et al. 2010, Bertsch et al. 2013, Halter et al. 2013, den Bakker et 
al. 2014).  
The turn of the century introduced post-genomics to the Listeria research 
field, after the complete genome sequences of Lm (EGD-e) and L. innocua (CLIP 
11262) (Fig. 1) were published (Glaser et al. 2001). Soon after, whole-genome 
sequences of other Lm strains also became available (Nelson et al. 2004, Kuenne 
 
Fig. 1. Circular genome maps of Lm EGD-e and L. innocua CLIP 11262, showing the position and orientation of 
genes. From the outside: Circles 1 and 2, L. innocua and Lm genes on the plus and minus strands, respectively. Color 
code: green, L. innocua genes; red, Lm genes; black, genes specific for Lm or L. innocua, respectively; orange, rRNA 
operons; purple, prophages. Numbers on the second circle indicate the position of known virulence genes: 1, virulence 
locus (prfA-plcA-hly-mpl-actA-plcB); 2, clpC; 3, inlAB; 4, iap; 5, dal; 6, clpE; 7, lisRK; 8, dat; 9, inlC; 10, arpJ; 11, clpP; 12, 
ami; 13, bvrABC. Circle 3, G/C bias (G+C/G-C) of Lm. Circle 4, G+C content of Lm (<32.5% G+C in light yellow, 32.5 to 
43.5% in yellow, and >43.5% G+C in dark yellow). The scale in megabases (Mb) is indicated on the outside of the genome 
circles, with the origin of replication at position 0. (From Glaser et al. 2001) 
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et al. 2013) and, progressively, those of other Listeria species (Hain et al. 2006b, 
Steinweg et al. 2010, Buchrieser et al. 2011). Comparative genomics enabled – 
among other possibilities – the identification of differences important for the 
comprehension of the phylogenetic relationship of Listeria spp. To understand the 
evolution of Listeria pathogenicity, Schmid and colleagues made a phylogenetic 
analysis focused on the comparison of multiple virulence-associated loci in the 
different species. Their analyses indicated that L. grayi was likely the first to 
diverge within the genus and lose its pathogenic capacity, followed by the 
branching of Lm and L. innocua into one lineage, and of L. ivanovii, L. seeligeri 
and L. welshimeri into another (Schmid et al. 2005).  
Early on, Listeria classification relied on the serotyping of somatic (O) and 
flagellar (H) antigens. Based on this method, 16 Listeria serotypes were identified, 
13 of which are found in Lm (1/2a, 1/2b, 1/2c, 3a, 3b, 3c, 4a, 4ab, 4b, 4c, 4d, 4e 
and 7) (Seeliger and Höhne 1979, Seeliger and Langer 1989, Gorski 2008). 
Serotyping, however, is not very specific due to the high antigenic overlap 
between serotypes. Thus, more specific genetic-based typing methodologies 
(genotyping) led to the organization of Lm serotypes into four lineages: lineage I 
(1/2b, 3b, 4b, 4d and 4e), lineage II (1/2a, 1/2c, 3a and 3c), lineage III (4a and 4c), 
and lineage IV (7) (Orsi et al. 2011).   
 
A.3. General features 
 
Lm is a small, rod-shaped (0.5×1–2 μm), non-encapsulated, non-sporulating, 
facultative anaerobic, Gram-positive bacterium (Rocourt and Buchrieser 2007). It 
expresses four-to-six peritrichous flagella at temperatures up to 25 °C, which 
confer motility to Lm while in the environment. This flagellar motility decreases with 
further increase in temperature until it is completely lost at 37 °C (temperature 
inside a host) due to transcriptional repression of the flagellar assembly system 
(Peel et al. 1988, Gründling et al. 2004).  
Lm is a physiologically robust bacterium, able to grow under a broad range of 
temperatures (<0 to 45 °C) and pH (4.3 to 9, optimal at 7), and high osmotic 
pressures (up to 10% NaCl) (Shahamat et al. 1980, Junttila et al. 1988, Parish and 
Higgins 1989, George and Lund 1992). These properties make Lm a virtually 
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ubiquitous microorganism, able to adapt to the demands of a wide variety of 
ecological environments. Indeed, Lm has been isolated from soil, water, sewage, 
plants and animal feces (Fenlon 1999), where it lives as a saprophyte (Weis and 
Seeliger 1975).  
Despite the elevated phenotypic similarity within the genus, Lm can be 
distinguished from other Listeria spp. through a set of biochemical tests that 
assess hemolytic (red blood cell-lysing) activity and acid production (fermentation) 
from carbohydrate sources (Rocourt et al. 1983). In the case of Lm, it is the only 
hemolytic Listeria that ferments L-rhamnose but not D-xylose. 
Since the publication of the first Listeria genomes in 2001 (Glaser et al. 
2001), multiple other species and strains have also had their genomes sequenced 
and analyzed. With few exceptions, the average Lm genome size varies between 
2.7 and 3.0 Mb – with an average G+C content of about 38%, typical of Firmicutes 
– and contains about 2900 protein-coding sequences (Table 1) (Hain et al. 2006a, 
Buchrieser 2007). These numbers are very similar to those of other Listeria spp., 
such as L. innocua or L. welshimeri (Buchrieser 2007). Indeed, all Listeria 
genomes show a highly conserved organization, which reflects the strong 
phylogenetic closeness between listeriae (Buchrieser et al. 2003). Nonetheless, 
they also display genomic differences that are likely to be associated with inter- or 
intra-specific variations of certain phenotypic parameters, such as pathogenicity. In 
fact, a critical genetic difference between Lm and its non-pathogenic relatives 
L. innocua and L. welshimeri concerns the most important Lm virulence genes, 
Table 1. General features of published Listeria genome sequences.
a,b
 
 L. monocytogenes 
EGD-e 
L. monocytogenes 
F2365 
L. innocua 
CLIP11262 
L. welshimeri 
CIP8149 
Chromosome size (bp) 2,944,528 2,905,310 3,011,209 2,814,130 
% G+C content 38 38 37.4 36.4 
ORFs 2,853 2,847 2,973 2,780 
% Coding ORFs 89.2 88.4 89.1 88.7 
Prophages 1 2 5 1 
Plasmids – – 1 (79 ORFs) – 
Strain-specific genes 61 51 78 208 
Transposons 1 (Tn916-like) – – – 
rRNA genes 6 6 6 6 
tRNA genes 67 67 66 66 
a) Adapted from Buchrieser 2007. 
b) bp, base pairs; G+C, guanine and cytosine; ORF, open reading frame.  
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which are all absent from the homologous regions in both avirulent species 
(Schmid et al. 2005, Buchrieser 2007).  
 
A.4. Listeriosis 
 
A.4.1. Epidemiology 
 
The transmission of Lm to humans is achieved mainly through the 
consumption of contaminated food, although there were reports of infection 
transmitted between humans or acquired from animals (Allerberger and Wagner 
2010). Due to its remarkable fitness, Lm can survive to most standard industrial 
food-preserving methods (e.g. refrigeration, acid- or salt-based treatments) to 
persist and grow in a variety of raw and processed foods, including meats (e.g. 
charcuterie and deli), seafood, produce (fruits and vegetables), unpasteurized milk 
and dairy products (e.g. soft cheeses) (Swaminathan and Gerner-Smidt 2007b). 
Despite the environmental widespreadness of Lm and the continuous exposure of 
humans to this pathogen, listeriosis has a very low incidence in humans, with 1–10 
cases per million people reported every year. In recent years, the total number of 
annual cases has been increasing, particularly in developed countries (Denny and 
McLauchlin 2008, Goulet et al. 2008). In contrast to its low occurrence, the 
average rate of clinical case deaths reaches 20–30%, making it one of the most 
deadly food-borne infections, only surpassed by salmonellosis (Gould et al. 2013). 
Over 95% of all reported human listeriosis cases have been caused by Lm strains 
belonging to serotypes 1/2a, 1/2b, 1/2c, and 4b. Serotype 4b accounts for the 
majority of epidemic outbreaks, while serogroup 1/2 has been mostly associated 
with sporadic cases (Jacquet et al. 2002, Goulet et al. 2006). 
 
A.4.2. Pathophysiology 
 
Following its ingestion, Lm must be able to survive through the aggressive 
environment of the gastric compartment before arriving at the intestinal lumen. 
Once there, bacteria can penetrate further into the host organism by crossing the 
intestinal epithelium (Fig. 2). Depending on the host species, this trans-intestinal 
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passage occurs mainly via enterocytes (humans, gerbils and rabbits) or M-cells in 
Peyer’s patches (murines) (Vazquez-Boland et al. 2001, Lecuit 2005, Lecuit 2007). 
After translocation, bacteria are carried in the lymph and the blood to the spleen 
and the liver, the major target organs for Lm colonization, where they are quickly 
taken up by resident macrophages, such as Kupffer cells. In the liver, the majority 
of the captured bacteria are destroyed inside these phagocytic cells, but a 
substantial number is able to survive and infect nearby hepatocytes, where the Lm 
population can recover and spread to adjacent cells and tissues. If the hepatic 
infection is not contained by the host immune system, uncontrolled bacterial 
multiplication will lead to the freeing of Lm into the bloodstream, resulting in 
bacteremia (Vazquez-Boland et al. 2001, Zenewicz and Shen 2007). Blood-borne 
Lm can then migrate to and infect secondary target organs, such as the brain and 
placenta (with consequent infection of the fetus), by crossing both the blood-brain 
and the placental barriers (Fig. 2) (Vazquez-Boland et al. 2001, Lecuit 2005, 
Lamont et al. 2011, Disson and Lecuit 2012). 
 
A.4.3. Clinical manifestations and treatment 
 
The prime mechanism of host defense against Lm infection is cell-mediated 
immunity (Mackaness 1960, Zenewicz and Shen 2007). Thus, the clinical severity 
 
 
Fig. 2. Schematic representation of the successive steps of human listeriosis. 
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of listeriosis is dependent on the functional status of the host immune system. In 
healthy immunocompetent hosts, listeriosis can be asymptomatic or, in the worst-
case scenario, manifest as a self-limiting and short-term febrile gastroenteritis. 
Immunodepressed individuals, such as the elderly, pregnant women, neonates, 
HIV carriers, and those undergoing immunosuppressive treatments, cannot mount 
a proper T cell-mediated immune response against bacterial pathogens, and are 
thus much more susceptible to Lm infection (Vazquez-Boland et al. 2001, 
Swaminathan and Gerner-Smidt 2007b, Hernandez-Milian and Payeras-Cifre 
2014). In these risk groups, listeriosis takes on a clinically more invasive and 
potentially lethal form, typically characterized by bacteremia, which can then 
evolve to systemic (septicemia) or more localized infections, either in the central 
nervous system (CNS) or in the fetoplacental system.  
CNS infections are the most predominant form of invasive listeriosis in non-
pregnant human adults (55–70% case reports), due to the tropism of Lm for 
nervous tissue (Vazquez-Boland et al. 2001, Hernandez-Milian and Payeras-Cifre 
2014), and manifest primarily as meningitis but also as meningoencephalitis 
(Disson and Lecuit 2012). Maternofetal and early-onset neonatal listeriosis are the 
most common pregnancy-associated variants of the disease. They are elicited in 
utero – mainly during the third trimester, when the maternal immune system is 
weakened – with the placental translocation of Lm from the maternal blood to the 
fetus. Whereas the mother is hardly affected, displaying flu-like symptoms in the 
worst case, infection of the fetus can become systemic and result in abortion or 
pre-term delivery of a stillborn or a live but severely affected infant. Less frequent, 
late-onset neonatal listeriosis develops in week-old neonates, probably after 
having contacted with contaminated maternal fluids during delivery. Commonly 
associated symptoms include fever and meningitis, but also gastroenteritis and 
pneumonia (Vazquez-Boland et al. 2001, Lamont et al. 2011). 
Antimicrobial therapy is the current standard treatment for listeriosis. It 
involves the intravenous administration of beta-lactamic antibiotics (ampicillin or 
penicillin) in combination with an aminoglycoside (e.g. gentamicin). Patients 
allergic to beta-lactams can be treated with alternative antimicrobial compounds, 
which include trimethoprim/sulfamethoxazole, erythromycin, vancomycin or 
fluoroquinolones. Pregnant women should not be given gentamicin, due to 
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potential teratogenic effects on the fetus. Treatment duration is variable but should 
typically last more than two weeks (Allerberger and Wagner 2010). 
 
A.5. Cellular infection cycle 
 
The remarkable capacity of Lm to overcome tight physiological barriers such 
as the intestinal epithelium, the placenta, and the blood-brain barrier (Lecuit 2005) 
comes from its ability to survive inside professional phagocytes and, more 
importantly, to invade non-phagocytic cells (e.g. epithelial and endothelial cells, 
fibroblasts and hepatocytes) (Cossart and Toledo-Arana 2008). Once inside a 
target cell, Lm proliferates and propagates the infection by spreading to other cells 
(Fig. 3).  
When Lm first encounters a non-phagocytic host cell, it makes use of a set of 
surface proteins that enable its direct contact and stable adhesion to the cell 
membrane (adhesins). Almost concurrently, Lm induces its own internalization by 
 
 
Fig. 3. Schematic representation of the successive steps of the Lm cellular infection cycle. Lm is depicted in red and 
host actin in green. (Adapted from Cossart and Toledo-Arana 2008) 
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engaging eukaryotic membrane receptors with invasion-promoting proteins 
(invasins) that trigger intracellular signaling cascades leading to a localized 
reshaping of the host cell cytoskeleton around the bacterium-cell interaction site. 
In a zipper-like fashion, Lm is gradually surrounded by host cell membrane and 
engulfed into an internalization vacuole. Soon after, aided by a secreted pore-
forming toxin, Lm disrupts its containing vacuole and reaches the host cytoplasm, 
where a high nutritional availability favors bacterial replication. Once in this 
compartment, Lm cells begin to recruit host actin filaments that initially surround 
the whole bacterial surface (actin cloud) but later reassembles at one pole into a 
long comet-like tail (actin tail). Actin polymerization/depolymerization dynamics in 
this structure generate a propulsive force that confers random intracellular motility 
and allows Lm to eventually reach the cell membrane, forcing it into a protrusion 
that can be taken up by a neighboring uninfected cell. The resulting Lm-containing 
double-membrane secondary vacuole is rapidly lysed, enabling the bacterium to 
restart the infection cycle in a new cell without re-exposure to the extracellular 
environment (Fig. 3) (Vazquez-Boland et al. 2001, Cossart and Toledo-Arana 
2008). 
 
A.5.1. Major virulence factors 
 
To successfully undertake each step of the host cell infection cycle, Lm is 
equipped with a highly diverse and evolutionarily perfected supply of virulence 
proteins, all of which are placed under the tight control of a complex, fine-tuned 
regulatory network (Camejo et al. 2011). In this section are described the most 
representative virulence factors involved in the different stages of the intracellular 
infection cycle. 
 
Internalins A and B 
 
Two members of the internalin family, internalin A (InlA) and B (InlB), were 
first bacterial proteins identified as mediators of Lm entry into host cells are 
(Gaillard et al. 1991, Dramsi et al. 1995). Members of this family contain a leucine-
rich repeat (LRR) domain with variable length (Fig. 4) that is generally involved in 
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interaction with other proteins (Cabanes et al. 2002). Extensive functional 
characterization has strengthened their role as major listerial invasins.  
InlA (800 aa) contains a second repeat region (B-repeat domain) that is 
separated from the LRR domain by an inter-repeat (IR) spacer region (Gaillard et 
al. 1991). In its C-terminal end, a cell wall-sorting signal region, containing an 
LPXTG motif, guides the covalent attachment of InlA to the peptidoglycan 
meshwork (Dhar et al. 2000) (Fig. 4). Together, the LRR and IR regions were 
shown to be indispensable and sufficient to support the entry of Lm into human 
epithelial cells (Lecuit 2007), as they form the minimal structure necessary to bind 
to the eukaryotic receptor for InlA, E-cadherin (E-cad) (Mengaud et al. 1996), a 
transmembrane glycoprotein expressed in epithelial cells and implicated in cell-cell 
adhesion. The InlA/E-cad interaction mimics the homotypal interaction between E-
cad molecules from adjacent epithelial cells, which forms the basis of the tensile 
strength of adherens junctions that bind cells together. In this sense, the 
engagement of E-cad by InlA initiates a complex signaling pathway that activates 
a localized actin cytoskeleton rearrangement and ultimately leads to a clathrin-
mediated internalization of the Lm-InlA/E-cad complex (Pizarro-Cerdá et al. 2012). 
Remarkably, variation of a single amino acid in E-cad dramatically changes host 
permissiveness to InlA-mediated infection, with humans and guinea pigs (E-
cadPro16) showing susceptibility to orally inoculated Lm, whereas murinae (E-
cadGlu16) are resistant (Lecuit et al. 1999).  
InlB (630 aa) displays a cell wall-anchoring C-terminal domain different from 
that of InlA, composed of multiple repeats that contain a conserved GW dipeptide 
(GW repeats) (Braun et al. 1997) (Fig. 4). These mediate the labile association 
with the Lm cytoplasmic membrane via non-covalent interactions with lipoteichoic 
acids (LTAs) (Jonquières et al. 1999), which results in co-existing surface-attached 
and secreted forms of InlB. In agreement with what was observed for InlA, the host 
cell invasive properties conferred by InlB (Braun et al. 1998) are also localized to 
the LRR domain (Braun et al. 1999). Unlike InlA, InlB has more than one 
interacting partner at the surface of eukaryotic cells. The most important is c-Met, 
a receptor tyrosine kinase known to bind hepatocyte growth factor (HGF). The role 
of this receptor in Lm infection was validated by showing that cells that did not 
express c-Met were resistant to InlB-mediated Lm entry (Shen et al. 2000). 
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Although some signaling players differ from those involved in the InlA-induced 
pathway, the Lm internalization mechanism activated by InlB/c-Met interaction 
similarly results in a reorganization of the actin network that promotes clathrin-
mediated bacterial endocytosis (Pizarro-Cerdá et al. 2012). InlB was also shown to 
bind gC1qR, the receptor for the globular part of the C1q complement component 
(Braun et al. 2000), and glycosaminoglycans (GAGs) (Jonquières et al. 2001), 
both through its GW repeat domain (Jonquières et al. 2001, Marino et al. 2002). 
GAGs are able to sequester InlB molecules from the Lm surface and aggregate 
them around the host cell adhesion site, potentiating c-Met activation (Jonquières 
et al. 2001). 
The diversified nature of their receptors and the differential cell- and tissue-
specific expression result in a distinct cell tropism for Lm internalins: while InlA 
mostly promotes invasion of epithelial cells, such as those in the intestine and 
placenta (Gaillard et al. 1991, Lecuit et al. 2004), InlB mediates Lm entry into a 
wider variety of cell types, including hepatocytes (Dramsi et al. 1995), fibroblasts 
(Dramsi et al. 1997) and endothelial cells (Greiffenberg et al. 1998, Parida et al. 
1998). 
 
Listeriolysin O 
 
To escape from the internalization vacuole, Lm secretes monomers of the 
pore-forming toxin listeriolysin O (LLO), a member of the family of cholesterol-
dependent cytolysins (CDC) (Tweten et al. 2001), which oligomerize in the vacuole 
membrane as ring-like pore complexes (Shatursky et al. 1999, Tweten et al. 
2001). LLO was the first Listeria virulence protein to be identified and functionally 
characterized in the context of infection. Mutants in the LLO-encoding gene, hly 
(for hemolysin), were drastically attenuated in virulence (>5 logs) in the mouse 
model (Gaillard et al. 1986, Kathariou et al. 1987). In cultured cells, they were 
unable to replicate because they remained trapped inside the vacuole (Gaillard et 
al. 1987, Portnoy et al. 1988), confirming the role of LLO in vacuolar membrane 
lysis. This role is not only confined to primary vacuoles, but also to the double-
membrane secondary vacuole formed after Lm spreads from cell to cell (Gedde et 
al. 2000).  
 
CHAPTER I – INTRODUCTION 
 
 
 32 
The cytolytic activity of LLO is optimal at a low pH (5.5) and lost almost 
completely at neutral pH (Geoffroy et al. 1987), explaining why the toxin is most 
active within the acidic vacuolar environment and loses its function upon Lm 
release into the cytoplasm (Beauregard et al. 1997). This pH-dependent regulation 
protects the host cell from further membrane damage, thus preserving an 
intracellular niche for Lm survival and proliferation (Glomski et al. 2003). An 
additional regulatory switch resides in the 5’ coding region of the hly mRNA, 
encoding the N-terminal region of LLO. The presence of a PEST-like sequence 
within the LLO N-terminus (Fig. 4), suggested that it targeted LLO for cytosolic 
degradation (Rechsteiner and Rogers 1996, Decatur and Portnoy 2000). However, 
further studies denied this hypothesis (Lety et al. 2001) and implicated this hly 
mRNA region in translational repression of LLO during exponential growth of Lm 
(Schnupf et al. 2006), a situation verified in the host cell cytoplasm. 
 
Fig. 4. Schematic representation of Lm virulence proteins InlA, InlB, LLO and ActA. Both InlA and InlB contain the 
signature internalin N-terminal LRR domain, which is followed by an IR region and a B-repeat (BR) domain. However, their 
C-terminal region is different: InlA has a sorting signal (SS) sequence with an LPTXG motif (enables covalent linkage to 
peptidoglycan), while InlB has GW dipeptide-containing module repeats (mediate non-covalent association with cell wall 
components). LLO contains an N-terminal PEST-like sequence, a central domain with two α-helices (TMH1 and TMH2) that 
span host cell membranes to form pores, and an acidic triad (Asp208, Glu247, Asp320) that mediates the pore-forming 
activity through pH-dependent conformational changes (Hamon et al. 2012); and a C-terminal cholesterol-binding motif 
(CBM). ActA is anchored to the membrane by a C-terminal transmembrane (TM) anchor and encodes its actin 
polymerization activity in two distinct domains: one recruits actin monomers and the actin nucleator Arp2/3 complex, while 
the other binds Ena/VASP family proteins that control actin filament assembly speed and direction. SP, signal peptide. 
(Adapted from Cabanes et al. 2002, Hamon et al. 2012, Köster et al. 2014 and Travier et al. 2013) 
 
 
 
CHAPTER I – INTRODUCTION 
 
 
 33 
Other bacterial and host factors were shown to cooperate with the 
intravacuolar activity of LLO. Two bacterial proteins with phospholipase C (PLC) 
activity, PI-PLC and PC-PLC (encoded by the Lm virulence locus genes plcA and 
plcB), facilitate LLO-mediated escape from primary and secondary vacuoles, 
respectively (Smith et al. 1995), and in some cases, are able to mediate Lm 
escape in the absence of LLO (Marquis et al. 1995). Host proteins GILT and CFTR 
were also shown to support LLO function (Singh et al. 2008, Radtke et al. 2011). 
A substantial body of evidence gathered in recent years has revealed 
additional roles for LLO in Lm infection other than vacuole rupture. Most of these 
novel functions are exerted extracellularly and are associated with signaling 
events: activation of NF-κB (Kayal et al. 1999), MAPK (Tang et al. 1996, Weiglein 
et al. 1997), calcium flux (Dramsi and Cossart 2003) and phosphoinositide 
metabolism pathways (Sibelius et al. 1996); downregulation of SUMOylation (Ribet 
et al. 2010); apoptosis of dendritic and T-cells (Guzman et al. 1996, Carrero et al. 
2004); upregulation of cell adhesion molecules and cytokines (Yoshikawa et al. 
1993, Nishibori et al. 1996, Kayal et al. 1999); mitochondrial fragmentation (Stavru 
et al. 2011) and histone modifications (Hamon and Cossart 2011). 
 
ActA 
 
Actin-mediated intracellular motility is a hallmark of the Lm cellular infection. 
The polymerization of actin filaments to form a polarized, dynamic tail structure 
with propulsive force is mediated by a 639-aa surface protein named ActA (Fig. 4) 
(Domann et al. 1992, Kocks et al. 1992). Encoded in the main Lm virulence locus 
(Vazquez-Boland et al. 1992), ActA alone was shown to be sufficient for 
recruitment of actin filaments (Pistor et al. 1994) and confer motility to otherwise 
non-motile bacteria (Kocks et al. 1995) and Lm mutants were non-motile in the 
host cell cytoplasm and avirulent in the mouse model (Domann et al. 1992, Kocks 
et al. 1992).  
This protein is anchored to the bacterial membrane by a C-terminal 
transmembrane domain (Domann et al. 1992, Kocks et al. 1992), and contains two 
other domains responsible for actin filament-mediated motility. Near the N-
terminus, three regions homologous to WASP protein sequences are essential for 
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actin filament polymerization and elongation (Lasa et al. 1997), through their 
recruitment of actin monomers and of the host actin nucleator Arp2/3 complex 
(Welch et al. 1998, Boujemaa-Paterski et al. 2001, Zalevsky et al. 2001). The 
presence of a proline-rich repeat (PRR) domain in the middle of ActA is not 
required for motility but is important for regulation of the actin filament tail speed 
and directionality (Fig. 4) (Lasa et al. 1995, Auerbuch et al. 2003). This domain 
binds members of the eukaryotic Ena/VASP protein family (Chakraborty et al. 
1995), which not only recruit profilin, an actin monomer-binding protein (Theriot et 
al. 1994), but also modulate Arp2/3 complex activity by limiting filament branching 
and favoring the polymerization of parallel filaments (Samarin et al. 2003). A 
recent study demonstrated that the region between the Ena/VASP-binding domain 
and the transmembrane anchor is important for Lm aggregation and biofilm 
formation via ActA-ActA interactions, and that this activity if crucial for bacterial 
persistence in the intestinal tract (Travier et al. 2013). 
Besides the pivotal role in Lm intracellular motility, ActA was also shown to 
be involved in other cellular infection events, such as epithelial cell invasion 
(Alvarez-Dominguez et al. 1997, Suarez et al. 2001), vacuole escape (Poussin 
and Goldfine 2010) and autophagy evasion (Yoshikawa et al. 2009). 
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B. GRAM-POSITIVE CELL ENVELOPE 
 
The bacterial cell envelope is an elaborate, multilayered structure that 
provides structural support and protection from the external environment, while 
allowing exchange of nutrients and waste products. In Gram-negative organisms, 
this structure is composed of three concentric layers: a cytoplasmic (or inner) 
membrane, a peptidoglycan cell wall, and an outer membrane. In contrast, Gram-
positive species lack an outer membrane but, in compensation, their peptidoglycan 
cell wall layer is significantly thicker to confer adequate resistance to turgor 
pressure and protection from external aggressions (Fig. 5) (Silhavy et al. 2010).  
The work presented in this thesis is centered on Listeria monocytogenes, a 
Gram-positive pathogen. In accordance, this section describes the main 
components and features of this type of cell envelope.  
 
B.1. Peptidoglycan 
 
The presence of a cell wall layer made of peptidoglycan is a common 
characteristic to both Gram-negative and Gram-positive bacteria. However, unlike 
its Gram-negative homologue, the peptidoglycan cell wall is the major structural 
 
Fig. 5. Schematic representation of the basic cell envelope structure of Gram-negative and Gram-
positive bacteria. Both bacterial classes possess a cytoplasmic membrane (CM) surrounded by a rigid cell 
wall (CW) layer. However, while the Gram-negative cell wall is conceiled by a second membrane (outer 
membrane, OM), the Gram-positive cell wall is the outermost surface layer and is significantly thicker. 
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component of the Gram-positive cell envelope, displaying a thickness of 30–100 
nm with multiple connected layers (Silhavy et al. 2010). Additionally, it acts as a 
scaffold for the surface positioning of proteins and other glycopolymers with 
relevant physiological roles (Neuhaus and Baddiley 2003, Dramsi et al. 2008).  
Peptidoglycan is a highly polymerized macromolecule composed of linear, 
parallel glycan strands linked perpendicularly by short peptide bridges (Fig. 6A). 
The glycan portion is constituted by alternating units of N-acetylglucosamine 
(GlcNAc) and N-acetylmuramic acid (MurNAc) linked by β(1–4) glycosydic bonds. 
The average glycan strand length is 50-250 GlcNAc-MurNAc repeats (Ward 1973). 
The stem peptide element is linked to each MurNAc residue through its C3-linked 
lactoyl group and is typically constituted by the pentapeptide L-Ala-γ-D-Glu-N2X-D-
Ala-D-Ala. N2X represents a diamino acid: L-Lys, in most Gram-positive species, or 
meso-2,6-diaminopimelic acid (mDpm), in most Gram-negative species and Bacilli 
(including Listeria). The muropeptide GlcNAc-MurNAc-pentapeptide constitutes 
the basic peptidoglycan subunit precursor (Fig. 6B) (Vollmer 2008).  
The diamino acid residue is important for the cross-linkage between glycan 
strands, which occurs between its free (ε) amino group and the carboxyl group of 
the first D-Ala (position 4) of another stem peptide. In the case of Lm and other 
species with mDpm-type peptidoglycan, the interpeptide linkage is a direct bond 
between mDpm and D-Ala (Fiedler 1988), while a pentaglycine (Gly5) bridge 
performs this role in L-Lys-type peptidoglycan (Fig. 6C). However, several other 
amino acid residues, stem peptide positions and interpeptide bridges have been 
catalogued by Schleifer and Kandler, who created a classification system for all 
these peptidoglycan types (Schleifer and Kandler 1972). According to this system, 
the Lm peptidoglycan belongs to the A1γ type (Kamisango et al. 1982). 
As a result of the transpeptidation reaction, the terminal D-Ala is cleaved out 
in the mature peptidoglycan (Vollmer 2008). Additionally, the diamino acid is the 
acceptor anchor for covalently bound surface proteins (Dramsi et al. 2008). 
 
B.1.1. Peptidoglycan metabolism 
 
The continuous remodeling of the cell wall is paramount for bacterial growth 
and division, and requires a dynamic balance between peptidoglycan assembly 
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and turnover. Coordination between these processes is thus mandatory to prevent 
morphological malformations and concomitant functional defects, such as the 
mislocalization of surface molecules (Popowska 2004, Vollmer et al. 2008a). 
 
B.1.1.1. Peptidoglycan assembly 
 
Peptidoglycan is assembled outside of the bacterial cell through the 
polymerization of muropeptide subunits generated on the cytoplasmic side of the 
 
Fig. 6. Schematic representation of the peptidoglycan structure and the most common types of 
peptidoglycan strand cross-connections. (A) Peptidoglycan is a three-dimensional mesh-like structure 
composed of linear glycan strands connected between each other by peptide bridges. (B) Composition of a 
basic peptidoglycan monomer: a GlcNAc-MurNAc disaccharide linked by the latter to pentapeptide stem 
containing typically L-Ala, D-Glu, a diamino acid (mDpm or L-Lys), and two terminal D-Ala residues. In mature 
peptidoglycan, the last D-Ala is cleaved off during transpeptidation or by carboxypeptidases. (C) Common 
types of linkages between stem peptides from different glycan strands. In A1γ-type peptidoglycans, the ε-
amino group of mDpm (in blue) is directly linked to the carboxyl group of D-Ala in position 4. In S. aureus (A3α 
type), the ε-amino group of L-Lys (in green) is linked indirectly to D-Ala by a penta-glycine bridge (in red). 
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membrane (van Heijenoort 1998). Following translocation, these building blocks 
are transferred and integrated into existing peptidoglycan chains by the action of a 
multifunctional family of surface proteins called penicillin-binding proteins (PBPs) 
(Fig. 7).  
PBPs are membrane-anchored proteins that can be divided into high 
molecular weight (HMW) PBPs – the major players in peptidoglycan assembly – 
and low molecular weight (LMW) PBPs, both of which are characterized by the 
presence of an archetypal DD-peptidase domain (Macheboeuf et al. 2006). In 
HMW PBPs, the peptidase domain is located at the C-terminus and catalyzes 
transpeptidation reactions between adjacent glycan strands. Additionally, they may 
contain an N-terminal domain with transglycosylase activity, necessary for 
elongation of glycan strands (bifunctional PBPs). LWM PBPs perform roles linked 
to peptidoglycan maturation and recycling (Macheboeuf et al. 2006, Sauvage et al. 
2008). The PBP peptidase domain recognizes the D-Ala-D-Ala moiety of immature 
stem peptides and cleaves the DD-bond. Penicillin and other β-lactam antibiotics 
take advantage of their structural similarity with the D-Ala-D-Ala dipeptide to bind 
irreversibly to and inhibit most PBPs, thus promoting bacterial death by perturbing 
cell wall synthesis (Tipper and Strominger 1965, Ghuysen 1994).  
In silico studies have allowed the identification of ten PBP-like protein-
encoding genes in the Lm genome (Guinane et al. 2006, Korsak et al. 2010), and 
β-lactam-binding assays confirmed that nine expressed functional PBPs (Korsak 
et al. 2010). They comprise five HMW proteins – class A members PBPA1 and 
PBPA2 (former PBP1 and PBP4), and class B members PBPB1, PBPB2 (former 
PBP3 and PBP2) and PBPB3 – and four LMW PBPs, including carboxypeptidase 
PBPD1 (former PBP5) and two β-lactamases (Korsak et al. 2010). Studies on 
listerial PBPs have largely focused on the determination of their affinity to several 
β-lactam derivatives (Gutkind et al. 1990, Pierre et al. 1990, Vicente et al. 1990, 
Guinane et al. 2006, Zawadzka-Skomial et al. 2006). In some cases, mutational 
approaches allowed the elucidation of the role of some PBPs towards Lm 
pathogenesis. For instance, PBPB1, PBPD1, but mostly PBPA2 and PBPC1, were 
found to be important for the colonization of the mouse spleen (Guinane et al. 
2006). Depletion of these PBPs resulted in variable degrees of morphological 
defects (Guinane et al. 2006, Korsak et al. 2010), and the pleiotropic effects 
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elicited by such modifications are likely to be responsible for the attenuated 
virulence. 
 
B.1.1.2. Peptidoglycan turnover 
 
Peptidoglycan renovation relies on the activity of autolysins, another family of 
surface-associated enzymes that catalyze the hydrolysis of every existing covalent 
bond in the mature peptidoglycan matrix. The nature and location of the bond(s) 
cleaved by an autolysin is determined by its functional specificity within the 
broader family of peptidoglycan hydrolases (Vollmer et al. 2008b). N-
acetylglucosaminidases (NAGases) and N-acetylmuramidases (NAMases) cleave 
the glycan strand β(1,4) bond after GlcNAc and MurNAc, respectively. N-
acetylmuramyl-L-alanine amidases (or simply amidases) separate the stem 
peptide from the glycan chain by breaking the bond between MurNAc and L-Ala. 
Finally, endopeptidases and carboxypeptidases hydrolyze the amide bonds within 
and between stem peptides (Vollmer et al. 2008b) (Fig. 7). The existence of 
multiple autolysins sharing the same activity and substrate attests for the 
functional redundancy associated with peptidoglycan hydrolases, a situation that 
has complicated the characterization of their individual role. 
The genome of Lm strain EGD-e is predicted to encode six NAGases, four 
NAMases, four amidases, and a multiplicity of peptidoglycan peptidases, but only 
a few have been experimentally validated (Popowska 2004, Bierne and Cossart 
2007, Pinto et al. 2013). The only predicted NAGases with confirmed 
peptidoglycan hydrolase activity are MurA and Auto, although their substrate 
specificity remains to be verified (Carroll et al. 2003, Cabanes et al. 2004). MurA is 
necessary for proper cell separation during growth and its absence or dysfunction 
results in virulence defects, namely in adhesion to host cells (Lenz et al. 2003, 
Alonzo et al. 2011). Auto is important for entry into non-phagocytic cells and 
virulence in mice and guinea pigs (Cabanes et al. 2004). The contribution of both 
autolysins towards Lm virulence possibly takes place through different 
mechanisms. This is suggested by their distinct cell wall association domains 
(MurA contains LysM repeats, Auto has GW modules; discussed below), which 
hint at a differential cell wall localization, and by their relative importance for cell 
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wall remodeling, since murA mutant cells cannot separate properly and grow in 
filaments, while aut mutants maintain a normal morphology (Carroll et al. 2003, 
Cabanes et al. 2004). Two putative Lm amidases contain C-terminal GW module 
repeats, suggesting similar surface association requirements; among them is the 
autolysin and virulence-promoting adhesin Ami (Milohanic et al. 2001).  
Although none of the NAMases have been characterized in a virulence-
oriented perspective, two were recently shown to possess lysozyme-like activity in 
the presence of cell wall substrate and to be required for stimulating the replication 
of quiescent bacteria, possibly through their impact in cell wall reshaping and thus 
in cell growth and division (Pinto et al. 2013). Nonetheless, IspC, a NAMase-like 
protein with a significant contribution to Lm infection, was identified in a serotype 
4b strain (Wang and Lin 2007, 2008). Interestingly, IspC mutants were not affected 
in their growth in vitro and cell morphology, but showed cell type-dependent 
defects in nearly every step of the cellular infection cycle (Wang and Lin 2008). 
The presence of an NlpC/p60 domain, related to the CHAP (cysteine, 
histidine-dependent amidohydrolase/peptidase) superfamily is common to many 
 
Fig. 7. Lm peptidoglycan metabolism and the surface proteins involved in its assembly and turnover. 
The peptidoglycan sacculus is polymerized from cytoplasmic precursors with the help of penicillin-binding 
proteins (PBPs, yellow). High-molecular-weight PBPs, such as PBPA2, contain transglycosylase (TGD) and 
transpeptidase domains (TPD) that catalyze, respectively, glycan chain elongation and stem peptide bridging 
between adjacent chains. Other PBPs include the low-molecular-mass carboxypeptidases, which cleave the 
terminal D-alanyl-D-alanine stem peptide bond (e.g. PBPD1), and beta-lactamases, which degrade PBP-
inhibiting antibiotics to promote bacterial survival (e.g. PBPC1). On the other hand, the degradation of mature 
peptidoglycan, during bacterial elongation/division or autolysis, is mediated by autolysins (green), a family of 
surface hydrolases that can cleave the peptidoglycan at different sites: within the glycan chain (N-
acetylglucosaminidases or N-acetylmuramidases) or the stem peptide (endo- and carboxypeptidases), or 
between both (N-acetylmuramoyl-L-alanine amidases). Interestingly, autolysins commonly associate non-
covalently with the bacterial surface via cell wall-binding repeats, such as the GW modules in Ami, Auto and 
IspC, or the LysM repeats in MurA and p60. (Reproduced from Carvalho et al. 2014) 
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peptidoglycan hydrolases. Interestingly, most NlpC/p60 proteins are found in 
Bacillus and Listeria, but not in Staphylococcaceae, which express proteins with 
another CHAP-type domain (Bateman and Rawlings 2003, Layec et al. 2008). This 
is most likely a reflection of the affinity of the NlpC/p60 domain for the γ-D-Glu-
mDpm bond (Rigden et al. 2003), which is replaced by a γ-D-Glu-L-Lys linkage in 
staphylococci. Four Lm EGD-e proteins contain putative NlpC/p60 domains and 
were predicted to possess cell wall hydrolase activity (Bierne and Cossart 2007). 
Two of them, p45 (or Spl) and p60 (also CwhA or Iap), have been studied and 
their function validated. Spontaneous mutants secreting lower amounts of p60 
showed a filamentous morphology and reduced host cell invasion efficiency, 
suggesting that p60 is required for entry into non-phagocytic cells. Indeed, 
exogenously added p60 not only restored Lm invasiveness (Kuhn and Goebel 
1989), but also disrupted bacterial chains into individual cells, due to its cell wall-
degrading activity (Wuenscher et al. 1993). Lack of functional p60 results in 
septum abnormalities that disrupt actin-based intracellular motility, impairing 
optimal cell-to-cell spread and, overall, virulence (Hess et al. 1996, Pilgrim et al. 
2003, Faith et al. 2007). 
 
B.2. Surface proteins and anchoring mechanisms 
 
Proteins located at the bacterial cell surface carry out important and often 
vital functions, which – as described before – can be related with the interaction of 
the bacterium with its surrounding environment or with physiological events 
associated with cell surface maintenance or remodeling (e.g. growth/division). The 
correct localization of these proteins at the cell surface is therefore a requisite for 
proper activity.  
In Lm and other Gram-positive bacteria, the cell wall is a preponderant 
component of the cell envelope and provides the main structural framework for 
protein anchoring (Navarre and Schneewind 1999). Protein-cell wall association 
can be established in two ways (Fig. 8): (i) stable covalent bonding between the 
peptidoglycan matrix and particular protein sorting motif sequences (LPXTG and 
NXXTX proteins), or (ii) labile, non-covalent interaction between cell wall 
components and cell wall-recognizing protein domains (LysM and GW proteins). 
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The cytoplasmic membrane also serves as a docking site for surface proteins, 
either directly through membrane-spanning domains (membrane proteins) or 
indirectly via a lipid anchor molecule (i.e. lipoproteins) (Fig. 8) (Cabanes et al. 
2002, Desvaux et al. 2006). 
 
B.2.1. Cell wall-associated proteins 
 
B.2.1.1. LPXTG and NXXTX proteins 
 
The precursors of proteins covalently anchored to the Gram-positive cell wall 
feature a C-terminal sorting signal sequence of about 30–40 residues comprising 
(i) an LPXTG pentapeptide motif (where X is any amino acid), followed by (ii) a 
hydrophobic domain, and (iii) a short positively charged tail (Schneewind et al. 
1992). Whereas the hydrophobic and charged domains of the sorting signal can 
display variability in their sequence and/or length, the LPXTG motif is much 
conserved (Fischetti et al. 1990, Schneewind et al. 1992). Studies with C-terminal 
truncates of the staphylococcal protein A revealed that proper cell wall anchoring 
requires a complete sorting signal, and hinted that the hydrophobic and charged 
residues downstream of the LPXTG motif are responsible for retaining the 
polypeptide in the bacterial membrane until its recognition by a surface 
transpeptidase enzyme called sortase (Schneewind et al. 1992, Schneewind et al. 
1993). The LPXTG motif is accommodated within the sortase active site, where a 
catalytic cysteine initiates cleavage of the peptide bond between the threonine and 
the glycine residues. The cleaved protein becomes temporarily bound to the 
sortase (Ton-That et al. 1999), which prevents its diffusion to the extracellular 
medium. The protein is then transferred to its final acceptor, lipid II (a membrane 
lipid-bound peptidoglycan precursor), where a new bond is formed between the 
free amine group of the stem peptide diamino acid residue (mDpm in Lm) and the 
C-terminal threonine carboxyl group (Fig. 8) (Ton-That et al. 1997). 
Proteins with LPXTG motifs are found in a multiplicity of Gram-positive 
organisms (Navarre and Schneewind 1999, Mazmanian et al. 2001, Hendrickx et 
al. 2009, Pérez-Dorado et al. 2012). However, Lm stands out as the species with 
the largest number, encoding 41 proteins (over 1% of its genome) (Glaser et al. 
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2001, Cabanes et al. 2002), seven of which are currently described as virulence 
factors (Table 2). InlA, important for entry into epithelial cells and virulence in mice 
(Gaillard et al. 1991, Lingnau et al. 1995), was the first to be identified, long before 
the Lm genome was sequenced. The list comprises four other internalin family 
members (Bierne et al. 2007) – InlF (Kirchner and Higgins 2008), InlH (Pucciarelli 
et al. 2005, Personnic et al. 2010), InlJ (Sabet et al. 2005, Sabet et al. 2008), and 
InlK (Dortet et al. 2011) – with roles in host cell adhesion and immune evasion, 
and two non-internalins – Vip (Cabanes et al. 2005) and LapB (Reis et al. 2010) – 
important for entry into cells.  
A subset of covalently attached cell wall proteins feature a sorting signal 
different from that found in LPXTG proteins. This alternative signal is characterized 
by an NXXTX consensus sequence that targets surface protein precursors for 
processing by a second sortase, called sortase B to distinguish from the LPXTG-
specific sortase or sortase A (Fig. 8) (Comfort and Clubb 2004, Mariscotti et al. 
 
Fig. 8. Schematic representation of the main classes of surface proteins found in Lm. Proteins 
covalently associated to the peptidoglycan are processed by membrane transpeptidase enzymes called 
sortases, which recognize and cleave specific C-terminal sorting signal sequences (LPXTG or NXXTX) to 
append the mature protein to mDpm residues in the peptidoglycan. All other proteins associate with the 
bacterial cell surface through non-covalent interactions that take place between cell wall-binding repeat 
domains (e.g. GW and LysM repeats) and cell envelope components (e.g. LTAs), or through protein tethering 
to the cytoplasmic membrane by means of N-terminally linked phospholipid anchors (lipoproteins) or short N- 
or C-terminal transmembrane regions rich in hydrophobic residues. 
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2009). Sortase B enzymes have fewer substrates, which are usually encoded by 
genes arranged in an operon together with the sortase B gene, srtB (Marraffini et 
al. 2006). Interestingly, they are involved in heme-iron scavenging and uptake 
(Mazmanian et al. 2002, Maresso and Schneewind 2006, Xiao et al. 2011, Klebba 
et al. 2012), indicating that the sortase B-mediated anchoring mechanism may 
have evolved differently from sortase A to become more specialized in the 
anchoring of proteins required for iron homeostasis.  
Lm encodes only two proteins with NXXTX motifs (Table 2) (Bierne et al. 
2004), both of which require sortase B for cell wall anchoring (Pucciarelli et al. 
2005). One of them, SvpA (surface virulence protein A), is a surface-associated 
protein required for iron acquisition and persistence in mouse organs (Newton et 
al. 2005). The other, Lmo2186, possesses two putative sorting motifs, 
NKVTN and NPKSS (underlined residue is common to both), but only the latter is 
necessary for surface anchoring (Mariscotti et al. 2009). SvpA was first 
characterized as a virulence factor, as its absence resulted in deficient escape 
from macrophage phagosomes (Borezée et al. 2001). However, more recent data 
indicated that neither SvpA nor Lmo2186 are essential to promote infection 
(Newton et al. 2005), agreeing with results demonstrating that sortase B is 
dispensable for virulence (Bierne et al. 2004). Instead, they are implicated in heme 
scavenging under conditions of low iron availability, and are currently designated 
heme-binding proteins (Hbp) 2 and 1, respectively (Xiao et al. 2011). 
 
Table 2. Examples of LPXTG and NXXTX proteins in Lm. 
Protein Gene Size (aa) Function References 
LPXTG proteins 
InlA lmo0433 800 Host cell invasion  Gaillard et al. 1991;  
Lingnau et al. 1995 
InlF lmo0409 821 Host cell adhesion and invasion  Kirchner and Higgins 2008 
InlH lmo0263 548 Modulation of host inflammatory 
response (IL-6 production) 
Personnic et al. 2010 
InlJ lmo2821 851 Host cell adhesion (in vivo) Sabet et al. 2008 
InlK lmo1290 598 Autophagy evasion Dortet et al. 2011 
LapB lmo1666 1711 Host cell adhesion and invasion Reis et al. 2010 
Vip lmo0320 399 Host cell invasion Cabanes et al. 2005 
NXXTX proteins 
SvpA/Hbp2 lmo2185 569 Heme acquisition Xiao et al. 2011 
Hbp1 lmo2186 207 Heme acquisition Xiao et al. 2011 
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B.2.1.2. LysM proteins 
 
Lysin motif (LysM) domains are encountered in proteins from a broad variety 
of organisms, such as plants, fungi, bacteria, and viruses (Buist et al. 2008). 
Initially found in bacterial and phage lysins, from which the motif took its name 
(Birkeland 1994), the LysM domain is characterized by a variable number of 
roughly 40–80-residue repeats, spaced by stretches rich in serine, threonine, and 
asparagine (Buist et al. 1995). Their presence in proteins with cell wall-degrading 
activity suggested that LysM repeats are important for retention of these enzymes 
in the peptidoglycan (Fig. 8) (Joris et al. 1992, Birkeland 1994). This hypothesis 
was validated through binding studies using the LysM domains of Lactococcus 
lactis and Enterococcus faecalis autolysins (Steen et al. 2003, Eckert et al. 2006). 
Further studies singled out GlcNAc as the peptidoglycan moiety bound by LysM 
(Buist et al. 2008). However, instead of an expected uniform surface distribution, 
many LysM-containing proteins appear localized to specific sites by the excluding 
action of cell wall components, such as lipoteichoic acids (Steen et al. 2003), or 
peptidoglycan modifications, such as O-acetylation (Veiga et al. 2007).  
LysM domains are found in six Lm proteins (Bierne and Cossart 2007), 
among which are the p60 and MurA autolysins (Table 3) (Lenz et al. 2003). The N-
terminal region of p60 contains two LysMs separated by a Src homology 3 (SH3)-
like domain (Bierne and Cossart 2007), which presumably mediate binding to 
specific peptidoglycan sites important for p60 activity. In contrast, MurA contains 
four LysM repeats near its C-terminus (Carroll et al. 2003), which may be 
important to position the MurA catalytic site in a manner distinct of p60 to optimize 
its activity. A third LysM protein (Lmo2522) was recently characterized in Lm as 
one of two novel listerial resuscitation-promoting factors, i.e. muralytic enzymes 
important for jump-starting the growth of dormant bacteria (Pinto et al. 2013). 
 
B.2.1.3. GW proteins 
 
Many surface proteins interact non-covalently with the cell wall through a 
domain containing a variable number of tandemly arranged repeat sequences, 
called GW modules (Fig. 8). First discovered in the Lm invasion protein InlB 
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(Braun et al. 1997), its name derives from the presence of a conserved glycine 
(G)-tryptophan (W) dipeptide. InlB contains three GW modules in its C-terminal 
cell wall association domain that are required and sufficient to confer cell wall-
binding properties to the protein (Braun et al. 1997). InlB variants lacking this 
domain are unable to associate to the surface of non-invasive Listeria and 
promote their entry into eukaryotic cells (Braun et al. 1998). Structural analysis of 
the GW module revealed an interesting resemblance with SH3 domains, known to 
be involved in protein-protein interaction in signal transduction pathways (Kaneko 
et al. 2008). However, steric hindrance issues discarded a functional SH3-like 
activity for GW modules (Marino et al. 2002).  
The binding strength of proteins containing GW modules is proportional to 
the number of modules. This is illustrated by comparing the surface association 
levels of InlB and Ami, another GW protein with autolytic activity and an important 
role in bacterial adhesion to host cells (Milohanic et al. 2000, Milohanic et al. 2001, 
Asano et al. 2012). Containing eight GW modules, Ami is found exclusively in 
association with the bacterial surface, whereas InlB (only three modules) is 
detected in both cell envelope and in secreted protein fractions (Braun et al. 
1997). Lm encodes seven other GW proteins (Table 3), all of which have a 
Table 3. LysM and GW proteins in Lm. 
Protein Gene Size (aa) Function References 
LysM proteins 
MurA/NamA lmo2691 590 Autolysin (NAGase) Carroll et al. 2003 
p60/Iap lmo0582 482 Autolysin (endopeptidase) Kuhn and Goebel 1989; 
Wuenscher et al. 1993 
Lmo2522 lmo2522 277 Autolysin (putative NAMase) Pinto et al. 2013 
Lmo0880 lmo0880 462 Unknown  
Lmo1303 lmo1303 109 Unknown  
Lmo1941 lmo1941 239 Unknown  
GW proteins 
InlB lmo0434 630 Host cell invasion Braun et al. 1997 
Ami lmo2558 917 Autolysin (MurNAc-L-Ala amidase) Milohanic et al. 2000; 
Milohanic et al. 2001 
Auto lmo1076 572 Autolysin (NAGase) Cabanes et al. 2004 
Lmo1215 lmo1215 289 Autolysin (NAGase)
a
 Bierne and Cossart 2007 
Lmo1216 lmo1216 328 Autolysin (NAGase)
a
 Bierne and Cossart 2007 
Lmo1521 lmo1521 427 Autolysin (MurNAc-L-Ala amidase)
a
 Bierne and Cossart 2007 
Lmo2203 lmo2203 375 Autolysin (NAGase)
a
 Bierne and Cossart 2007 
Lmo2591 lmo2591 508 Autolysin (NAGase)
a
 Bierne and Cossart 2007 
Lmo2713 lmo2713 312 Unknown Bierne and Cossart 2007 
a) Bioinformatic prediction from conserved domains 
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predicted amidase domain in common with Ami (Cabanes et al. 2002), hinting that 
they also may possess autolytic functions. Indeed, one of them, Auto, was 
described to also function as an autolysin (Cabanes et al. 2004). Staphylococcal 
autolysins are also associated to the bacterial surface by structural motifs 
resembling listerial GW modules (Oshida et al. 1995, Heilmann et al. 1997, Hell et 
al. 1998, Allignet et al. 2001), strongly suggesting that this cell wall association 
protein motif has evolved with the purpose of mediating the reversible surface 
binding of proteins with autolytic activity (Milohanic et al. 2001). 
Lipoteichoic acids (LTAs) were identified as the InlB surface anchor, binding 
to its cell wall association domain. The interaction with these cell envelope 
glycopolymers is highly specific, as LTAs from L. innocua or S. pneumoniae are 
not able to capture InlB (Jonquières et al. 1999). The cell wall association domain 
of InlB also mediates its interaction with GAGs present at the surface of host cells 
and with gC1qR, significantly potentiating InlB-mediated invasion (Braun et al. 
2000, Jonquières et al. 2001, Banerjee et al. 2004, Asano et al. 2012). 
 
B.2.2. Membrane-associated proteins 
 
B.2.2.1. Lipoproteins 
 
Bacterial lipoproteins contribute to important physiological roles, such as 
substrate binding and transport, antibiotic resistance, signaling, and protein folding 
(Sutcliffe and Russell 1995, Hutchings et al. 2009). They were also shown to take 
an active part in virulence-associated processes, such as adhesion, invasion, and 
immunomodulation (Kovacs-Simon et al. 2011, Nakayama et al. 2012).  
Lipoproteins are expressed as immature polypeptides, which are converted 
to prolipoproteins by the addition of a lipid moiety at a specific motif in the distal 
portion of the N-terminal signal peptide. This motif, called lipobox, is characterized 
by a four-residue sequence containing a conserved cysteine (Sutcliffe and 
Harrington 2002, Babu et al. 2006). The sulfhydryl group of the cysteine 
establishes a thioester bond with phospholipid-derived diacylglycerol, in a reaction 
catalyzed by the Lgt transferase (Kovacs-Simon et al. 2011). The N-terminal lipid 
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anchor inserts into the outer leaflet of the bacterial cytoplasmic membrane (Fig. 8), 
enabling the surface retention of the protein upon signal peptide cleavage.  
In Lm, the biological importance of lipoproteins is emphasized by their 
preponderance in the surface proteome: 68 of 133 surface proteins were predicted 
to be lipoproteins, based on the presence of an N-terminal lipobox (Glaser et al. 
2001), and 26 were later confirmed experimentally (Baumgärtner et al. 2007). 
Interestingly, nearly half of listerial lipoproteins are presumed to act as substrate-
binding components of ABC transporter systems (Bierne and Cossart 2007), 
performing the equivalent functions of periplasmic solute-binding proteins in Gram-
negative bacteria (Tam and Saier 1993). This is the case of lipoproteins OppA, 
which participates in oligopeptide uptake, and LpeA, which belongs to the LraI 
family of manganese-importing ABC transporter components (Novak et al. 1998), 
although supporting evidence for this function in L. monocytogenes have yet to be 
obtained. Another substrate-carrying lipoprotein, OpuC, operates in the transport 
of L-carnitine, important for Lm osmotolerance and persistence in mice organs 
(Sleator et al. 2001). Fifteen other Lm lipoproteins were predicted to perform 
enzymatic roles (Bierne and Cossart 2007). Among them, the best studied and 
with a significant contribution to infection is the surface chaperone PrsA2 
(Chatterjee et al. 2006, Alonzo et al. 2009, Zemansky et al. 2009, Forster et al. 
2011). 
 
B.2.2.2. Hydrophobic tail proteins 
 
Surface proteins can be associated with the bacterial cytoplasmic membrane 
through an N- or C-terminal tail region comprised of hydrophobic amino acid 
residues that spans and stably inserts the protein in the lipid bilayer, during 
translocation (Fig. 8). The orientation of the proteins in the membrane is pre-
determined by the presence and localization of positively charged residues relative 
to the membrane-spanning domain (stop-transfer signals) (Dalbey et al. 2011).  
From the ten predicted Lm surface proteins with a putative C-terminal 
hydrophobic tail (Bierne and Cossart 2007), only ActA has been biochemical and 
functionally characterized (Domann et al. 1992, Kocks et al. 1992). A large number 
of listerial enzymes linked with cell wall metabolism and surface protein processing 
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– e.g. sortases (Mazmanian et al. 2000), signal peptidases (Paetzel et al. 2000) 
and PBPs – are anchored to the bacterial membrane by an N-terminal 
hydrophobic tail (Bierne and Cossart 2007), which in many cases corresponds to a 
signal peptide sequence lacking a cleavage site recognized by a signal peptidase. 
 
B.2.3. Proteins with unknown association mechanism 
 
Several proteins secreted by Lm lack any recognizable surface-targeting 
sequences. Moreover, a part of these proteins is associated with the cell envelope 
despite having no predicted surface-binding domains (Schaumburg et al. 2004, 
Trost et al. 2005). Consistent and, in some cases, significant secretion of the same 
proteins in different studies seems to discard or at least minimize the contribution 
of bacterial cell lysis to their extracytoplasmic localization. In turn, it suggests that 
they use a non-classical type of secretion mechanism (Schaumburg et al. 2004). 
So far, FbpA is the only known example of an unconventionally secreted and 
surface-associated protein with a described virulence-promoting function. Like 
many streptococcal fibronectin-binding proteins, FbpA lacks all the classical cell 
surface sorting and anchoring sequences. However, the protein was still detected 
in the Lm cytoplasmic membrane after subcellular fractionation. FbpA was found 
to facilitate adhesion to hepatocytes in vitro and to support liver infection in mice 
(Dramsi et al. 2004). 
 
B.3. Teichoic acids 
 
In addition to surface proteins, the Gram-positive peptidoglycan is densely 
decorated with different families of secondary glycopolymers, which include 
teichoic acids, teichuronic acids, and S-layer protein-associated glycans 
(Weidenmaier and Peschel 2008). From these, only teichoic acids are synthesized 
in Listeria, where they make up to 60% of the dry cell wall mass (Fiedler et al. 
1984). 
First discovered in 1958 by Baddiley and colleagues (Armstrong et al. 1958), 
teichoic acids (TAs; from the Greek teichos, i.e. “wall”) are described as a broad 
family of surface glycopolymers constituted by phosphodiester-linked polyol 
 
CHAPTER I – INTRODUCTION 
 
 
 50 
subunits that can also contain glycosyl or D-alanyl ester groups (Baddiley 1970, 
Ward 1981). The abundance of phosphate groups confers strong anionic 
properties to TAs, which contribute to the net negative charge of the bacterial 
surface. This electrostatic status is fundamental for cell envelope-related 
processes, such as cationic homeostasis (required for optimal activity of surface 
proteins) and trafficking of nutrients, proteins and antibiotics (Neuhaus and 
Baddiley 2003). Moreover, the presence of TAs at the Gram-positive cell surface is 
also important for the targeting and anchoring of surface proteins (e.g. autolysins), 
with impact in cell growth and division; for providing protection against 
antimicrobial compounds, and for host-pathogen interactions (Weidenmaier and 
Peschel 2008). 
Depending on their type of linkage to the cell surface, TAs are distributed into 
two groups: lipoteichoic acids (LTAs) and wall teichoic acids (WTAs). 
 
B.3.1. Lipoteichoic acids (LTAs) 
 
B.3.1.1. LTA structure and biogenesis 
 
LTAs comprise a structurally diverse group of TAs (Neuhaus and Baddiley 
2003) that are attached to the outer leaflet of the bacterial membrane through a 
glycolipid anchor, which consists of a sugar moiety (di- or oligosaccharide) linked 
to diacylglycerol (DAG) (Fischer et al. 1990). In representative Firmicutes species 
like B. subtilis, S. aureus and Lm, the LTA backbone comprises a linear chain of 
1,3-linked glycerol 1-phosphate (GroP) repeats that are variably substituted with D-
alanyl and/or glycosyl residues at the C2 hydroxyl group (Fig. 9A) (Fischer et al. 
1990). Multiple analytical studies on the LTA composition have indicated an 
average chain length of 17–27 GroP units (Hether and Jackson 1983, Uchikawa et 
al. 1986b, Fischer 1994). Whereas these bacteria share the same LTA backbone 
composition, their glycolipid anchors show variation in the sugar moiety: glucose-
glucose (Glc-Glc)-DAG (B. subtilis and S. aureus) or galactose-glucose (Gal-Glc)-
DAG (Lm, Fig. 9A) (Uchikawa et al. 1986b, Jorasch et al. 2000, Kiriukhin et al. 
2001). The anchor is synthesized in the cytoplasmic side of the bacterial 
membrane and translocated to the extracellular side to accept GroP subunits 
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derived enzymatically from outer leaflet membrane phospholipids for 
polymerization of the LTA backbone (Reichmann and Gründling 2011). In contrast 
to S. aureus and B. subtilis, which use respectively one and up to four enzymes to 
synthesize the LTA backbone (Reichmann and Gründling 2011), Lm requires two 
enzymes: one (LtaP) to prime the anchor with the first GroP molecule, and the 
other (LtaS) to extend the chain with further GroP subunits (Fig. 9B). Only LtaS is 
essential for LTA synthesis, and its depletion results in temperature-sensitive 
growth and defects in cell shape and septal division (Webb et al. 2009).  
 
B.3.1.2. LTA modifications and functions 
 
Modifications of the LTA backbone, such the addition of D-alanine or glycosyl 
groups, are carried out outside the cell by enzymatic complexes that translocate 
the cytoplasmic substrates across the membrane and append them to the LTA 
chain (Percy and Gründling 2014).  
LTA D-alanylation is catalyzed by the products of the dltABCD operon 
(Perego et al. 1995, Neuhaus and Baddiley 2003, Reichmann et al. 2013), and the 
resulting D-alanyl ester linkage is highly sensitive to changes in temperature, pH 
and salt concentration (Hurst et al. 1975, Fischer and Rosel 1980, Macarthur and 
Archibald 1984). Mutational studies in different bacteria have highlighted the 
importance of this LTA modification in physiological functions, such as regulation 
of autolysis (Steen et al. 2005, Fedtke et al. 2007) and cation homeostasis 
(Archibald et al. 1973). Importantly, it also plays an essential role in bacterial 
pathogenesis, as demonstrated by the reduced host cell adhesion and virulence 
levels of dltA mutants of Lm (Abachin et al. 2002). Interestingly, the increased 
adhesion of dltA mutants of Enterococcus faecalis to uroepithelial cells suggests 
that the contribution of this LTA modification towards infection is cell type-
dependent (Wobser et al. 2014). In addition, D-alanylation of LTAs was also shown 
to provide significant protection against cationic antimicrobial peptides (CAMPs) 
(Abachin et al. 2002). This protective mechanism is based on the reduction of the 
cell envelope net negative charge by the addition of positively charged D-alanyl 
groups, thus decreasing CAMP affinity for the bacterial surface (Peschel et al. 
1999).  
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The mechanism and role of LTA glycosylation are still poorly understood 
topics. What is known so far is that the occurrence, degree and type of glycosyl 
residues used in this modification can vary between species and even between 
strains (Iwasaki et al. 1986, Iwasaki et al. 1989). Interestingly, Listeria strains were 
found so far to be only glycosylated with Gal (Hether and Jackson 1983, Uchikawa 
et al. 1986b). Although the enzymatic players have not yet been identified, it is 
hypothesized that cytoplasmic nucleotide-activated sugars are captured by a 
glycosyltransferase, which transfers the sugar moiety to a membrane lipid anchor; 
this sugar-lipid complex is translocated across the membrane and recognized by a 
second glycosyltransferase, which picks up the sugar and links it to the LTA 
backbone (Percy and Gründling 2014). 
 
Fig. 9. Structure and biosynthesis pathway of Lm LTAs. (A) LTA polymers are composed of a 
poly(glycerol-phosphate) backbone chain (pink) that is attached to the cytoplasmic membrane via a glycolipid 
anchor consisting of a Gal-Glc disaccharide (blue) linked to a phospholipid-derived diacylglycerol molecule 
(yellow). The backbone subunits can be substituted with D-Ala or Gal. (B) LTA biosynthesis starts with the 
glycolipid anchor assembly on the inner leaflet of the cytoplasmic membrane by the concerted action of LafA 
and LafB. The anchor is then translocated to the extracellular side (presumably by the LafC transmembrane 
protein), where a phospholipid-derived GroP molecule is transferred to the disaccharide by LtaP. Additional 
GroP units are introduced by a second protein, LtaS, which is essential for LTA biogenesis. UDP, uridine 
diphosphate. (Adapted from Reichmann and Grundling 2011) 
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Numerous evidences of morphological and septal formation phenotypes 
associated with LTA mutants have implied the participation of these surface 
glycopolymers in cell growth/division-related processes. A recent study in S. 
aureus confirmed this by demonstrating a direct interaction between the LTA 
biosynthesis and cell division protein machineries (Reichmann et al. 2014). LTAs 
have also potent immunostimulatory properties (Morath et al. 2001). They are 
known to interact with and activate Toll-like receptor (TLR) 2, for which only the 
glycolipid anchor and a few backbone subunits are required (Deininger et al. 
2003). This activation was shown to be stronger in the presence of D-alanylated 
subunits (Deininger et al. 2007). In addition, LTAs are specifically recognized by 
innate immunity lectin-like proteins such as L-ficolin, one of components of the 
lectin pathway of complement system activation (Lynch et al. 2004), and surfactant 
protein D, an innate immunity mediator in the lung (van de Wetering et al. 2001). 
 
B.3.2. Wall teichoic acids (WTAs) 
 
B.3.2.1. WTA structure and biogenesis 
 
WTAs are covalently anchored to the cell wall, where they make up as much 
as 60% of its carbohydrate composition (Baddiley 1972, Neuhaus and Baddiley 
2003). They are attached to the peptidoglycan by a linkage unit that contains a 
conserved GroP-N-acetylmannosamine (ManNAc)-β(1,4)-GlcNAc triad linked by a 
phosphodiester bond to the C6 hydroxyl group of MurNAc residues  (Araki and Ito 
1989). In Lm, the first WTA backbone subunit is connected to the conserved 
linkage unit via a Glc-Glc bridge, which is thought to further distance the main 
chain from the peptidoglycan (Fig. 10A) (Kaya et al. 1985).  
WTAs are biochemical and structurally heterogeneous polymeric complexes, 
a diversity that is mainly observed in the type of backbone monomers and glycosyl 
substituent groups (Naumova et al. 2001). The most common WTA backbone 
(type I) comprises a linear chain of phosphodiester-linked repeats of either glycerol 
3-phosphate (GroP) or ribitol 5-phosphate (RboP) (Brown et al. 2013), although 
other polyols can also be found (Naumova et al. 2001). Backbone length can 
surpass 40 units, which depending on the attachment point in the cell wall may 
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Fig. 10. Structure of Lm WTAs and representative biosynthesis pathway from S. aureus. (A) Lm WTA 
polymers are composed of a poly(ribitol-phosphate) backbone chain (pink) that is attached to the 
peptidoglycan matrix (MurNAc residues) via a unique linkage unit (blue). The backbone subunits are 
substituted with GlcNAc and L-rhamnosyl (L-Rha) groups. (B) The WTA biosynthetic pathway in Lm has not 
been specifically addressed and characterized in detail, but it is assumed closely similar to that of S. aureus, 
which also produces RboP-type WTAs. The WTA polymer is sequentially assembled by the Tar enzymes 
onto a bactoprenol-phosphate anchor on the inner leaflet of the cytoplasmic membrane. Backbone 
substitution with glycosyl groups also takes place in the cytoplasm before the lipid-anchored polymer is 
translocated across the membrane by the TarGH complex. Outside, a set of WTA ligases (LCPs in S. aureus) 
cleave the polymer from its lipid anchor and mediate its attachment to the peptidoglycan matrix. (Adapted 
from Swoboda et al. 2010) 
 
 
allow WTAs to extend beyond the cell envelope surface (Umeda et al. 1992). 
Studies have shown that while some species can only produce WTAs with a single 
type of polyol (e.g. RboP in S. aureus and Lm), others are able to use different 
types (e.g. B. subtilis: strain 168, GroP; strain W2, RboP) (Baddiley et al. 1961, 
Kamisango et al. 1983, Iwasaki et al. 1986).  
Although structurally similar, WTAs have a biosynthetic pathway completely 
distinct from that of LTAs (Ward 1981) and which has been best characterized in 
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B. subtilis and S. aureus. The WTA polymer is synthesized at the inner leaflet of 
the cytoplasmic membrane, on top of undecaprenyl-phosphate (C55-P, also called 
bactoprenol-phosphate), a membrane-associated lipid anchor that is also recruited 
by the peptidoglycan biosynthesis machinery (van Heijenoort 1998). The linkage 
unit is the first component to be assembled through a pathway highly conserved 
across Gram-positive bacteria (Fig. 10B). It begins with the transfer of GlcNAc-1-
phosphate from cytoplasmic UDP-GlcNAc to C55-P in a step catalyzed by the 
TagO/TarO enzyme (Soldo et al. 2002). Interestingly, two TagO orthologues with 
redundant activity were recently identified in the Lm genome (Eugster and 
Loessner 2012). Subsequent TagA/TarA-mediated binding of ManNAc to GlcNAc 
commits the lipid-anchored intermediate towards WTA bionsynthesis, and 
TagB/TarB concludes linkage unit synthesis by transfering a GroP molecule from 
CDP-glycerol to ManNAc (Ginsberg et al. 2006). Afterwards, the WTA biosynthetic 
pathways diverge depending on whether the polymer is built with RboP or GroP 
monomers. In each case, the required enzymes are encoded by genes usually 
organized in operons and prefixed with the tar (teichoic acid ribitol) or tag (teichoic 
acid glycerol) designations, respectively (Brown et al. 2013). It is unclear if WTAs 
cross the membrane during or after their polymerization or how their translocation 
through the Ta(g/r)GH complex is processed, but once the polymer is transferred 
to the other side of the membrane, a family of WTA ligases (LCP proteins in S. 
aureus) promotes their attachment to the peptidoglycan (Fig. 10B) (Chan et al. 
2013).  
 
B.3.2.2. WTA modifications and functions 
 
Similarly to LTAs, the backbone of WTAs can be tailored with D-alanyl esters 
and/or glycosyl groups. In the case of Rbo-type WTAs, which have three available 
hydroxyl groups, D-alanine binds to the C2 hydroxyl group, while O-glycosylation 
occurs at position C4 (Neuhaus and Baddiley 2003). Unlike D-alanine residues, 
which are bound to the polymer only after it is translocated to the extracellular 
space (Neuhaus and Baddiley 2003), sugar substitution is performed in the 
bacterial cytoplasm by a variable number and type of glycosyltransferases (Brown 
et al. 2013). As in LTAs, the WTA content in D-alanine is highly dependent of 
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environmental changes (Neuhaus and Baddiley 2003), in stark contrast with the 
stability of the sugar substituents (Collins et al. 2002). A recent study suggesting 
the requirement of LTAs for the D-alanylation of WTAs (Reichmann et al. 2013) 
appears to substantiate a previously proposed model whereby the D-alanyl groups 
of WTAs are donated by LTAs (Haas et al. 1984). However, the mechanism and 
putative enzymes involved in this transfer still need to be addressed.  
A wide variety of glycosyl residues can be found associated to WTA subunits 
as branching substituent groups or even integrated in the main chain (non-type I 
WTAs): Glc, Gal, L-rhamnose (L-Rha), and N-acetylated amino sugars (Naumova 
et al. 2001). Further WTA heterogeneity can arise from the stereochemical nature 
of the glycosidic bond (Nathenson et al. 1966), which can interfere with WTA 
structure and its potential functions and interactions at the cell envelope.  
The structural and biochemical similarities between WTAs and LTAs bring 
about a considerable functional overlap and redundancy that has complicated a 
clear understanding of the exact role of each glycopolymer in different aspects of 
bacterial physiology. As LTAs, WTAs are also intimately related with cell growth 
and division processes, as mutants lacking these polymers present morphological 
defects (Brown et al. 2013). Indeed, co-localization of WTA and peptidoglycan 
biogenetic machineries was observed (Formstone et al. 2008), and evidence 
showing mislocalization of important septal peptidoglycan cross-linking enzymes in 
the absence of WTAs (Atilano et al. 2010, Qamar and Golemi-Kotra 2012) attest 
this functional relationship. In addition, WTA depletion also interferes with cell 
division as it deregulates autolytic activity at the septum, indicating that WTAs are 
essential in regulation of autolysis, either by controlling autolysin localization or 
their activity (Brown et al. 2013). 
Other WTA functions shared with LTAs include the regulation of cationic 
homeostasis in the cell envelope, where WTAs extending beyond the cell wall 
surface can act as cation “scavengers”, capturing these ions from the extracellular 
environment (Kern et al. 2010); protection against antimicrobial molecules (e.g. 
fatty acids, antibiotics and cationic peptides) (Peschel et al. 1999, Peschel et al. 
2000, Collins et al. 2002, Kohler et al. 2009, Brown et al. 2012, Farha et al. 2013); 
and pathogenesis (Collins et al. 2002, Weidenmaier et al. 2004, Kristian et al. 
2005, Weidenmaier et al. 2005, Walter et al. 2007). In most, if not all, backbone 
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modification with D-alanine performs a central role.  
Interestingly, unlike S. aureus, Lm WTAs are not D-alanylated (Fiedler 1988), 
which suggests that functions associated with this modification are performed by 
LTAs and casts even more uncertainty on the actual WTA-specific functions. On 
the other hand, glycosylation was shown to confer immunogenic properties to Lm 
WTAs (Kamisango et al. 1983) and enable the binding of bacteriophages 
(Wendlinger et al. 1996), as previously observed (Juergens et al. 1963, Torii et al. 
1964, Chatterjee et al. 1969). Evidences linking WTA glycosylation with Lm 
pathogenesis were obtained from studies with transposon-generated mutants. 
EGD (serotype 1/2a) mutants were screened in a mouse model for virulence 
attenuation (Autret et al. 2001), and multiple attenuated clones were found to 
contain an insertion in gtcA, a gene coding for a glycosyltransferase responsible 
for the tailoring of serotype 4b and 1/2a WTAs with Gal and GlcNAc, respectively 
(Promadej et al. 1999, Eugster et al. 2011). In another study, the pathogenic 
potential of a serotype 4b gtcA mutant was strongly reduced in intragastrically 
infected mice. Moreover, the absence of GtcA decreased the ability of Lm to 
invade an enterocytic cell line, suggesting that GtcA-mediated WTA glycosylation 
is important for the intestinal phase of listeriosis (Faith et al. 2009). 
 
B.3.2.3. WTA diversity in Listeria monocytogenes 
 
In 1969, Ullmann and Cameron described the immunochemical properties of 
cell wall carbohydrates isolated from several Lm serotypes and their main 
antigenic constituents (Ullmann and Cameron 1969). As TAs began being 
regarded as O antigens, further research from groups in Germany and Japan, 
during the 1980s, led to the characterization of the WTA structure, composition 
and properties from every known Lm serotype (Kamisango et al. 1983, Fiedler et 
al. 1984, Fujii et al. 1985, Uchikawa et al. 1986a). Their extensive work revealed 
the large variety of glycosylation patterns across different serotypes and even 
within serotypes from the same serogroup (Fig. 11). It is this significant WTA 
tailoring diversity that constitutes in part the basis for serotyping classification 
within this species. 
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Fig. 11. WTA backbone subunit composition from different Lm serotypes. WTAs from serogroups 1/2 
(1/2a, 1/2b and 1/2c) and 3 (3a, 3b and 3c), and serotype 7 have a typical poly(RboP) backbone, which can 
be variably substituted with GlcNAc and/or L-Rha, or unsubstituted at all. The backbone subunits of serogroup 
4 (4a, 4b and 4c) WTAs are more complex, as a GlcNAc residue is integrated into the chain, forming a 
poly(RboP-GlcNAc)-type polymer, and substitution with Glc and/or Gal occurs on this sugar instead of RboP.  
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C. ANTIMICROBIAL PEPTIDES 
 
It was known since the late 19th century that many human secretions and 
fluids exhibited antimicrobial properties, which were later associated with particular 
peptides and small proteins present in their composition (Skarnes and Watson 
1957). In the first half of the 20th century, several peptide antibiotics were identified 
and began being isolated from bacteria and fungi for clinical purposes (Perlman 
and Bodanszk.M 1971). In the 1950s, these antimicrobial peptides (AMPs) were 
thought to interact electrostatically with anionic surface components of both Gram-
negative and Gram-positive bacteria, and shown to have the ability to restrict and 
neutralize microbial infections and to boost additional immune response 
mechanisms (Skarnes and Watson 1957). In the following decades, AMPs were 
also identified in plants, insects and vertebrate animals (Cederlund et al. 2011).  
AMPs are produced by a wide variety of organisms across all domains of life, 
from bacteria to humans (Zasloff 2002, Yang et al. 2014), and constitute what is 
probably the oldest branch of immunity effectors. Since the identification of 
lysozyme in 1922, the total number of natural antimicrobial peptides/proteins has 
expanded vastly to over 2,500, according to the March 2015 update of the 
Antimicrobial Peptide Database (http://aps.unmc.edu/AP) (Wang et al. 2009). This 
growth has also been driven by the enormous interest in the potential therapeutic 
applicability of novel AMPs, particularly in the treatment of bacterial pathogens 
with increasing resistance to traditional antibiotics (Hancock and Sahl 2006).  
This section presents the main classes of AMPs, describing their structural 
and biochemical properties, as well as the most common mechanisms of action. In 
addition, strategies developed by bacteria to resist against the activity of AMPs are 
also addressed. 
 
C.1. General features and properties 
 
Despite the source and sequence diversity of the many known natural AMPs 
(Wang et al. 2009), they contain conserved characteristics that are important for 
their antimicrobial activity: size, charge, amphipathicity and structural conformation 
(Brogden 2005, Cederlund et al. 2011).  
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AMPs have an average length of 30 amino acid residues (Wang et al. 2009, 
Cederlund et al. 2011), which corresponds to an average molecular weight of 
<5 kDa. The smallest known AMPs, called gageotetrins, are di- and tetrapeptide 
lipoproteins produced by a marine B. subtilis strain (Tareq et al. 2014). With 99 
and 130 residues, respectively – long enough to be considered small proteins – 
human lysozyme and β2 microglobulin are among the longest polypeptides with 
antimicrobial activity (Wang et al. 2009).  
A prevalence of basic (arginine, histidine and lysine) over acidic (glutamate 
and aspartate) amino acid residues confers an overall positive charge to AMPs 
(+2 to +9; average +3) (Cederlund et al. 2011). This cationic character is important 
for the interaction with surface of bacteria, which has a typical net negative charge 
conferred by anionic components, such as the Gram-negative lipopolysaccharide 
(LPS) or the Gram-positive teichoic acids. Nevertheless, some AMPs can also be 
anionic (Brogden 2005) and, in this case, their interaction with bacterial surfaces 
appears to be mediated by cationic salt bridges (Harris et al. 2009).  
Another feature of AMPs is their hydrophobicity: in average, they contain 40–
50% of hydrophobic residues (Cederlund et al. 2011). These hydrophobic residues 
are usually distributed through the AMP sequence to promote amphipathicity, i.e. 
polar and apolar residues are spatially constricted to different sides of the AMP 
secondary structure. This characteristic is important for solubility in aqueous 
environments and for AMP activity, which requires integration into membrane lipid 
bilayers (Lohner et al. 2001, Brogden 2005, Ramadurai et al. 2010). 
AMPs exist in different structural conformations (Fig. 12): (i) linear α-helices, 
(ii) packed β-sheets, stabilized by internal disulfide bonds; or (iii) extended 
unorganized structures enriched in specific residues (e.g. proline, arginine or 
tryptophan) (Brogden 2005, Wiesner and Vilcinskas 2010). The first two structures 
are the most common in nature (Giuliani et al. 2007, Cederlund et al. 2011).  
Many alpha-helical AMPs are unstructured in aqueous environment and only 
acquire their final conformation upon interaction with target membranes. This 
characteristic appears important to prevent AMP cytotoxicity in eukaryotic cells 
(Nguyen et al. 2011). Bend-inducing residues and/or polar sidechains in the 
hydrophobic face of an alpha-helical AMP create an “imperfect amphipathicity” that 
favors an efficient membrane insertion and disruption (Mihajlovic and Lazaridis 
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2010, Nguyen et al. 2011). Although intramolecular disulfide bonds are a 
characteristic feature in β-sheet AMPs and help to stabilize this secondary 
structure and protect it from proteolytic degradation, they are not essential for 
antimicrobial activity (Kluver et al. 2005, Ramamoorthy et al. 2006). 
In unstructured extended AMPs, the preponderance of specific amino acids 
such as tryptophan and arginine is critical in many aspects. The positive charges 
of arginine attract the peptide towards the anionic bacterial surface, while 
tryptophan residues not only stabilize the peptide in solution via intramolecular 
hydrophobic interactions, but promote a strong association to the interfacial region 
of lipid bilayers (Yau et al. 1998, Chan et al. 2006). Furthermore, an energetically 
favorable stacked interaction between the sidechains of both amino acids allows 
arginine residues to be masked by tryptophan and penetrate the strong apolar 
membrane environment (Yau et al. 1998). Many extended AMPs exert their 
antimicrobial function not at the membrane level but targeting intracellular 
components (e.g. proteins and nucleic acids) (Nguyen et al. 2011). 
 
A B C 
   
LL-37 Human β-defensin-3 Indolicidin 
 
Fig. 12. Main structural conformations of AMPs. (A) Linear α-helices (e.g. LL-37), (B) β-sheets (e.g. 
human β-defensin-3), and (C) extended disordered peptides (e.g. indolicidin). Peptide backbone (ribbon) is 
shown in green, hydrophobic side chains in light blue, polar side chains in red, and disulfide bridges in yellow. 
Notice the bilateral segregation of hydrophobic and polar residues in LL-37 (important for membrane 
integration) and the multiple tryptophan sidechains in indolicidin. (PDB IDs: LL-37, 2K6O; human β-defensin-3, 
1KJ5; indolicidin, 1G89) 
 
 
C.2. Classes 
 
AMPs can be classified based in numerous criteria: biosynthesis pathway, 
biological source, activity, biochemical properties, secondary structure, internal 
bonding profile and cellular targets (Wang et al. 2009).  
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The simplest classification is based on whether AMPs are generated by 
ribosomal translation of gene-encoded transcripts or by a ribosome-independent 
multienzymatic pathway (Wiesner and Vilcinskas 2010). Many bacterial and fungal 
peptide antibiotics (e.g. bacitracin, vancomycin and polymyxin B) are synthesized 
through the latter pathway and often possess unusually configurated and non-
proteinogenic amino acid residues that can be further modified (Hancock and 
Chapple 1999). Ribosomally synthesized AMPs are produced by both bacteria – 
where they take the name of bacteriocins – and eukaryotes. 
 
C.2.1. Bacteriocins 
 
Bacteriocins comprise not only bacterial peptides but also proteins with 
antimicrobial activity, although it is mostly used in reference to the former group 
(Cotter et al. 2005). These are highly heterogeneous molecules that are produced 
in response to environmental stresses, such as nutritional shortage and lack of 
space, to provide a competitive advantage over other microbes. Their variable 
spectra of activity enable producing bacteria to kill within (narrow spectrum) or 
outside (broad spectrum) of their species. Importantly, producers contain 
mechanisms that confer immunity to their own bacteriocins (Cotter et al. 2005). 
A large majority of the currently known bacteriocins are produced by Gram-
positive species, notably Lactobacillales (or lactic acid bacteria, LAB), which 
include various genera such as Lactococcus, Lactobacillus, Enterococcus and 
Streptococcus (Cotter et al. 2005, Hammami et al. 2010). It is not surprising that 
the growth of research in the area of bacteriocins has been fostered by the food 
preservation and clinical industries (Cotter et al. 2005, Cotter et al. 2013, Yang et 
al. 2014). Nonetheless, bacteriocins from Gram-negative bacteria (mainly E. coli) 
and even in Archaea have also been identified and characterized (Hammami et al. 
2010).  
 
C.2.1.1. Gram-negative bacteriocins 
 
Gram-negative bacteriocins are divided into two groups: colicins and 
microcins (Table 4) (Yang et al. 2014). The first group includes large proteins (25–
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80 kDa) generally encoded in a plasmid-borne gene cluster (Cascales et al. 2007). 
Besides the colicin, the cluster encodes a self-immunity protein, required to protect 
the producer cell, and a lysis protein, to enable colicin export (van der Wal et al. 
1995, Cascales et al. 2007). Colicins contain three functional domains: a central 
receptor-binding domain, which recognizes and binds to a target cell surface 
receptor (Ton or Tol system proteins (Cramer et al. 1995)); an N-terminal 
translocation domain, to transport the surface-bound colicin across the OM; and a 
C-terminal catalytic domain that can exhibit (i) peptidoglycan hydrolase, (ii) 
membrane pore-forming or (iii) nuclease activities (Cascales et al. 2007). 
Contrary to colicins, microcins are significantly smaller polypeptides 
(<10 kDa, hence the prefix “micro”) and may present post-translational 
modifications (PTMs), such as adenyl groups, thiazole/oxazole rings and lasso-
type cyclization. They are heat- and pH-stable, resistant to proteolytic digestion 
and exhibit a highly potent activity (nM range) against a small subset or targets 
(Duquesne and Destoumieux-Garzón 2007). Like colicins, they are encoded in 
large gene clusters present in plasmids (and also in the chromosome), and 
expressed as immature precursors (promicrocins) with cleavable N-terminal signal 
peptides. Together with the genes encoding the promicrocin and the self-immunity 
protein(s), further genes coding for an ABC transporter-based export system and 
PTM enzymes are also included (Duquesne and Destoumieux-Garzón 2007). 
Table 4. Examples of Gram-negative bacteriocins.
a
 
Bacteriocin Source MW
b
 Activity 
Colicins    
B Escherichia coli 54,742 Pore formation 
E2 Escherichia coli 61,561 DNase 
E3 Escherichia coli 57,960 16S rRNase 
E5 Escherichia coli 58,254 tRNase 
M Escherichia coli 29,453 Peptidoglycan hydrolase 
Microcins    
Class I (<5 kDa, PTMs) 
B17 Escherichia coli 3,094 DNA gyrase inhibition 
J25 Escherichia coli 2,107 RNA polymerase inhibition 
Class IIa (5–10 kDa, absence of PTMs) 
L Escherichia coli 8,884 Disruption of the inner membrane integrity 
Class IIb (5–10 kDa, linear, potential C-terminal PTMs) 
E492 Escherichia coli, Klebsiella 
pneumoniae 
7,886 Disruption of the inner membrane integrity 
a) Data compiled from: Yang et al. 2014, Duquesne et al. 2007, Morin et al. 2011; Bieler et al. 2006. 
b) Molecular weight (values in Daltons) 
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Microcins are classified into two classes: class I, including low-molecular weight 
peptides (<5 kDa) with extensive PTMs; and class II, comprising heavier peptides 
(5–10 kDa). The latter group is subdivided into classes IIa (no PTMs) and IIb 
(chromosome-encoded linear peptides with potential C-terminal PTMs). 
Functionally, microcins were found to target the cytoplasmic (or inner) membrane 
as well as the intracellular enzymatic complexes required for nucleic acid 
synthesis (Duquesne and Destoumieux-Garzón 2007). 
 
C.2.1.2. Gram-positive bacteriocins 
 
The majority of Gram-positive bacteriocins are biochemically similar to Gram-
negative microcins, in that they are also low-molecular weight (<10 kDa), heat-
stable peptides that may contain PTMs, although not as extreme as the ones 
present in microcins. They are also encoded in a cluster with a self-immunity gene 
and are exported via an ABC transporter system (Duquesne and Destoumieux-
Garzón 2007). 
These Gram-positive AMPs are distributed between two classes (Table 5). 
Historically, a third class encompassed large-sized antimicrobial proteins called 
bacteriolysins (e.g. lysostaphin and enterolysin A) (Schindler and Schuhardt 1964, 
Nilsen et al. 2003), which were similar in structure and activity to colicins. 
However, they are no longer considered bacteriocins and this class was 
constituted as a separate group (Cotter et al. 2005). 
 
Class I (lantibiotics) 
 
Class I bacteriocins consist of small peptides (<5 kDa) featuring PTMs such 
as dehydrated (dehydroalanine and dehydrobutyrine) and/or thiother-containing 
(lanthionine and β-methyllanthionine) amino acids (Islam et al. 2012). The unusual 
lanthionine amino acid – for which members of this class are also called 
lantibiotics (lanthionine-containing antibiotics) – results from a thioether bond 
between the sidechains of cysteine and dehydrated residues. This intramolecular 
link generates the ring or loop structures that are typical of lantibiotics (Fig. 13) 
(Cotter et al. 2005). Depending on the number and location of these lanthionine 
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bridges, lantibiotics can have linear (type A) or globular (tybe B) conformations 
(Jung 1991). While type-A peptides are cationic, type-B are usually neutral or 
anionic (Islam et al. 2012). A third type includes lantibiotics comprised of two 
peptides acting synergistically, an example of which is lacticin 3147 (Fig. 13) 
(Lawton et al. 2007). 
The antimicrobial activity of lantibiotics is exerted through (i) inhibition of cell 
wall biosynthesis and/or (ii) formation of membrane pores (Islam et al. 2012). 
Nisin A, the best known lantibiotic and first bacteriocin to be identified (Rogers and 
Whittier 1928), is a bifunctional type-A peptide that kills Gram-positive bacteria by 
inhibiting peptidoglycan synthesis, through its binding to lipid II, and making pores 
in the membrane (Fig. 14) (Brotz et al. 1998b, Wiedemann et al. 2001). This dual 
role is encoded in its bipartite structure, whereby the binding of the N-terminus end 
of nisin to lipid II pyrophosphate (Hsu et al. 2004) positions the flexible C-terminus 
end for membrane insertion (van Heusden et al. 2002). Mersacidin, a type-B 
lantibiotic is only able to interact with lipid II to disrupt cell wall synthesis (Brotz et 
al. 1998b). Two-peptide lantibiotics seem to have receptor-binding and pore-
forming activities allocated to different peptides (Martin et al. 2004).  
Another lantibiotic receptor is phosphatidylethanolamine (PE), a membrane 
phospholipid. By binding to PE, cinnamycin and duramycins inhibit phospholipase 
A2 activity (Fredenhagen et al. 1990). Interestingly, lantibiotics like the 
enterococcal cytolysin can also act as virulence factors against mammalian cells 
(Van Tyne et al. 2013). 
 
Class II (non-lantibiotics) 
 
The members of this class are also small (<10 kDa) and heat-stable 
peptides, but unlike lantibiotics they do not contain lanthionine residues or other 
complex PTMs (Cotter et al. 2005). They are highly potent AMPs (nM range) that 
function by disrupting the membrane (Nissen-Meyer et al. 2009).  
Four subclasses accommodate class II bacteriocins according to structure 
and sequence similarity (Cotter et al. 2005): (i) class IIa, pediocin-like or Listeria-
active peptides; (ii) class IIb, two-peptide peptides; (iii) class IIc, cyclic peptides; 
and (iv) class IId, linear non-pediocin-like single peptides.  
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Class IIa (pediocin-like). This designation originates from one of the first 
identified members of this subclass (pediocin PA-1), which currently contains over 
20 peptides and is probably the most well-characterized due to their high 
antimicrobial specificity towards Listeria (Eijsink et al. 1998). These peptides range 
between 38 (e.g. leucocin A, mesentericin Y105) and 47 (e.g. carnobacteriocin B2) 
residues and contain an N-terminal region with a highly conserved 
YGNG(V/L)XC(X)4CXV sequence (“pediocin box”) and a less conserved 
hydrophobic C-terminal region (Nissen-Meyer et al. 2009). Structural studies 
revealed that the cationic N-terminal region forms a disulfide bond-stabilized β-
sheet structure that sits at the membrane interface, while the C-terminal domain is 
folded into a hydrophobic hairpin structure (Fregeau Gallagher et al. 1997) that 
buries into the apolar core of the membrane bilayer. The structure and sequence 
variability of the C-terminal hairpin play an important role in determining target cell 
specificity (Johnsen et al. 2005), by recognizing the mannose-specific 
 
Fig. 13. Schematic representation of the structure of the lantibiotics nisin A, gallidermin and lacticin 
3147. These Gram-positive bacteriocins possess characteristic lanthionine residues (red) that are formed 
when a thioether linkage is created between the sulfhydril group of a cysteine and dehydrated residues (blue), 
such as  dehydroalanine (Dha) and dehydrobutyrine (Dhb). When Dha is involved, a lanthionine bridge (Ala-
S-Ala) is formed, whereas a β-methyl-lanthione bond (Abu-S-Ala) is created when Dhb is the acceptor 
residue. Other unusual amino acids (yellow), such as D-alanine (D-Ala) or 2-oxobutyrate (2-ob) might also be 
present. Abu, aminobutyrate. (Adapted from Cotter et al. 2005 and Kellner et al. 1988) 
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phosphotransferase system (Man-PTS) permease (Fig. 14) (Ramnath et al. 2000, 
Dalet et al. 2001, Hechard et al. 2001, Diep et al. 2007), similarly to microcin E492 
(Duquesne and Destoumieux-Garzón 2007). In this case, the corresponding self-
immunity factors counteract pediocin-like activity by interfering with their 
recognition of the mannose permease (Johnsen et al. 2005). 
 
Class IIb (two-peptide). This subclass contains bacteriocins that are only 
active when two related non-active peptides come together (Moll et al. 1996), 
similar to two-peptide lantibiotics (Lawton et al. 2007). Lactococcin G from 
Lactococcus lactis was the first of currently over 15 class IIb bacteriocins to be 
identified (Nissen-Meyer et al. 2009). Other examples include enterocin 1071, 
lactacin F, ABP-118 and various plantaricins (Nissen-Meyer et al. 2009). 
Unstructured while separate in solution (Hauge et al. 1998), the two peptides fold 
into alpha-helical conformations when they interact with each other and insert into 
membranes. Recently, their receptor was revealed to be UppP, an integral 
membrane protein that regenerates bactoprenol-phosphate for peptidoglycan and 
WTA biosynthesis (Fig. 14) (Kjos et al. 2014). This inter-peptide interaction is 
promoted and stabilized by GXXXG motifs present in both peptides (Rogne et al. 
2008). In the membrane, the two-peptide bacteriocin forms a selective ion-
permeable pore that dissipates the proton-motive force and lead to cell death 
(Nissen-Meyer et al. 2009). Mutagenesis studies demonstrated that the target 
specificity region of these bacteriocins was located to the β peptide N-terminus 
(Oppegard et al. 2007), and that the self-immunity protein recognizes the 
bacteriocin helix-helix structure (Nissen-Meyer et al. 2009). 
 
 Class IIc (cyclic). In the last step of biosynthesis, peptides from this 
subclass of bacteriocins undergo cyclization by covalent linkage of their N- and C-
termini, through a yet unclear enzymatic mechanism (Maqueda et al. 2008). Apart 
from subtilosin A (Babasaki et al. 1985, Kawulka et al. 2003), all cyclic bacteriocins 
are positively charged peptides (Nissen-Meyer et al. 2009). Their mode of action is 
similar to class IIb bacteriocins and cyclization appears to promote overall 
structure stabilization and increased resistance to proteolysis (Maqueda et al. 
2008). The first identified and best-studied cyclic bacteriocin is enterocin AS-48 
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(Galvez et al. 1986, Martinez-Bueno et al. 1994), an alpha-helical globular peptide 
with broad antimicrobial spectrum. Membrane insertion requires structural 
transition from a water-soluble to a membrane-bound conformation, which 
exposes hydrophobic helices that penetrate the membrane (Maqueda et al. 2008).  
 
Class IId (single, linear, non-pediocin-like). In this subclass are included 
single, linear, unmodified peptides with no sequence similarity with pediocin-like 
bacteriocins (Cotter et al. 2005). Its first member, lactococcin A, was isolated in 
1991 from L. lactis and shown to have a narrow antimicrobial spectrum (Holo et al. 
1991, van Belkum et al. 1991). Interestingly, its mechanism of action is similar to 
class IIa peptides: binding to the Man-PTS permease to induce membrane 
permeabilization (Fig. 14). Lactococcin A inhibition by self-immunity proteins works 
 
Fig. 14. Mechanisms of action of representative Gram-positive bacteriocins. Bacteriocins can promote 
bacterial death by disrupting the cell wall biosynthesis or by directly creating pores in the cytoplasmic 
membrane, both mechanisms leading to cell lysis. Lantibiotics (class I) bind to and hijack the peptidoglycan 
precursor lipid II, while class IIb peptides have been shown to bind to UppP, a bactoprenol-phosphate (C55-
P) recycling membrane protein. Some of these receptor-bound AMPs, like nisin A, can additionally interact 
with the lipid bilayer and induce pore formation. Other class II members (e.g. pediocins and lactococcin A) are 
also able to disrupt the membrane integrity, after binding with high specificity to Man-PTS membrane proteins. 
(Adapted from Cotter et al. 2013).  
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by preventing this interaction (Diep et al. 2007). Staphylococcal) class IId 
bacteriocins have been identified (e.g. aureocins A53 and A70).  
 
C.2.2. Defensins 
 
Defensins were first identified in rabbit peritoneal neutrophil granulocytes as 
small cationic peptides with broad-spectrum antimicrobial activity (Selsted et al. 
1984). Soon after, similar peptides were also isolated from human neutrophils 
Table 5. Examples of Gram-positive bacteriocins.
a
 
Bacteriocin Producing strains MW
b
 Activity References 
Class I (lantibiotics) 
Type A (linear) 
Nisin A Lactococcus lactis 3,352 Cell wall synthesis 
inhibition 
Membrane pore formation 
Brotz et al. 1998b; 
Wiedemann et al. 2001 
Epidermin Staphylococcus 
epidermidis Tü 3298, 
1580 
2,164 Cell wall synthesis 
inhibition 
 
Allgaier et al. 1986; 
Götz et al. 2014 
Gallidermin Staphylococcus 
gallinarum Tü 3298 
2,164 Cell wall synthesis 
inhibition 
 
Kellner et al. 1988; 
Götz et al. 2014 
Type B (globular) 
Mersacidin Bacillus sp. HIL-
Y85/54728 
1,824 Cell wall synthesis 
inhibition 
 
Chatterjee et al. 1992; 
Brotz et al. 1998a  
Two-peptide     
Lacticin 3147 Lactococcus lactis  
DPC3147 
3,449 (A1)
c
 
3,006 (A2)
c
 
Cell wall synthesis 
inhibition 
Membrane pore formation 
Ryan et al. 1996; 
McAuliffe et al. 1998 
Class II (non-lantibiotics) 
Class IIa (pediocin-like) 
Pediocin PA-1 Pediococcus 
acidilactici PAC-1.0 
4,629 Membrane disruption Henderson et al. 1992 
Class IIb (two-peptide) 
Lactococcin G Lactococcus lactis 
LMGT2081 
4,346 (α) 
4,110 (β) 
Membrane disruption Nissen-Meyer et al. 
1992; 
Moll et al. 1996 
Class IIc (cyclic) 
Enterocin AS-48 Enterococcus 
faecalis S-48 
7,149 Membrane disruption Gálvez et al. 1986; 
Martinez-Bueno et al. 
1994 
Class IId (single, linear, non-pediocin-like) 
Lactococcin A Lactococcus lactis 
ssp. cremoris 
LMG2130 
5,778 Membrane disruption Holo et al. 1991 
a) Data compiled from: Yang et al. 2014, Cotter et al. 2005, Nissen-Meyer et al. 2009, Wang et al. 2009. 
b) Molecular weight (values in Daltons). 
c) Values obtained from BACTIBASE (Hammami et al. 2010). 
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(Ganz et al. 1985) and detected also in epithelial cells (Ouellette et al. 1989, 
Diamond et al. 1991). Nowadays, defensins are known to be present not only in 
mammals but also in birds, reptiles, invertebrates, as well as in plants and fungi, 
presenting themselves as one the oldest and most conserved AMP families (Wong 
et al. 2007).  
Elucidation of the structure and activity of defensins was obtained with the 
extensive study and characterization of the peptides from mammalian origin. 
Regardless of their biological source, defensins have two defining features: (i) an 
anti-parallel β-sheet fold and (ii) six conserved cysteine residues that pair up 
covalently through three intramolecular disulfide bridges and help stabilizing the 
peptide structure (Ganz 2003).  
According to the relative position of the cysteines within the peptide 
sequence and the cysteine pairs linked by disulfide bonds, defensins can be 
distributed into alpha (α)- and beta (β)-defensins. While in α-defensins, two of the 
three disulfide bonds occur between C1–C6 and C3–C5, in β-defensins they occur 
between C1–C5 and C3–C6 (Fig. 14). However, this mismatch does not translate 
into significant conformational differences between both groups (Zimmermann et 
al. 1995). Moreover, the proximal chromosomal localization of genes for both 
defensin families indicates that they evolved from a common ancestral defensin 
(Liu et al. 2007) and diverged with rodents and primates, where α-defensins are 
exclusively synthesized (Patil et al. 2004). A third group of α-defensin-derived 
cyclic peptides were identified in rhesus macaque leukocytes. Their unusual 
structure and molecular origin puts these defensins into another sub-family: the 
theta (θ)-defensins (Fig. 15) (Tang et al. 1999). They have evolved in simians and 
are still found in Old World monkeys but mutations led to their inactivation in 
humans and other hominid primates (Cole et al. 2002, Nguyen et al. 2003). 
Contrasting with other defensins, θ-defensins are significantly better antiviral 
effectors (Munk et al. 2003). 
Both α- and β-defensins are generated by successive proteolytic cleavages 
of larger (up to 100 aa) inactive precursors called preprodefensins (Harwig et al. 
1992, Valore and Ganz 1992). These contain an N-terminal leader peptide (~19 
aa, pre-sequence) and the C-terminal mature defensin (15–45 aa) (Ganz 2003). 
The precursor of α- and θ-defensins, but not of β-defensins, contains a large 
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central pro-domain (~40 aa) with acidic nature. This pro-piece seems to balance 
the positive charge of the C-terminal defensin region within the overall propeptide, 
and inhibit undesirable cytotoxic effects of the mature peptide within the producer 
cell (Michaelson et al. 1992, Valore et al. 1996). As for θ-defensins, they arise 
from the head-to-tail cyclization of two nonapeptide fragments excised from larger 
α-defensin paralog precursors (Fig. 15) (Tang et al. 1999).  
Unsurprisingly, defensins are highly abundant in phagocytes and epithelia 
(Table 6), which constitute primary sites of host interaction with microorganisms. In 
particular, subcellular granules like those present in neutrophils and Paneth cells – 
 
Fig. 15. Genetic organization and protein processing of defensins. Defensin peptides are initially 
expressed as part of a larger precursor (preprodefensin), containing an N-terminal signal peptide (SP), a 
central pro-domain, and the mature bioactive peptide in the C-terminus. Following cleavage of the C-terminal 
peptide, three intramolecular disulfide bonds are established between the six conserved cysteines. In (A) α-
defensins, pairing occurs with C1-C6, C2-C4 and C3-C5, while in (B) β-defensins, it involves C1-C5, C2-C4 
and C3-C6. The biogenesis of (C) θ-defensins requires the ligation/cyclization of two mature nonapeptides, 
each with three cysteines. HNP3, human neutrophil peptide 3; HBD2, human beta-defensin 2; RTD1, rhesus 
theta-defensin 1; UTR, untranslated region. (Adapted from Ganz 2003, Selsted and Ouellette 2005).  
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epithelial cells located at the bottom of intestinal crypts, a highly sterile niche due 
to the abundance of AMPs secreted by these cells – contain the highest 
concentration of defensins, in the mM range (Ganz 1987, Ayabe et al. 2000).  
Defensin synthesis and secretion can be constitutive or triggered by local 
pro-inflammatory or bacterial stimuli (Table 6) (Ganz 2003). In granulocytes, 
synthesis, Golgi maturation and vesicular storage of α-defensins concur with 
granulopoiesis in the bone marrow (Yount et al. 1995). After phagocytosis, these 
granules fuse with phagosomes, releasing the mature defensin peptides onto the 
ingested microorganism(s). Intestinal α-defensins such as mouse cryptdins (i.e. 
crypt defensins) and the human defensin-5 (HD5) are also constitutively 
synthesized. However, they are processed into their bioactive forms in different 
ways: whereas cryptdins are activated by the matrix metalloproteinase 7 (MMP-7, 
or matrilysin) and stored as bioactive peptides in Paneth cell secretory granules 
(Wilson et al. 1999), the HD5 propeptide is cleaved by a trypsin isoform only 
Table 6. Examples of mammalian defensins.
a,b
 
Defensins Cell/tissue source Synthesis Release
c
 
Alpha (α)-defensins 
HNP1–4 
(human) 
Granulocytes, monocytes, 
lymphocytes 
Constitutive, inducible (pro-
inflammatory cytokines, NOD2 
agonists) 
Degranulation 
(phagocytosis) 
HD5–6 
(human) 
Paneth cells, urogenital 
tissue cells 
Constitutive, inducible (NOD2 
agonists) 
Degranulation (bacterial 
antigens, cholinergic 
agonists) 
Cryptdins 
(mouse) 
Paneth cells Constitutive, inducible (NOD2 
agonists) 
Degranulation (bacterial 
antigens, cholinergic 
agonists) 
Beta (β)-defensins 
HBD1 
(human) 
Epithelial cells (e.g. 
keratinocytes), monocytes 
Constitutive, inducible (LPS, IFN-γ) Secretion 
HBD2–3 
(human) 
Epithelial cells (e.g. 
keratinocytes), monocytes, 
DCs 
Inducible (pro-inflammatory 
cytokines, TLR and NOD agonists) 
Secretion 
HBD4 
(human) 
Epithelial cells (testis, 
epididymis) 
Inducible (bacteria, PMA) Secretion 
TAP 
(bovine) 
Trachea Inducible (bacteria, LPS) Secretion 
Theta (θ)-defensins 
RTD1 
(rhesus 
macaque) 
Neutrophils, Paneth cells Constitutive, inducible (virus) Degranulation 
(phagocytosis) 
Secretion 
a) Data compiled from: Hazlett and Wu 2011, Ganz 2003, Diamond et al. 2000, Kaiser and Diamond 2000, Tang et al. 1999 
and Lucero et al. 2013. 
b) DCs, dendriti cells; IFN-γ, interferon-gamma; NOD2, nucleotide-binding oligomerization domain (NOD)-containing 
protein 2; PMA, phorbol myristate acetate; TAP, tracheal antimicrobial peptide. 
c) Degranulation-inducing stimuli are listed between parentheses. 
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during or after secretion (Ghosh et al. 2002). In any case, Paneth cell 
degranulation into the crypts occurs quickly in response to the sensing of bacteria 
or bacterial antigens (Ayabe et al. 2000). Other epithelial defensins, such as the 
human β-defensins 2 (HBD2), HBD3 and HBD4 and the bovine tracheal β-
defensin, are transcriptionally induced by cytokines or microbial factors, which 
activate signaling pathways mediated by NF-κB or other transcription factors 
(Table 6) (Diamond et al. 2000, Hertz et al. 2003, Liu et al. 2003, Sorensen et al. 
2003, Proud et al. 2004).  
Besides their main and direct antimicrobial activity, defensins have also been 
found to play an important role in the inflammatory response by modulating the 
production of pro-inflammatory cytokines and chemokines (Nagaoka et al. 2008, 
Miles et al. 2009). In addition, defensins can also behave as chemoattractant 
factors for various cellular players of the innate and adaptive immune responses 
and stimulate angiogenesis (Yang et al. 1999, Yang et al. 2000, Chavakis et al. 
2004, Rohrl et al. 2010). Unlike their antimicrobial activity, the chemotactic 
properties of defensins are highly dependent on their structure (Wu et al. 2003). 
 
C.2.3. Cathelicidins 
 
The cathelicidins are another well-characterized family of AMPs, and 
together with defensins, the most important class of mammalian AMPs. However, 
unlike defensins, they are not as evolutionarily conserved and widespread in 
nature, with all its currently known members having been identified in vertebrates, 
including humans, murines and several domesticated even-toed ungulates 
(Table 7) All cathelicidin-expressing species have multiple genes for these AMPs, 
except humans, monkeys, murines, rabbits and guinea pigs, which have only one 
(Kościuczuk et al. 2012). Also contrasting with the defensin family is the high 
heterogeneity verified among mature cathelicidin peptides, which can range in 
length between 12 and 100 residues and present all kinds of structures (Zanetti et 
al. 1995). Indeed, cathelicidins can adopt the more common linear α-helical (e.g. 
human LL-37, rabbit CAP-18 and mouse CRAMP), a disulfide-bridged β-stranded 
(protegrins) or a linear unstructured Pro/Arg/Trp-rich conformation (e.g. porcine 
PR-39 and bovine bactenecins and indolicidin) (Gennaro and Zanetti 2000). 
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Despite their significant structural diversity, an element common to all 
cathelicidin peptides and that constitutes the hallmark of this family resides in the 
N-terminal domain of their unprocessed precursors (Zanetti et al. 1995). Whereas 
the C-terminal region of cathelicidin prepropeptides shows high sequence 
variability, consistent with the diversity observed in the mature peptides, the N-
terminal preproregion is very much conserved. Linking the signal peptide (~30 aa) 
at the N-terminus to the C-terminal bioactive peptide is a propiece (99–114 aa) 
with 70% homology to a cysteine proteinase inhibitor protein, called cathelin (for 
cathepsin L inhibitor) (Zanetti et al. 1995), found in pig leukocytes (Fig. 16) 
(Ritonja et al. 1989). It is the presence of this cathelin-like prodomain that lends its 
name to the cathelicidin family (Zanetti et al. 1995) and which enabled that a Bac5, 
a bactenecin previously isolated from bovine neutrophils (Gennaro et al. 1989) 
was identified as the first cathelicidin member (Zanetti et al. 1993). Cathelicidin 
precursors were first detected in neutrophil cells, thus cathelicidins are 
alternatively named myeloid antimicrobial peptides (MAP) and some mature 
peptides carry the acronym in the name (e.g. porcine PMAP-23 or sheep SMAP-
29) (Kościuczuk et al. 2012). 
Cathelicidin precursors are transcribed from four-exon genes, where the first 
three exons encode the N-terminal preproregion and the more variable exon 4 
encodes the mature AMP-containing domain (Fig. 16). Binding sites for 
hematopoietic and pro-inflammatory transcription factors have been identified in 
some promoters, indicating potentially inducible cathelicidin expression 
(Gudmundsson et al. 1995, Zhao et al. 1995, Larrick et al. 1996). Like defensins, 
neutrophil cathelicidins are expressed and processed in myeloid precursor cells in 
the bone marrow, accumulating as inactive preforms in cytoplasmic granules 
(Zanetti et al. 1990, Sorensen et al. 1997). The lack of antimicrobial activity of the 
propeptide appears to result from an inhibitory action of the cathelin domain, 
whose anionic nature cancels the cationicity of the C-terminal AMP domain 
(Scocchi et al. 1992). Upon proper stimulation, the propeptides are released by 
degranulation and processed into their final bioactive form following a neutrophil 
elastase-mediated proteolytic cleavage of a consensus sequence located at the 
end of the cathelin domain (Zanetti et al. 1991, Zanetti et al. 1995, Panyutich et al. 
1997). However, not every cathelicidin precursor is fully processed (Sorensen et 
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al. 1999). Conversely, the same propeptide may require different proteases to 
become active. This is the case of the LL-37 precursor, hCAP-18, which can be 
cleaved by proteinase-3 in neutrophils (Sorensen et al. 2001) or other proteases in 
other tissues to generate different cleavage products (Sorensen et al. 2003, 
Murakami et al. 2004). 
Initially believed to be exclusively produced in immature granulocytes, the 
human and murine cathelicidins were also found to be synthesized by other 
leukocytes (e.g. monocytes, NK cells) as well as different types of cells (e.g. 
keratinocytes and epithelial cells of the intestinal, respiratory and urogenital tracts), 
where their expression is constitutive and/or inducible by microbial, inflammatory 
or developmental factors (Zanetti 2005). 
Due to their cationic and amphipathic properties, cathelicidins exert their 
antimicrobial activity by targeting and disrupting anionic microbial membranes, 
through the formation of transmembrane pores (Ramanathan et al. 2002). Bovine 
bactenecins and porcine peptides, however, have been shown to target 
intracellular components without compromising the membrane (Lee et al. 2009). 
Cathelicidins are active against both Gram-negative and Gram-positive bacteria, 
although with structure-dependent potency differences. Moreover, some 
cathelicidins, like LL-37 and the porcine indolicidin and protegrin-1, are able to 
 
Fig. 16. Structural organization of cathelicidin genes and protein precursors. Cathelicidin peptides are 
expressed as part of a larger precursor encoded by four different exons, of which the last encodes specifically 
the mature peptide. The cathelicidin precursor contains an N-terminal signal peptide (SP), a central pro-
domain highly homologous to the protease inhibitor cathelin, and the mature bioactive peptide in the C-
terminus. The final proteolyitic cleavage, which releases the mature peptide, occurs during secretion upon 
certain stimuli and is mediated by neutrophil elastases or other proteases, such as proteinase-3. UTR, 
untranslated region. (Adapted from Ramanathan et al. 2002).  
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neutralize fungi and enveloped viruses (Ramanathan et al. 2002, Kai-Larsen and 
Agerberth 2008).  
Cathelicidin peptides can additionally perform other non-microbicidal 
functions that contribute to the mounting of a prompt and adequate immune 
response against microbial pathogens or other biological challenges. For instance, 
the rabbit and human CAP-18 propeptides and the mature LL-37 and porcine 
peptides were shown to bind and inactivate LPS, reducing its toxic effects during 
infection (Bevins 1994, Larrick et al. 1994, Larrick et al. 1995, Falla et al. 1996, 
Kirikae et al. 1998). PR-39 was implicated in tissue protection against excessive 
inflammation by inhibiting ROS generation via the phagocyte NAPDP oxidase (Shi 
et al. 1996). PR-39 and LL-37 were also detected in wound fluids, where they 
promote the activation of tissue repair and cell proliferation mechanisms, including 
angiogenesis (Gallo et al. 1994, Vandamme et al. 2012). In addition, both AMPs 
display chemoattractant properties, stimulating leukocyte recruitment to sites of 
Table 7. Examples of mammalian cathelicidins.
a
 
Cathelicidin Origin Cell/tissue source Functions 
Alpha (α)-helical 
hCAP-18/LL-37 Human Neutrophils, monocytes, lymphocytes, 
epithelial cells (keratinocytes, 
intestinal, respiratory and urogenital 
mucosae) 
Antimicrobial activity (pore formation), 
LPS inhibition, wound repair, 
angiogenesis, immune response 
modulation (leukocyte chemotaxis) 
CRAMP Mouse Neutrophils, mast cells, spleen, 
epithelial cells (keratinocytes, 
gastrointestinal, respiratory and 
urogenital mucosae) 
Antimicrobial activity (pore formation) 
CAP-18 Rabbit Neutrophils Antimicrobial activity, LPS inhibition 
BMAPs Cattle Neutrophils, lymphoid organs, tongue, 
mammary glands, reproductive tract 
Antimicrobial activity (pore formation), 
immune response modulation, tumor 
cell apoptosis 
Beta (β)-sheet 
Protegrins Pig Bone marrow, neutrophils, leukocytes Antimicrobial activity (pore formation), 
LPS inhibition 
Extended Pro/Arg/Trp-rich 
Bactenecins Cattle Neutrophils, lymphoid organs Antimicrobial activity (pore formation, 
inhibition of cell wall, protein and 
nucleic acid synthesis) 
Indolicidin Cattle Neutrophils Antimicrobial activity (inhibition of 
nucleic acid synthesis). LPS 
inhibition, immune response 
modulation 
PR-39 Pig Bone marrow, neutrophils, lymphoid 
organs, small intestine  
Antimicrobial activity (inhibition of 
nucleic acid synthesis), immune 
response stimulation (leukocyte 
chemotaxis) 
a) Data compiled from: Ramanathan et al. 2002, Zanetti 2004, Zanetti 2005 and Kosciuczuk et al. 2012. 
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inflammation (Huang et al. 1997, Yang et al. 2000). This places cathelicidins, 
alongside other AMPs, in the molecular bridge connecting the innate and adaptive 
arms of immunity.  
 
C.3. Mechanisms of action 
 
C.3.1. Cytoplasmic membrane disruption 
 
The main target of AMPs is the microbial membrane, whose disruption 
ultimately results in cell death. The physicochemical properties of AMPs selected 
them as ideal bacterial killing effectors, due to their inherent affinity and specificity 
for prokaryotic cell surface. Indeed, their cationic nature drives an electrostatic 
interaction with the anionic cell envelope of bacteria, while bypassing the neutrally 
charged eukaryotic membrane. This net negative charge is not only conferred by 
secondary surface glycopolymers (e.g. LPS or TAs) but also by acidic membrane 
phospholipids (Brogden 2005), such as phosphatidylglycerol (PG), 
phosphatidylserine and cardiolipin (Yeaman and Yount 2003). In contrast, 
eukaryotic membranes contain neutral phospholipids like PE, phosphatidylcholine 
and sphingomyelin, and are further supplemented and differentiated with the 
presence of neutral sterols (Yeaman and Yount 2003). Upon binding to bacterial 
surfaces, additional parameters such as hydrophobicity, amphipathicity and 
structural conformation play a key role in AMP interaction with the cytoplasmic 
membrane. Moreover, the peptide/lipid ratio guides the orientation of AMPs in the 
membrane: as the first increases, so does the perpendicularity of peptides relative 
to the bilayer and the propensity for membrane disruption (Lee et al. 2004, 
Brogden 2005). 
Depending on their intrinsic properties and on membrane composition and 
architecture, AMPs can mediate destabilization of the membrane integrity by 
different mechanisms (Nguyen et al. 2011). Three main or classic models are 
acknowledged: (i) the barrel-stave, (ii) the toroidal-pore, and (iii) the carpet model 
(Fig. 17) (Yeaman and Yount 2003). 
As its name indicates, the barrel-stave mechanism results in the formation of 
a barrel-like ring transmembrane pore, where each stave corresponds to an AMP 
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monomer from a larger oligomerized complex (Fig. 17) (Ehrenstein and Lecar 
1977). As an increasing number of peptide molecules begin to penetrate the 
membrane surface, thermodynamically favorable monomer aggregation promotes 
a transmembrane pore configuration, where internal hydrophobic residues face out 
towards the apolar membrane core and hydrophilic sidechains line the inner 
aqueous channel (Breukink and de Kruijff 1999). The fungal α-helical peptide 
antibiotic alamethicin is one of very few and best-studied AMPs following this type 
of mechanism (Fox and Richards 1982, Sansom et al. 1991, Beven et al. 1999). 
Comparatively, the toroidal-pore model is observed in a much larger number 
and diversity of AMPs such as mellitin, magainins, protegrins and LL-37 (Yang et 
al. 2001, Henzler Wildman et al. 2003). In this membrane-disruptive mechanism, a 
transmembrane pore is also formed but differs structurally from the barrel-stave 
pore in that phospholipids are intercalated with the peptide monomers (Fig. 17). As 
α-helical peptides bind to the membrane, they push the outer membrane leaflet 
inwards, forcing a positive curvature strain that promotes further peptide insertion 
(Hallock et al. 2003). Processive AMP oligomerization together with the fusion of 
both membrane leaflets into a toroid-like surface result in the assembly of a toroid-
like pore with a luminal lining composed of the hydrophilic surface of peptide 
monomers alternated with the polar head groups of phospholipids (Matsuzaki et al. 
1996, Hara et al. 2001, Yang et al. 2001). Toroidal pores have less monomers but 
appear to be wider than barrel-stave pores, which seems to result from the 
electrostatic stability provided by the alternation of anionic (phospholipid) and 
cationic (peptide) charges on the channel surface (Yang et al. 2001). Further 
studies on the interaction of mellitin with membranes pointed however that toroidal 
pores may not be as structurally organized or require that many monomers to be 
formed (Sengupta et al. 2008). 
The third model is also the only that does not rely in structured pore 
formation for membrane disruption. In the “carpet” mechanism, linear α-helical 
AMPs, such as the invertebrate cecropins (Oren and Shai 1998), or the more 
globular β-sheet defensins (Ganz 2003) adhere to the outer membrane leaflet in a 
dispersed fashion – covering it like a carpet – until they reach a threshold 
concentration which triggers its disintegration in a detergent-like manner, often 
resulting in formation of micelles (Fig. 17) (Ladokhin and White 2001, Shai and 
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Oren 2001). AMPs like mellitin, which forms toroidal pores, can also dissolve the 
membrane through the carpet mechanism at highly critical concentrations (Oren 
and Shai 1998), suggesting that the carpet model is an extreme consequence of 
the toroidal pore mechanism (Brogden 2005). 
 
C.3.2. Inhibition of intracellular targets 
 
Although disruption of the cytoplasmic membrane integrity is the principal 
mechanism of AMP-induced cell death, many examples have been identified of 
AMPs that kill microbes without compromising the membrane, and of AMPs whose 
membrane-disruptive mechanisms are not sufficient to justify their antimicrobial 
activity. In these cases, such AMPs were revealed to target and inhibit intracellular 
components and enzymatic pathways important for cell viability (Ganz and Lehrer 
1995, Yeaman and Yount 2003, Brogden 2005). 
Peptidoglycan is a unique bacterial structure that confers physical support 
and protection. Therefore, AMPs targeting its biosynthetic machinery are regarded 
as highly effective killing agents. As mentioned before, lantibiotics were shown to 
inhibit cell wall synthesis as a consequence of using lipid II as membrane receptor, 
hijacking it from both peptidoglycan and WTA biosynthesis pathways (Islam et al. 
 
Fig. 17. Main models of AMP-mediated disruption of bacterial cytoplasmic membrane. In the barrel-
stave model, a barrel-like ring transmembrane pore is formed, where each stave corresponds to a monomer 
from a larger oligomerized complex. The hydrophobic side of the peptide (blue) is faced against the apolar 
membrane core while the hydrophilic side (red) is faced towards the inner aqueous channel. In the toroidal 
pore model, a similar complex is formed but monomers are intercalated by phospholipid head groups as  
result of the curvature and fusion of the two membrane leaflets. The carpet model consists in a dispersed 
micelle-like dissolution of the membrane as the amount of bound peptide reaches a critical threshold. Some 
AMPs may follow more than one of these models during their interaction with bacterial membranes. 
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2012). Recently, the defensin HNP-1 was also reported to act through this same 
mechanism (de Leeuw et al. 2010). Furthermore, lantibiotics like nisin and lacticin 
3147 use this receptor as a platform for assembling transmembrane pores, leading 
to the leakage of intracellular content and membrane destabilization (Islam et al. 
2012). Nisin and Pep5, another lantibiotic, were also shown to stimulate autolytic 
activity in Staphylococcus simulans (Bierbaum and Sahl 1987), which could result 
in uncontrolled cell wall lysis and death.  
On the other hand, the toad-derived linear α-helical buforin II was found to 
cross the cytoplasmic membrane without compromising its integrity and 
accumulate in the cytoplasm, where it targets nucleic acids (Park et al. 1998, Park 
et al. 2000) possibly by binding to histone H2A (Cho et al. 2009).  
Previous studies detected AMP molecules on the cytoplasmic side of the 
membrane after disassembly of transient toroidal pores, suggesting this as a 
mechanism to translocate AMPs across the membrane to further interact with 
intracellular targets (Uematsu and Matsuzaki 2000). This appears to be the case 
of buforin II, where a proline residue plays a critical role in membrane translocation 
through the formation of short-lived toroidal pores (Elmore 2012). Similarly, the 
cathelicidins indolicidin and PR-39 kill bacteria by accessing to their cytoplasm, 
without lysing the membrane, and interfering with both protein and DNA synthesis 
(Boman et al. 1993, Subbalakshmi and Sitaram 1998). Moreover, these two 
peptides were found to induce bacterial filamentation (Shi et al. 1996, 
Subbalakshmi and Sitaram 1998), which could be a consequence of DNA 
replication stalling.  
Pyrrhocoricin and apidaecin, two small proline-rich insect AMPs that target 
mostly Gram-negative bacteria, bind to the bacterial chaperone proteins DnaK and 
GroEL, inhibiting their protein folding assistance activity (Otvos et al. 2000, Kragol 
et al. 2001). It is suspected that apidaecin might be translocated into the 
cytoplasm by a process similar to pediocin-like bacteriocins, i.e. through binding to 
an IM permease/transport component (Castle et al. 1999).  
The Gram-negative class I microcins are another example of AMPs that 
cross the cytoplasmic membrane harmlessly to interfere with nucleic acid 
synthesis (Duquesne and Destoumieux-Garzón 2007). 
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C.4. Bacterial mechanisms of resistance 
 
Millions of years of co-existence enabled bacterial pathogens to evolve 
strategies to resist against host defense mechanisms and effectors like AMPs 
(Peschel and Sahl 2006). In general, these strategies prevent AMPs to accomplish 
either of the following steps: (i) reach or (ii) attach to the bacterial surface, (iii) 
irreversibly permeabilize or (iv) translocate the cytoplasmic membrane; or (v) 
inhibit vital intracellular processes (Yeaman and Yount 2003, Brogden 2005).  
As a first line of protection, bacteria may secrete proteins that inactivate 
AMPs by proteolysis. Linear α-helical peptides, such as LL-37, are particularly 
susceptible to the activity of proteases from both Gram-negative and Gram-
positive species because of their exposed backbone (Resnick et al. 1991, Guina et 
al. 2000, Schmidtchen et al. 2002, Belas et al. 2004, Nyberg et al. 2004, 
Sieprawska-Lupa et al. 2004, Kooi and Sokol 2009). In contrast, AMPs with a 
more packed conformation or containing structurally stabilizing features like 
intramolecular disulfide bridges (e.g. defensins and protegrins), thioether bonds 
(lantibiotics) or abundant proline residues are considerably less prone to 
proteolysis (Peschel and Sahl 2006). Moreover, secreted bacterial proteins may 
also neutralize AMPs by binding and entrapping them before they reach the 
bacterial surface, as exemplified by staphylokinase and streptococcal M1 and SIC 
proteins (Frick et al. 2003, Jin et al. 2004, Lauth et al. 2009). Alternatively, some 
bacteria are able to assemble a capsule around their surface, which physically 
blocks AMPs from interacting with the membrane. Indeed, unencapsulated strains 
have showed higher sensitivity to AMPs than their wild-type capsulated congeners 
(Campos et al. 2004, Llobet et al. 2008). 
Despite these tactics, the majority of the bacterial defense mechanisms 
against AMPs involve changes in the architecture or composition of the bacterial 
cell envelope to render it less vulnerable to AMP attachment or penetration. 
 
C.4.1. Modification of cell envelope components 
 
As previously mentioned, a unique bacterial characteristic explored by AMPs 
to exert their activity is the net negative electrostatic charge of the cell envelope, 
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which promotes AMP attraction and association due to their cationic nature. 
Therefore, a major defensive strategy employed by both Gram-negative and 
Gram-positive bacteria is to biochemically adjust the surface charge to reduce its 
electronegativity and concomitantly weaken AMP affinity towards it (Peschel 
2002). This is generally accomplished by the addition of molecules containing free 
protonated amino groups to the structure of phosphate-rich surface components, 
whereby the positive charge of the amino group would cancel the negative charge 
of a nearby phosphate group.  
In Gram-negative bacteria, this modification procedure is performed on the 
lipid A moiety of LPS, an OM-linked glycopolymer and one of the main AMP 
attractors to the bacterial surface. In this case, aminated compounds such as 
aminoarabinose (Stinavage et al. 1989, Guo et al. 1997) and ethanolamine (Zhou 
et al. 2001, Tran et al. 2006) are appended to the lipid A phosphate groups to 
mask their negative charge. The importance of these alterations towards bacterial 
AMP resistance is attested by the reduced in vivo virulence of mutant strains 
lacking either of these LPS modification mechanisms (Gunn et al. 2000, Cullen et 
al. 2011). Alternatively, lipid A acyl chains can be esterified with glycine (Hankins 
et al. 2012) or with additional fatty acids, which appears to promote AMP 
resistance by producing a membrane less fluid and permissive for AMP insertion 
and disruption (Guo et al. 1997, Brogden 2005). Again, failure to perform this 
process yields strains with increased AMP susceptibility (Guo et al. 1998, Robey 
et al. 2001). 
TAs are the major phosphate-rich cell surface components in Gram-positive 
bacteria, and thus the primary target of surface charge modulation mechanisms. 
D-alanine esters are highly common TA substituents and the introduction of these 
aminated groups contribute significantly to the masking of the Gram-positive 
surface electronegativity and for increased resistance to different AMPs (Fig. 18) 
(Peschel et al. 1999, Abachin et al. 2002, Collins et al. 2002, Kristian et al. 2005, 
Kovacs et al. 2006, Abi Khattar et al. 2009, McBride and Sonenshein 2011). 
Interestingly, a recent study in Streptococcus agalactiae proposed that D-
alanylation of TAs confers resistance to AMPs preferentially by hindering their 
penetration through the cell wall than by influencing their initial binding to the 
bacterial surface (Saar-Dover et al. 2012). 
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Alternatively, positively charged amino acid esters can also be linked to the 
head groups of outer leaflet membrane phospholipids. In Lm, this enzymatic 
reaction is catalyzed by a multiple peptide resistance factor (MprF) protein that 
transfers L-lysine from cytoplasmic tRNA precursors to the terminal glycerol of PG, 
forming lysyl-PG, which unlike PG has a net positive charge (+1) due to the two 
protonated amino groups of L-lysine (Fig. 18). Similarly to TA D-alanylation, 
absence of MprF-mediated lysyl-PG generation compromises bacterial survival 
when challenged with AMPs, as observed with S. aureus and Lm (Peschel et al. 
2001, Kristian et al. 2003, Thedieck et al. 2006, Andra et al. 2011). 
O-acetylation is a widespread post-assembly peptidoglycan modification 
mechanism (Vollmer 2008). It is catalyzed by an integral membrane O-
acetyltransferase that captures acetyl-containing substrates from the cytoplasm 
and transfers the acetyl group to the C6-linked hydroxyl group of MurNAc residues 
in the assembled peptidoglycan strands (Clarke et al. 2002). First discovered in S. 
aureus (Bera et al. 2005), orthologue genes coding for such an enzyme were 
recently identified also in Lm (Aubry et al. 2011) and H. pylori (Wang et al. 2012). 
This modification was demonstrated to favor bacterial resistance against the 
 
Fig. 18. Mechanisms of charge modulation of Lm cell envelope components. The anionic character of 
Lm cell envelope components such as TAs or some membrane phospholipids (negatively charged phosphate 
groups in red) can be masked with the addition of positively charged molecules (blue). These modifications 
typically involve esterification with certain amino acids, where protonated amino groups contain a positive 
charge. In Lm, LTAs undergo D-alanylation through the action of the Dlt pathway (Neuhaus and Baddiley 
2003), while the head group of phosphatidylglycerol is substituted with L-lysine by the action of MprF, leading 
to a charge reversal (-1 to +1).  
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muramidase activity of lysozyme (Dupont and Clarke 1991, Bera et al. 2006, Veiga 
et al. 2007, Aubry et al. 2011, Guariglia-Oropeza and Helmann 2011, Wang et al. 
2012). Interestingly, Lm mutant strains lacking this enzyme, thus devoid of O-
acetylated peptidoglycan, showed increased vulnerability to the lantibiotic 
gallidermin (Aubry et al. 2011). 
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The main goal of our research group is to expand the knowledge on the 
molecular mechanisms employed by Lm to interact with a host organism and 
promote pathogenesis. To achieve this, it is essential to have a global perspective 
of how this bacterial pathogen behaves in the context of infection, of how it reacts 
and adapts to the multiple biological cues – favorable and harmful – within a 
susceptible host. In this sense, a couple of studies performed array-based 
analyses of the transcriptional response of Lm during infection of cell lines in vitro, 
in order to identify genes that were important for invasion, survival and proliferation 
within host cells (Chatterjee et al. 2006, Joseph et al. 2006). However, unlike what 
had been done with other pathogenic bacteria (La et al. 2008), no information was 
available regarding the transcriptional profiling of Lm in a natural infection context, 
i.e. inside a living host organism.  
To fill this void, we performed the first in vivo transcriptome analysis of Lm, 
where whole-genome expression changes in bacteria infecting the mouse spleen 
were compared against those of bacteria growing in vitro (Camejo et al. 2009) 
(see publication in Chapter VI). The resulting data showed that Lm modifies the 
expression levels of about 20% of its genome throughout infection, mostly by gene 
upregulation. All the major virulence-associated genes and regulators were found 
to be highly transcribed, as expected, but several other genes with 
uncharacterized functions or with no previously known connection with Lm 
pathogenesis were also activated (Camejo et al. 2009). Among these 
uncharacterized genes, those lacking orthologues in non-virulent Listeria species 
(such as L. innocua), were of particular interest for their potential involvement in 
Lm infection.  
Included in this group were four contiguous genes – lmo1081 to lmo1084 – 
that displayed significant overexpression in vivo. Moreover, the encoded proteins 
were annotated as homologues of the products of the rmlABCD gene cluster, 
which catalyze the metabolic pathway responsible for the biosynthesis of L-
rhamnose (Giraud and Naismith 2000). Interestingly, this monosaccharide is 
produced in bacteria but not in animals (Tonetti et al. 1998). However, even more 
striking is its presence at the cell surface of several pathogenic bacteria, where it 
can be found associated with important virulence structures such as the LPS O-
antigen, rhamnolipids or the mycobacterial arabinogalactan (Ma et al. 2001, 
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Samuel and Reeves 2003, Zulianello et al. 2006). These observations led us to 
consider that the Lm equivalent of this rmlABCD cluster might also be involved in 
virulence-promoting processes.  
Therefore, the aims of this work were to determine the purpose of the 
rmlABCD cluster homologue in Lm biology and assess its potential 
contribution to Lm virulence. For this, relevant mutant strains were generated 
and analyzed in vitro with the intention of addressing the main biochemical role of 
the cluster-encoded proteins in Lm. The elucidation of this role led to the 
investigation of further related mechanisms with key importance in aspects like Lm 
resistance against microbicidal molecules and surface protein anchoring. To 
evaluate the involvement of the cluster in Lm pathogenesis, these mutant strains 
were also tested in vivo, using the mouse model of infection.  
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The results produced by this work are presented in two parts: 
 
 PART I – L-Rhamnosylation of Listeria monocytogenes wall teichoic acids 
promotes resistance to antimicrobial peptides by delaying interaction 
with the membrane  
Here, we describe the role of the Lm rml gene cluster, showing its requirement 
for L-rhamnosylation of Lm WTAs, and present functional and mechanistic 
evidences linking this event with bacterial resistance to AMPs. Ultimately, we 
confirm the important contribution of this particular WTA glycosylation 
mechanism to Lm pathogenesis. 
These findings were published on PLoS Pathogens (22 May 2015), and the 
published version is appended in Chapter VI. 
 
 PART II – L-Rhamnosylation of Listeria monocytogenes wall teichoic 
acids is required for efficient surface anchoring of GW proteins  
In this part, we include unpublished data from ongoing work that highlight other 
important processes in Lm depending on the WTA L-rhamnosylation status, 
such as bacterial autolysis and invasion of host cells. We show that 
contribution to these events is supported by a newly identified role for L-
rhamnosylated WTAs in the anchoring of a particular family of Lm surface 
proteins sharing similar cell surface-binding domains. 
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I.1. Abstract 
 
Listeria monocytogenes is an opportunistic Gram-positive bacterial pathogen 
responsible for listeriosis, a human foodborne disease. Its cell wall is densely 
decorated with wall teichoic acids (WTAs), a class of anionic glycopolymers that 
play key roles in bacterial physiology, including protection against the activity of 
antimicrobial peptides (AMPs). In other Gram-positive pathogens, WTA 
modification by amine-containing groups such as d-alanine was largely correlated 
with resistance to AMPs. However, in L. monocytogenes where WTA modification 
is achieved solely via glycosylation, WTA-associated mechanisms of AMP 
resistance were unknown. Here, we show that the L-rhamnosylation of 
L. monocytogenes WTAs relies not only on the rmlACBD locus, which encodes the 
biosynthetic pathway for L-rhamnose, but also on rmlT encoding a putative 
rhamnosyltransferase. We demonstrate that this WTA tailoring mechanism 
promotes resistance to AMPs, unveiling a novel link between WTA glycosylation 
and bacterial resistance to host defense peptides. Using in vitro binding assays, 
fluorescence-based techniques and electron microscopy, we show that the 
presence of L-rhamnosylated WTAs at the surface of L. monocytogenes delays the 
crossing of the cell wall by AMPs and postpones their contact with the listerial 
membrane. We propose that WTA L-rhamnosylation promotes L. monocytogenes 
survival by decreasing the cell wall permeability to AMPs, thus hindering their 
access and detrimental interaction with the plasma membrane. Strikingly, we 
reveal a key contribution of WTA L-rhamnosylation for L. monocytogenes virulence 
in a mouse model of infection. 
 
 
 
 
CHAPTER III – RESULTS 
 
 
 99 
I.2. Author Summary 
 
Listeria monocytogenes is a foodborne bacterial pathogen that preferentially 
infects immunocompromised hosts, eliciting a severe and often lethal disease. In 
humans, clinical manifestations range from asymptomatic intestinal carriage and 
gastroenteritis to harsher systemic states of the disease such as sepsis, meningitis 
or encephalitis, and fetal infections. The surface of L. monocytogenes is decorated 
with wall teichoic acids (WTAs), a class of carbohydrate-based polymers that 
contributes to cell surface-related events with implications in physiological 
processes, such as bacterial division or resistance to antimicrobial peptides 
(AMPs). The addition of other molecules to the backbone of WTAs modulates their 
chemical properties and consequently their functionality. In this context, we 
studied the role of WTA tailoring mechanisms in L. monocytogenes, whose WTAs 
are strictly decorated with monosaccharides. For the first time, we link WTA 
glycosylation with AMP resistance by showing that the decoration of 
L. monocytogenes WTAs with L-rhamnose confers resistance to host defense 
peptides. We suggest that this resistance is based on changes in the permeability 
of the cell wall that delay its crossing by AMPs and therefore promote the 
protection of the bacterial membrane integrity. Importantly, we also demonstrate 
the significance of this WTA modification in L. monocytogenes virulence. 
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I.3. Introduction 
 
Listeria monocytogenes (Lm) is a ubiquitous Gram-positive bacterium and 
the causative agent of listeriosis, a human foodborne disease with high incidence 
and morbidity in immunocompromised hosts and other risk groups, such as 
pregnant women, neonates and the elderly. Clinical manifestations range from 
febrile gastroenteritis to septicemia, meningitis and encephalitis, as well as fetal 
infections that can result in abortion or postnatal health complications 
(Swaminathan and Gerner-Smidt 2007b). The most invasive and severe forms of 
the disease are a consequence of the ability of this pathogen to overcome 
important physiological barriers (intestinal epithelium, blood-brain barrier and 
placenta) by triggering its internalization and promoting its intracellular survival into 
phagocytic and non-phagocytic cells. Once inside a host cell, a tightly coordinated 
life cycle, whose progression is mediated by several specialized bacterial factors, 
enables Lm to proliferate and spread to neighboring cells and tissues (Cossart and 
Toledo-Arana 2008, Camejo et al. 2011). 
The Lm cell wall is composed of a thick peptidoglycan multilayer that serves 
as a scaffold for the anchoring of proteins, among which are several virulence 
factors (Carvalho et al. 2014) (see publication in Chapter VI), and of 
glycopolymers such as teichoic acids, which account for up to 70% of the protein-
free cell wall mass (Fiedler et al. 1984, Fiedler 1988). These anionic polymers are 
divided into membrane-anchored teichoic acids (lipoteichoic acids, LTAs) and 
peptidoglycan-attached teichoic acids (wall teichoic acids, WTAs). In Listeria, 
WTAs are mainly composed of repeated ribitol-phosphate subunits, whose 
hydroxyl groups can be substituted with a diversity of monosaccharides (Fiedler et 
al. 1984). While the polymer structure and the chemical identity of the substituent 
groups of LTAs are rather conserved across listeriae (Uchikawa et al. 1986b, 
Ruhland and Fiedler 1987), they display a high variability in WTAs, even within the 
same species (Weidenmaier and Peschel 2008). Specific WTA substitution 
patterns are characteristic of particular Lm serotypes: N-acetylglucosamine is 
common to serogroups 1/2 and 3, and to serotype 4b, but serogroup 1/2 also 
contains L-rhamnose, whereas serotype 4b displays D-glucose and D-galactose 
(Uchikawa et al. 1986a). The broad structural and chemical similarity of LTAs and 
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WTAs results in a considerable degree of functional redundancy, which has 
complicated the characterization of these macromolecules and the assignment of 
specific biological roles. However, studies on Gram-positive bacteria have 
revealed their contribution to important physiological functions (e.g. cell envelope 
cationic homeostasis (Marquis et al. 1976), regulation of autolysin activity (Peschel 
et al. 2000), assembly of cell elongation and division machineries (Schirner et al. 
2009), defense against antimicrobial peptides (Peschel et al. 1999)) and to 
virulence-promoting processes, such as adhesion and colonization of host tissues 
(Weidenmaier et al. 2004, Weidenmaier et al. 2005).  
Antimicrobial peptides (AMPs) are a large family of small peptides (<10 kDa) 
produced by all forms of living organisms (Cederlund et al. 2011), which constitute 
a major player of the innate immune response against microbial pathogens. 
Despite their structural diversity, the majority of AMPs share both cationic and 
amphipathic properties that favor respectively their interaction with the negatively 
charged prokaryotic surface and insertion into the plasma membrane (Peters et al. 
2010, Cederlund et al. 2011). Subsequent pore formation or other AMP-mediated 
membrane-disrupting mechanisms induce bacterial death through direct cell lysis 
or deleterious interaction with intracellular targets (Brogden 2005). Bacteria have 
evolved multiple strategies to avert killing by AMPs (Peschel and Sahl 2006, 
Koprivnjak and Peschel 2011). One strategy consists in the modification of their 
cell surface charge, a process achieved mainly by masking anionic glycopolymers 
with positively charged groups, thus decreasing their affinity to AMPs. In Gram-
positive pathogens, D-alanylation of teichoic acids is a well-characterized 
mechanism and was demonstrated to be important for bacterial resistance to host-
secreted AMPs (Koprivnjak et al. 2002, Neuhaus and Baddiley 2003). In contrast, 
the contribution of WTA glycosylation mechanisms in AMP resistance has not yet 
been investigated. 
We have previously reported genome-wide transcriptional changes occurring 
in Lm strain EGD-e during mouse infection (Camejo et al. 2009). Our analysis 
revealed an elevated in vivo expression of the lmo1081-1084 genes, here 
renamed as rmlACBD because of the high homology of the corresponding proteins 
with enzymes of the L-rhamnose biosynthesis pathway. In this work, we show that 
the decoration of Lm WTAs with L-rhamnose requires the expression of not only 
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the rmlACBD locus but also of rmlT, an upstream-flanking gene encoding a 
putative rhamnosyltransferase. We also demonstrate that Lm becomes more 
susceptible to AMPs in the absence of WTA L-rhamnosylation and predict that this 
effect is due to an increase of the Lm cell wall permeability to these bactericides, 
which results in a faster disruption of the plasma membrane integrity with lethal 
consequences for the bacterial cell. Importantly, we present evidence that this 
WTA tailoring process is required for full-scale Lm virulence in the mouse model of 
infection. 
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I.4. Results 
 
I.4.1. The rmlACBD locus is required for the presence of L-rhamnose in Lm 
WTAs  
 
To identify new Lm genes potentially critical for the infectious process, we 
previously performed the first in vivo transcriptional profiling of Lm EGD-e. Among 
the Lm genes displaying the largest increase in transcription throughout infection, 
we identified a set of previously uncharacterized genes that are included in a 
pentacistronic operon (lmo1080 to lmo1084) (Toledo-Arana et al. 2009). This 
operon is found in L. monocytogenes strains belonging to serogroups 1/2, 3 and 7, 
and is absent from serogroup 4 strains (Doumith et al. 2004) (Fig. 19). 
Interestingly, aside from Listeria seeligeri 1/2b strains, this locus is not found in 
any other Listeria spp., such as the nonpathogenic Listeria innocua or the 
ruminant pathogen Listeria ivanovii, which pinpoints it as a genetic feature of a 
particular subset of pathogenic Listeria strains and suggests that its expression 
may be important to Listeria pathogenesis in humans.  
The four proteins encoded by the lmo1081-lmo1084 genes share a high 
amino acid sequence homology with the products of the rmlABCD gene cluster. 
These genes are widely distributed among Gram-negative (e.g. Salmonella 
enterica (Li and Reeves 2000), Shigella flexneri (Macpherson et al. 1994), Vibrio 
cholerae (Li et al. 2003), Pseudomonas aeruginosa (Aguirre-Ramírez et al. 2012)) 
and Gram-positive species (e.g. Mycobacterium tuberculosis (Li et al. 2006), 
Streptococcus mutans (Tsukioka et al. 1997), Geobacillus tepidamans (Zayni et al. 
2007), Lactobacillus rhamnosus (Péant et al. 2005)) (Fig. 19), the majority of 
which being known pathogens or potentially pathogenic. Despite the inter-species 
variability observed in the genetic organization of the rml genes, the respective 
proteins exhibit a remarkable degree of conservation (Table S1). In light of this, we 
renamed the lmo1081-lmo1084 genes to rmlACBD, respectively (Fig. 19).  
The RmlABCD proteins catalyze the conversion of glucose-1-phosphate to a 
thymidine-diphosphate (dTDP)-linked form of L-rhamnose (Giraud and Naismith 
2000) (Fig. S1A), which is a component of the WTAs from most Listeria strains 
possessing the rml genes (Fiedler 1988). To address the role of rmlACBD in Lm 
WTA glycosylation with L-rhamnose, we constructed an Lm EGD-e derivative 
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mutant strain lacking the rmlACBD locus (ΔrmlACBD) (Fig. S2A) and investigated 
if the absence of these genes could affect the WTA L-rhamnosylation status. We 
 
 
 
Fig. 19. Genes encoding the L-rhamnose biosynthesis pathway are distributed in listeriae and other 
bacterial species. Comparison of the genomic organization of the L-rhamnose pathway genes in the genus 
Listeria and other bacteria. The corresponding species and strains are indicated on the left (Lmo, Listeria 
monocytogenes; Lin, Listeria innocua; Lse, Listeria seeligeri; Liv, Listeria ivanovii; Lwe, Listeria welshimeri; 
Smu, Streptococcus mutans; Mtu, Mycobacterium tuberculosis; Sen, Salmonella enterica serovar 
Typhimurium; Sfl, Shigella flexneri; Pae, Pseudomonas aeruginosa) and listerial serotypes are indicated on 
the right. Genes are represented by boxed arrows and their names are provided for strain EGD-e. Operons 
are underlined by dashed arrows and homologs of the rml genes are shown with identical colors. Numbered 
gaps indicate the genetic distance (Mb, mega base pairs) between rml genes located far apart in the 
chromosome. Bacterial genomic sequences were obtained from NCBI database and chromosomal alignments 
assembled using Microbial Genomic context Viewer and Adobe Illustrator. 
 
CHAPTER III – RESULTS 
 
 
 107 
prepared WTA hydrolysates from exponential phase cultures of wild type (EGD-e), 
ΔrmlACBD and a complemented ΔrmlACBD strain expressing rmlACBD from its 
native promoter within an integrative plasmid (ΔrmlACBD+rmlACBD). Samples 
were resolved by native PAGE and the gel stained with Alcian blue to visualize 
WTA polymer species. A mutant strain unable to synthesize WTAs 
(ΔtagO1ΔtagO2) (Eugster and Loessner 2012) was used to confirm that the 
detected signal corresponds to WTAs. Compared to the wild type sample, the 
ΔrmlACBD WTAs displayed a shift in migration, which was reverted to a wild type-
like profile in WTAs from the ΔrmlACBD+rmlACBD sample (Fig. 20A), indicating 
that the native WTA composition requires the presence of the rmlACBD genes. To 
confirm this, we investigated the WTA carbohydrate composition from these 
strains. WTA polymers were isolated from cell walls purified from bacteria in 
exponential growth phase, hydrolyzed and analyzed by high-performance anion 
exchange chromatography coupled with pulsed amperometric detection 
(HPAEC-PAD) to detect monosaccharide species. WTA extracts obtained from 
ΔrmlACBD bacteria completely lacked L-rhamnose, in contrast to those isolated 
from the parental wild type strain (Fig. 20B). The role of rmlACBD in Lm WTA 
L-rhamnosylation was definitely confirmed by the analysis of WTAs from 
ΔrmlACBD+rmlACBD bacteria, in which L-rhamnose was detected at levels similar 
to those observed in the wild type sample (Fig. 20B). Similar observations were 
made with purified cell wall samples that contain WTAs still attached to the 
peptidoglycan matrix (Fig. S3A). The absence of muramic acid, one of the 
peptidoglycan building blocks, from WTA extracts (Fig. 20B) indicates that 
L-rhamnose is specifically associated with WTAs and is not a putative 
peptidoglycan contaminant. This is corroborated by the absence of L-rhamnose in 
purified peptidoglycan samples (Fig. 20C).  
WTAs have been identified as important regulators of peptidoglycan cross-
linking and maturation (Atilano et al. 2010). To investigate if L-rhamnose 
decoration of WTAs has any involvement in the maturation of the Lm 
peptidoglycan, we performed HPLC analysis of the muropeptide composition of 
mutanolysin-digested peptidoglycan samples from wild type, ΔrmlACBD and 
ΔrmlACBD+rmlACBD bacteria. No differences in the nature and relative amount of 
muropeptide species were observed between strains (Fig. S3B), ruling out a role 
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for WTA L-rhamnosylation in the consolidation of the peptidoglycan architecture. 
Overall, these results confirm that a functional rmlACBD locus is required for the 
association of L-rhamnose with Lm WTAs, likely by providing the molecular 
machinery responsible for the synthesis of L-rhamnose. 
 
I.4.2. RmlT is required for the incorporation of L-rhamnose into Lm WTAs 
 
The rml operon in Lm includes a fifth gene, lmo1080, located upstream of 
rmlA (Fig. 19), which codes for a protein similar to the B. subtilis minor teichoic 
 
 
 
Fig. 20. A functional rml operon is required for glycosylation of Lm WTAs with L-rhamnose. (A) Alcian 
blue-stained 20% polyacrylamide gel containing WTA extracts from logarithmic-phase cultures of different Lm 
strains. (B–D) HPAEC-PAD analyses of the sugar composition of the (B) WTA, (C) peptidoglycan and (D) 
cytoplasmic fractions isolated from the indicated Lm strains. Samples were hydrolyzed in 3 M HCl (2 h, 95 ºC), 
diluted with water and lyophilized before injection into the HPLC equipment. Standards for ribitol (Rib), 
L-rhamnose (Rha), glucosamine (GlcN), and muramic acid (Mur) were eluted under identical conditions to 
allow peak identification. 
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acid biosynthesis protein GgaB, shown to possess sugar transferase activity 
(Freymond et al. 2006). Conserved domain analysis of the translated Lmo1080 
amino acid sequence revealed that its N-terminal region is highly similar (e-value 
10-22) to a GT-A family glycosyltransferase domain (Fig. S1B). In GT-A enzymes, 
this domain forms a pocket that accommodates the nucleotide donor substrate for 
the glycosyl transfer reaction, and contains a signature DxD motif necessary to 
coordinate a catalytic divalent cation (Breton et al. 2006). This motif is also found 
within the predicted glycosyltransferase domain sequence of Lmo1080 as a DHD 
tripeptide (Fig. S1B). For these reasons, we investigated whether Lmo1080, which 
we renamed here RmlT (for L-rhamnose transferase), was involved in the 
L-rhamnosylation of Lm WTAs. We constructed an Lm EGD-e mutant strain 
lacking rmlT (Fig. S2A) and analyzed the structure and sugar composition of its 
WTAs as described above. WTAs isolated from ΔrmlT bacteria displayed a faster 
migration in gel (Fig. 20A) and did not contain any trace of L-rhamnose (Fig. 20B), 
fully recapitulating the ΔrmlACBD phenotype. Reintroduction of a wild type copy of 
rmlT into the mutant strain (ΔrmlT+rmlT) resulted in a phenotype that resembles 
that of the wild type strain, with regards to WTA gel migration profile (Fig. 20A) and 
presence of L-rhamnose in the WTA fraction (Fig. 20B).  
To discard the possibility that the deletion of rmlT exerted a negative polar 
effect on the downstream expression of rmlACBD, potentially disrupting the 
synthesis of L-rhamnose used for WTA glycosylation, we compared the 
transcription of the rmlACBD genes in the wild type and ΔrmlT Lm strains by 
quantitative real-time PCR. Transcript levels were unchanged in the ΔrmlT 
background as compared to the wild type strain (Fig. S2B), indicating that the 
deletion of rmlT did not interfere with the transcription of rmlACBD. To definitely 
confirm that Lm ΔrmlT still holds the capacity to synthesize L-rhamnose, being only 
incapable to incorporate it in nascent WTA polymers, we evaluated the presence 
of L-rhamnose in the cytoplasmic compartment of this strain. The intracellular 
content of early exponential-phase bacteria from the wild type, ΔrmlACBD and 
ΔrmlT strains was extracted, hydrolyzed and analyzed by HPAEC-PAD to 
compare the sugar composition of cytoplasmic extracts. As shown in Fig. 20D, a 
peak corresponding to L-rhamnose was detected in the cytoplasmic samples from 
the wild type and ΔrmlT strains, but not from the ΔrmlACBD strain, clearly 
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demonstrating that, as opposed to ΔrmlACBD bacteria, ΔrmlT bacteria retain a 
functional L-rhamnose biosynthesis pathway. These results indicate that the 
depletion of L-rhamnose observed in ΔrmlT WTAs is a consequence of the 
absence of the WTA L-rhamnosyltransferase activity performed by RmlT. 
Therefore, we propose RmlT as the glycosyltransferase in charge of decorating 
Lm WTAs with L-rhamnose.  
 
I.4.3. WTA L-rhamnosylation promotes Lm resistance to AMPs 
 
WTAs were previously associated with bacterial resistance against salt 
stress (Chassaing and Auvray 2007) and host defense effectors, such as 
lysozyme (Bera et al. 2007, Atilano et al. 2010). We thus investigated the potential 
involvement of WTA L-rhamnosylation in these processes by assessing the growth 
of the ΔrmlACBD and ΔrmlT strains in the presence of high concentrations of 
either NaCl or lysozyme. As shown in Fig. 21A, no significant difference was 
observed between the growth of the wild type and the two mutant strains in BHI 
broth containing 5% NaCl. Similarly, no difference was detected between the 
growth behavior of these strains after the addition of different concentrations of 
lysozyme (50 μg/ml and 1 mg/ml) to bacterial cultures in the exponential phase 
(Fig. 21B). As expected, we observed an immediate and significant decrease in 
the survival of the lysozyme-hypersensitive ΔpgdA mutant (Boneca et al. 2007) 
(Fig. 21B). These data demonstrate that Lm does not require L-rhamnosylated 
WTAs to grow under conditions of high osmolarity nor to resist the cell wall-
degrading activity of lysozyme. 
WTAs were also found to be involved in bacterial resistance to host-secreted 
defense peptides (Peschel et al. 1999, Kovacs et al. 2006). To investigate the role 
of WTA L-rhamnosylation in Lm resistance to AMPs, we evaluated the in vitro 
survival of wild type, ΔrmlACBD and ΔrmlT Lm, as well as of the respective 
complemented strains, in the presence of biologically active synthetic forms of 
AMPs produced by distinct organisms: gallidermin, a bacteriocin from the Gram-
positive bacterium Staphylococcus gallinarum (Kellner et al. 1988); CRAMP, a 
mouse cathelicidin (Gallo et al. 1997), or its human homolog LL-37 (Vandamme et 
al. 2012). After two hours of co-incubation with different AMP concentrations, 
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surviving bacteria were enumerated by plating in solid media. The overall survival 
levels of Lm varied with each AMP, evidencing their distinct antimicrobial 
effectiveness (Fig. S4). However, when compared to the wild type strain, the 
ΔrmlACBD and ΔrmlT mutants displayed a consistent decrease in their survival 
levels in the presence of any of the three AMPs (Fig. 21C), in a dose-dependent 
manner (Fig. S4). Restoring WTA L-rhamnosylation through genetic 
complementation of the mutant strains resulted in an increase of the survival rate 
to wild type levels. This result demonstrated the important contribution of 
L-rhamnosylated WTAs towards Lm resistance against AMPs, pointing to a role for 
WTA glycosylation in bacterial immune evasion mechanisms.  
 
 
 
 
 
Fig. 21. WTA L-rhamnosylation promotes Lm resistance against AMPs. (A) Growth of Lm strains in BHI 
broth supplemented with 5% NaCl. A growth curve of wild type EGD-e in the absence of 5% NaCl was 
included as a control for optimal growth. (B) Growth of mid-exponential-phase Lm strains untreated (black 
symbols) or challenged with 50 μg/ml (gray symbols) or 1 mg/ml (white symbols) of lysozyme. Optical density 
of the shaking cultures was monitored spectrophotometrically at 600 nm. (C) Quantification of viable bacteria 
after treatment of mid-exponential-phase Lm strains (2 h, 37 ºC) with gallidermin (1 μg/ml), CRAMP or LL-37 
(5 μg/ml). Averaged replicate values from AMP-treated samples were normalized to untreated control samples 
and the transformed data expressed as the percentage of surviving bacteria relative to wild type Lm (set at 
100). Data represent mean±SD of three independent experiments. *, p≤0.05; ***, p≤0.001. 
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I.4.4. WTA L-rhamnosylation interferes with Lm cell wall crossing by AMPs 
 
The increased AMP susceptibility of Lm strains defective in WTA 
L-rhamnosylation suggests that this process is required to hinder the bactericidal 
activity of AMPs. Since AMPs generally induce bacterial death by disrupting the 
integrity of the plasma membrane, we hypothesized that the higher susceptibility of 
the ΔrmlACBD and ΔrmlT mutant strains resulted from an increased AMP-
mediated destabilization of the Lm membrane. In this context, two scenarios were 
envisioned: i) AMPs could be binding with higher affinity to the L-rhamnose-
deficient Lm cell wall, or ii) they could be crossing it at a faster pace, thus reaching 
the membrane more quickly than in wild type Lm. To explore these possibilities, 
we first investigated the binding affinity of the mouse cathelicidin CRAMP towards 
Lm cell walls depleted of L-rhamnose. For this, we incubated the different Lm 
strains with CRAMP for a short period and analyzed by flow cytometry the amount 
of Lm-bound peptide exposed at the cell surface and accessible for antibody 
recognition. We detected fluorescence associated with surface-exposed CRAMP 
in all strains (Fig. 22A). However, the mean fluorescence intensity (MFI) values 
were significantly reduced in both ΔrmlACBD and ΔrmlT mutants, in comparison to 
wild type Lm and the complemented strains (Figs. 22A and 22B). This suggests 
that CRAMP was less accessible to immunolabeling at the cell surface of Lm 
lacking L-rhamnosylated WTAs.  
The affinity of AMPs towards the bacterial surface is driven by electrostatic 
forces between positively charged peptides and the anionic cell envelope 
(Koprivnjak et al. 2002). To determine if variations of the Lm surface charge 
contributed to the reduced amount of CRAMP exposed at the surface of 
ΔrmlACBD and ΔrmlT bacteria, we compared the surface charge of Lm with or 
without L-rhamnosylated WTAs. For this, we analyzed the binding of cytochrome c, 
a small protein with positive charge at physiological conditions (isoelectric point 
~10), to the wild type and mutant Lm strains. As positive control, we used a mutant 
strain that cannot modify its LTAs with D-alanine (ΔdltA) and, as a result, displays 
a higher surface electronegativity and a concomitant higher affinity for positively 
charged compounds (Peschel et al. 1999, Abachin et al. 2002). As expected, the 
level of cytochrome c binding was higher with the ΔdltA strain than with the 
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respective wild type strain, as illustrated by a decreased percentage of unbound 
cytochrome c (Fig. 22C). However, no significant difference in cytochrome c 
binding levels was observed between ΔrmlACBD, ΔrmlT and wild type EGD-e 
strains (Fig. 22C), indicating that the absence of L-rhamnose in WTAs does not 
affect the Lm surface charge. This was further corroborated by zeta potential 
 
 
 
Fig. 22. WTA L-rhamnosylation interferes with the Lm cell wall crossing by AMPs. (A and B) Flow 
cytometry analysis of Lm surface-exposed CRAMP levels in mid-exponential-phase Lm strains, following 
incubation (5 min) in a 5-μg/ml solution of the peptide and immunolabeling with anti-CRAMP and Alexa Fluor 
488-conjugated antibodies. (A) Representative experiment showing overlaid histograms of CRAMP-treated 
(solid line) and untreated (dashed line) samples, with mean fluorescence intensity (MFI) values from treated 
samples indicated by vertical dashed lines. (B) Mean±SD of the MFI values of CRAMP-treated samples from 
three independent experiments. (C) Cell surface charge analysis of Lm strains deficient for WTA 
L-rhamnosylation as determined by cytochrome c binding assays. Mid-exponential-phase bacteria were 
incubated with equine cytochrome c (0.5 mg/ml), centrifuged and the supernatant was recovered for 
spectrophotometric quantification of the unbound protein fraction. Values from Lm-containing samples are 
expressed as the percentage of unbound cytochrome c relative to control samples lacking bacteria. Data 
represent the mean±SD of three independent experiments. (D and E) Flow cytometry analysis of total Lm-
associated CRAMP levels in mid-exponential-phase Lm strains, following incubation (5 min) with a 5-μg/ml 
solution of fluorescently labeled peptide (5-FAM-CRAMP). (D) Representative experiment showing overlaid 
histograms of FAM-CRAMP-treated (solid line) and untreated (dashed line) samples, with MFI values from 
treated samples indicated by vertical dashed lines. (E) Mean±SD of the MFI values of 5-FAM-CRAMP-treated 
samples from three independent experiments. (F) Fluorometric quantification of the unbound CRAMP fraction 
in the supernatant of suspensions of mid-exponential-phase Lm strains, following incubation (5 min) with a 5-
μg/ml solution of 5-FAM-CRAMP. Data are expressed as the percentage of unbound fluorescent peptide 
relative to control samples lacking bacteria, and represent the mean±SD of three independent experiments 
performed in triplicates. ns=not significant, p>0.05; **, p≤0.01; ***, p≤0.001. 
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measurements showing similar pH-dependent variations for both wild type and 
mutant strains (Fig. S5). Overall, these results allowed us to discard electrostatic 
changes as a reason behind the difference in CRAMP levels detected at the Lm 
cell surface.   
To further explore the decreased levels of surface-exposed CRAMP in Lm 
strains lacking L-rhamnosylated WTAs, we compared total levels of bacterium-
associated CRAMP in the different strains by flow cytometry, following a short 
incubation with a fluorescently labeled form of this AMP. The intensity of Lm-
associated CRAMP fluorescence was comparable for the wild type EGD-e, 
ΔrmlACBD and ΔrmlT strains (Figs. 22D and 22E), indicating that the overall 
peptide levels associated to Lm cells were similar between the different strains. 
Accordingly, the residual fluorescence in the supernatants obtained by 
centrifugation of the bacteria-peptide suspensions was also similar (Fig. 22F). As 
positive control we used the ΔdltA strain, which displayed a significantly stronger 
peptide binding than its parental wild type strain (Figs. 22D–F). These data 
strongly suggest that the increased CRAMP susceptibility of Lm strains lacking L-
rhamnosylated WTAs results from an improved penetration of CRAMP through 
their cell walls. 
Altogether, these results showed that L-rhamnosylated WTAs do not interfere 
with the Lm surface charge or with the binding efficiency of AMPs, but likely 
promote Lm survival by hindering the cell wall crossing by these bactericides. 
 
I.4.5. WTA L-rhamnosylation delays AMP interaction with the Lm plasma 
membrane 
 
In light of these results, we then examined whether WTA L-rhamnosylation 
interfered with the dynamics of AMP interaction with the Lm plasma membrane. 
We performed a time-course study to follow Lm membrane potential changes 
induced by CRAMP. In live bacteria, the membrane potential is an electric 
potential generated across the plasma membrane by the concentration gradients 
of sodium, potassium and chloride ions. Physical or chemical disruption of the 
plasma membrane integrity leads to the suppression of this potential 
(depolarization) (Shapiro 2000). Lm strains were incubated with DiOC2(3), a green 
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fluorescent voltage-sensitive dye that readily enters into bacterial cells. As the 
intracellular dye concentration increases with higher membrane potential, it favors 
the formation of dye aggregates that shift the fluorescence emission to red. After 
stabilization of the DiOC2(3) fluorescence, CRAMP was added to bacterial 
samples and the rate of Lm depolarization was immediately analyzed by 
measuring the red fluorescence emission decline in a flow cytometer. The 
decrease in the membrane potential was consistently greater in the ΔrmlACBD 
and ΔrmlT strains as compared to wild type Lm, particularly in the first 10-15 min 
(Fig. 23A), indicating that the Lm plasma membrane integrity is compromised 
faster by the action of CRAMP in the absence of L-rhamnosylated WTAs. To 
investigate if increased CRAMP-mediated disruption of the Lm membrane integrity 
was associated with increased permeabilization, we monitored in real time the 
entry of the fluorescent probe SYTOX Green into the different Lm strains, following 
the addition of CRAMP. This probe only enters into bacterial cells with a 
compromised membrane and displays a strong green fluorescence emission after 
binding to nucleic acids. As expected, when CRAMP was omitted from the 
bacterial suspensions, any increase in SYTOX Green-associated fluorescence 
was detected (Fig. 23B). However, in the presence of the peptide, the green 
fluorescence intensity of samples containing the ΔrmlACBD or ΔrmlT mutants 
increased earlier than in samples containing wild type Lm (Fig. 23B), eventually 
reaching similar steady-state levels at later time points (Fig. S7). These 
observations indicate that CRAMP-mediated increase of the Lm membrane 
permeability occurs faster in strains lacking L-rhamnosylated WTAs.  
To investigate the ultrastructural localization of the peptide, we performed 
immunoelectron microscopy on CRAMP-treated wild type and ΔrmlACBD Lm 
strains. Interestingly, CRAMP-specific labeling was not only detected in the Lm cell 
envelope, as expected, but also in the cytoplasm (Fig. 23C), suggesting that this 
AMP may additionally target components or processes inside Lm. Comparison of 
the subcellular distribution of CRAMP between these two bacterial compartments 
revealed a preferential cell envelope localization in wild type Lm, which contrasted 
with the slight but significantly higher cytoplasmic localization of the peptide in the 
ΔrmlACBD strain (Fig. 23D). These observations are in agreement with a model in 
which CRAMP crosses the Lm cell wall more efficiently in the absence of WTA L-
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rhamnosylation, therefore reaching the bacterial membrane and the cytoplasm 
comparatively faster.    
 
 
 
Fig. 23. WTA L-rhamnosylation delays AMP interaction with the Lm plasma membrane. (A) 
Depolarization rate of Lm strains in response to CRAMP. Mid-exponential-phase bacteria pre-stained (15 min) 
with 30 μM DiOC2(3) were challenged with 50 μg/ml CRAMP and changes in the membrane potential, 
expressed as the ratio of CRAMP-treated versus untreated samples, were monitored during 30 min. Data 
represent the mean±SD of three independent experiments. (B) SYTOX Green uptake kinetics of Lm strains in 
response to CRAMP-mediated membrane permeabilization. Exponential-phase bacteria were incubated 
(37 ºC) with PBS (white symbols) or 50 μg/ml CRAMP (black symbols), in the presence of 1 μM SYTOX 
Green, and the increase in green fluorescence emission was recorded over time. (C and D) Transmission 
electron microscopy analysis of the subcellular distribution of CRAMP in immunogold-labeled sections of mid-
exponential-phase wild type and ΔrmlACBD Lm strains treated with 50 μg/ml CRAMP (15 min, 37 ºC). (C) 
Representative images of contrasted sections of Lm cells showing CRAMP-specific gold labeling (10-nm black 
dots). Scale bar: 0.2 μm. (D) Quantification of the subcellular partition of CRAMP labeling in wild type and 
ΔrmlACBD Lm strains, for two independent assays. The percentages of cell envelope- and cytoplasm-
associated gold dots per bacterium were quantified (at least 90 cells per strain) and the results expressed for 
each strain as mean±SD. (E and F) Western blot analysis of levels of CRAMP bound to purified cell wall of 
different Lm strains. Purified cell wall (100 μg) was incubated with CRAMP (5 min), washed and digested 
overnight with mutanolysin. (E) Supernatants from mutanolysin-treated samples were resolved in 16% Tris-
tricine SDS-PAGE and immunoblotted for CRAMP. The Lm cell wall-anchored protein InlA was used as 
loading control. (F) Quantification of the relative CRAMP levels represented as the mean±SD of four 
independent blots. *, p≤0.05; **, p≤0.01. 
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Finally, to confirm that the presence of L-rhamnosylated WTAs hinders the 
capacity of AMPs to flow through the Lm cell wall, we assessed levels of CRAMP 
retained in purified cell wall samples from the wild type, ΔrmlACBD and ΔrmlT 
strains by Western blot. After incubation with CRAMP, peptides trapped within the 
peptidoglycan matrix were released by mutanolysin treatment of the cell wall and 
quantitatively resolved by SDS-PAGE. Immunoblotting revealed a small but 
consistent decrease in the amount of peptide associated with the cell wall from the 
two mutant strains in comparison with wild type Lm (Figs. 23E and 23F). This 
result indicates that the lack of L-rhamnose in WTAs results in a partial loss of the 
AMP retention capacity of the Lm cell wall, which induces an enhanced AMP 
targeting of the Lm plasma membrane and consequent bacterial killing. 
All combined, these data support a model where the L-rhamnosylation of 
WTAs alters the Lm cell wall permeability to favor the entrapment of AMPs. This 
obstructive effect hinders AMP progression through the cell wall and delays their 
lethal interaction with the plasma membrane. 
 
I.4.6. WTA L-rhamnosylation is crucial for AMP resistance in vivo and Lm 
virulence  
 
To evaluate the importance of WTA L-rhamnosylation in Lm pathogenicity, 
we assessed the in vivo virulence of Lm strains lacking L-rhamnosylated WTAs. 
BALB/c mice were inoculated orally with wild type, ΔrmlACBD or ΔrmlT strains, 
and the bacterial load in the spleen and liver of each animal was quantified three 
days later. The proliferative capacity of both ΔrmlACBD and ΔrmlT mutant strains 
was similarly reduced in both organs, although more significantly in the liver (Figs. 
24A and 24B). To determine if the decreased virulence of the mutant strains was 
due to a specific defect in the crossing of the intestinal epithelium, BALB/c mice 
were challenged intravenously, bypassing the intestinal barrier. Three days post-
infection, the differences between mutant and wild type strains, in both organs, 
were similar to those observed in orally infected animals (Figs. 24C and 24D), thus 
discarding any sieving effect of the intestinal epithelium on the decreased splenic 
and hepatic colonization by both ΔrmlACBD and ΔrmlT. Importantly, organs of 
mice infected intravenously with the complemented strains (ΔrmlACBD+rmlACBD 
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and ΔrmlT+rmlT) displayed bacterial loads comparable to wild type Lm-infected 
organs (Figs. 24C and 24D).  The attenuated in vivo phenotype of the ΔrmlACBD 
and ΔrmlT strains was not caused by an intrinsic growth defect, as demonstrated 
 
 
Fig. 24. WTA L-rhamnosylation is necessary for AMP resistance in vivo and Lm virulence. (A–D) 
Quantification of viable bacteria in the spleen and liver recovered from BALB/c mice (n=5), three days after (A 
and B) oral or (C and D) intravenous infection with sub-lethal doses of indicated Lm strains. Data are 
presented as scatter plots, with each animal indicated by a dot and the mean indicated by a horizontal line. (E 
and F) Quantification of the fecal shedding of wild type or ΔrmlACBD Lm strains after oral infection of (E) wild 
type (WT, cramp
+/+
) and (F) CRAMP knockout (KO, cramp
-/-
) 129/SvJ mice (n=5). Total feces produced by 
each animal at specific time points were collected and processed for bacterial enumeration in Listeria-
selective agar media. Data are expressed as mean±SD. (G and H) Quantification of viable bacteria in spleens 
and livers recovered from (G) wild type (WT, cramp
+/+
) and (H) CRAMP knockout (KO, cramp
-/-
) 129/Sv mice 
(n=5), three days after intravenous infection with sub-lethal doses of wild type or ΔrmlACBD Lm strains. Data 
are presented as scatter plots, with each animal represented by a dot and the mean indicated by a horizontal 
line. *, p≤0.05; **, p≤0.01; ***, p≤0.001. 
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by their wild type-like growth profiles in broth or inside eukaryotic cells (Fig. S8). 
These results confirmed the involvement of the rml operon in virulence, revealing a 
significant contribution of WTA L-rhamnosylation to Lm pathogenesis. Importantly, 
the in vivo attenuation of the ΔrmlT strain, which is unable to append L-rhamnose 
to its WTAs but is able to synthesize the L-rhamnose precursor, showed that 
although L-rhamnose biosynthesis is required to achieve optimal levels of 
virulence it is its covalent linkage to the WTA backbone that is crucial for the 
successful Lm host infection. 
To evaluate the protective role of WTA L-rhamnosylation against AMPs in 
vivo, we performed virulence studies in a CRAMP-deficient mouse model. To 
determine the influence of WTA L-rhamnosylation in Lm intestinal persistence, we 
performed oral infections of adult CRAMP knockout 129/SvJ mice (cramp-/-, KO) 
(Nizet et al. 2001) and of age- and background-matched wild type mice (cramp+/+, 
WT), with the wild type or ΔrmlACBD Lm strains and monitored the respective 
fecal carriage. In both WT and KO mice, we observed comparable dynamics of 
fecal shedding of the wild type and ΔrmlACBD strains (Figs. 6E and 6F). In 
agreement with the comparable virulence defects observed for WTA L-
rhamnosylation-deficient bacteria, following oral or intravenous inoculation of 
BALB/c mice (Figs. 24A–D), these results suggest a minor role for CRAMP in the 
control of Lm during the intestinal phase of the infection. 
We then inoculated WT and KO mice intravenously and quantified bacterial 
numbers in the spleen and liver, three days post-infection. In line with what was 
observed in BALB/c mice (Fig. 6C), the ΔrmlACBD strain showed significant 
virulence attenuation in both organs of WT mice (Fig. 24G). Interestingly, this 
virulence defect was nearly abolished in KO animals, with the ΔrmlACBD strain 
displaying an organ-colonizing capacity similar to wild type bacteria (Fig. 6H). In 
addition, bacterial loads were higher in the organs of KO mice than in those of WT 
animals (Figs. 24G and 24H). These data indicate that, in comparison to their WT 
congeners, KO mice are more susceptible to Lm infection, and confirm the in vivo 
listericidal activity of CRAMP.  
Altogether, these results highlight a key role for host-produced CRAMP in 
restraining Lm infection and demonstrate that WTA L-rhamnosylation also 
promotes resistance to AMPs in an in vivo context. 
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I.5. Discussion 
 
Teichoic acids are key players in the maintenance of the Gram-positive cell 
envelope integrity and functionality. They are typically decorated with D-alanine 
and/or a variety of glycosyl groups, which influence the overall properties of these 
polymers (Weidenmaier and Peschel 2008). Whereas D-alanylation of WTAs has 
been demonstrated to contribute towards bacterial defense against AMPs 
(Peschel et al. 1999, Koprivnjak et al. 2002), the involvement of glycosylation in 
this process has never been investigated. In this study, we show for the first time 
that the glycosylation of Lm WTAs with L-rhamnose is mediated by the WTA L-
rhamnosyltransferase RmlT and confers protection against AMPs in vitro and 
during mouse infection. Based on our data, we propose that this protection results 
from a delayed traversal of the Lm cell envelope by AMPs in the presence of L-
rhamnose-decorated WTAs. Most importantly, we reveal a key role for L-
rhamnosylated WTAs in the processes underlying Lm pathogenesis.  
Unlike S. aureus or B. subtilis (Neuhaus and Baddiley 2003), WTAs in 
Listeria are not decorated with D-alanine, undergoing only glycosylation with a 
small pool of monosaccharides (Uchikawa et al. 1986a, Fiedler 1988). Among 
these is L-rhamnose, which is the product of a remarkably conserved biosynthetic 
pathway that is encoded by the rmlABCD genes (Giraud and Naismith 2000). 
Interestingly, a significant number of bacteria harboring these genes are 
commonly pathogenic (Macpherson et al. 1994, Tsukioka et al. 1997, Li and 
Reeves 2000, Li et al. 2003, Li et al. 2006, Aguirre-Ramírez et al. 2012) and have 
L-rhamnose in close association with surface components (Chatterjee 1997, 
Frirdich and Whitfield 2005). In Listeria, the rmlACBD locus is only found in certain 
serotypes of Lm (1/2a, 1/2b, 1/2c, 3c and 7) and L. seeligeri (1/2b). These 
serotypes were all shown to have L-rhamnose in their WTAs, except for Lm 
serotypes 3c and 7 (Fiedler 1988), which appear to be unable to produce this 
sugar because of mutations within rmlA and rmlB, respectively (Fig. 19). Our 
results confirmed that the appendage of L-rhamnose to Lm WTAs requires the 
products of the rmlACBD locus. Ultimately, WTA glycosylation is catalyzed by 
glycosyltransferases, a class of enzymes that recognize nucleotide-sugar 
substrates and transfer the glycosyl moiety to a WTA subunit (Lairson et al. 2008). 
In silico analysis of lmo1080, the first gene of the operon including rmlACBD 
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(Fig. 19) showed that it encodes a protein with putative glycosyltransferase 
activity. The genomic location and predicted protein function were strong 
indicators that this gene might encode the transferase involved in the L-
rhamnosylation of Lm WTAs. Our data demonstrated that whereas lmo1080, that 
we renamed rmlT, is dispensable for rhamnose biosynthesis, it is required for the 
addition of L-rhamnose to WTAs in Lm strains with a functional L-rhamnose 
pathway, thus validating RmlT as the L-rhamnose-specific WTA 
glycosyltransferase in Lm. 
WTAs are associated with the natural resistance of S. aureus to 
peptidoglycan-degrading enzymes, such as lysozyme (Bera et al. 2007, Atilano et 
al. 2010). In contrast, absence of WTA decoration, but not of the polymers, was 
shown to induce an increase of the staphylococcal susceptibility to lysostaphin 
(Brown et al. 2012). Modifications of the Lm peptidoglycan, such as N-
deacetylation (Boneca et al. 2007), were found to contribute to protection against 
lysozyme, but the role of WTAs and in particular their decoration, was never 
addressed. Our results discard WTA L-rhamnosylation as a component of the Lm 
resistance mechanism to this host immune defense protein, as well as its 
involvement in the promotion of growth under osmotic conditions. Other innate 
immune effectors, such as antimicrobial peptides (AMPs), also target bacterial 
organisms (Guilhelmelli et al. 2013) that in turn have developed resistance 
strategies to avoid injury and killing induced by AMPs. Among these strategies is 
the reshaping and fine-tuning of cell envelope components to lower AMP affinity to 
the bacterial surface (Koprivnjak and Peschel 2011). Previous studies showed a 
clear link between the D-alanylation of WTAs and AMP resistance (Peschel et al. 
1999, Kovacs et al. 2006). In this context, we found here a similar role for WTA L-
rhamnosylation, showing that, in the absence of L-rhamnosylated WTAs, bacteria 
exhibit an increased susceptibility to AMPs produced by bacteria, mice and 
importantly by humans. Although from such distinct sources, AMPs used here 
share a cationic nature that supports their activity. However, while teichoic acid D-
alanylation is known to reduce the cell wall electronegativity (Peschel et al. 1999), 
glycosyl substituents of Lm WTAs are neutrally charged and WTA glycosylation 
should thus promote AMP resistance through a different mechanism.  
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It is well established that AMPs induce bacterial death mainly by tampering 
with the integrity of the plasma membrane. This can be achieved through multiple 
ways, all of which are driven by the intrinsic amphipathic properties of this class of 
peptides (Nguyen et al. 2011). Nonetheless, the initial interaction of AMPs with 
bacterial surfaces is mediated by electrostatic forces between their positive net 
charge and the anionic cell envelope (Koprivnjak et al. 2002). Our data show that, 
unlike D-alanylation (Vadyvaloo et al. 2004), WTA L-rhamnosylation does not 
interfere with the Lm cell surface charge, in agreement with L-rhamnose being an 
electrostatically neutral monosaccharide. Importantly, the reduced levels of 
surface-exposed CRAMP in Lm strains lacking L-rhamnosylated WTAs suggested 
instead that their increased susceptibility to this peptide was correlated with its 
improved penetration of the L-rhamnose-depleted Lm cell wall. We confirmed this 
premise with data showing that CRAMP-mediated cell depolarization and plasma 
membrane permeabilization events occur earlier in WTA L-rhamnosylation-
deficient Lm strains. In addition, we also observed a predominant cytoplasmic 
presence of CRAMP in these mutant strains, in contrast to the preferential cell 
envelope localization in wild type Lm, further suggesting a WTA L-rhamnosylation-
dependent kinetic discrepancy in the progression of CRAMP through the Lm cell 
envelope. Saar-Dover et al. demonstrated in the WTA-lacking Streptococcus 
agalactiae (GBS) that LTA D-alanylation promoted resistance to the human 
cathelicidin LL-37 by hindering cell wall crossing and plasma membrane 
disturbance (Saar-Dover et al. 2012). They proposed that the underlying 
mechanism does not rely on modulation of the surface charge but on LTA 
conformation-associated alterations of the cell wall packing density (Saar-Dover et 
al. 2012). Our data are in line with these observations and although we did not 
detect changes in the cell wall cross-linking status, we cannot ignore a possible 
impact of L-rhamnosylation on WTA polymer conformation accounting for changes 
in cell wall permeability. If one considers that the peptidoglycan, a multi-layered 
and compact structure, is densely populated with WTA polymers decorated with 
multiple units of the rather bulky L-rhamnose molecule, spatial constraints and 
increased cell wall density need to be accounted. In fact, we showed that purified 
Lm cell wall depleted of L-rhamnose does not retain CRAMP in its peptidoglycan 
matrix as effectively as cell wall containing L-rhamnosylated WTAs. In addition, we 
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have indications that soluble L-rhamnose interferes with CRAMP activity, 
improving the survival of WTA L-rhamnosylation mutants of Lm (data not shown). 
These observations suggest a potential interaction between L-rhamnose and 
AMPs, which could favor the “retardation effect” that ultimately promotes Lm 
survival. 
We previously reported a significantly increased transcription of rmlACBD 
during mouse spleen infection (Camejo et al. 2009), which suggested that WTA L-
rhamnosylation is highly activated by Lm to successfully infect this host organ. Our 
infection studies in mice confirmed the importance of this mechanism for Lm 
pathogenesis by revealing a significant virulence attenuation of WTA L-
rhamnosylation-deficient Lm strains. Surprisingly, the expression of rmlT appeared 
unchanged during mouse spleen infection as compared to growth in BHI (Camejo 
et al. 2009), suggesting that an increased L-rhamnose biosynthesis could be 
sufficient to induce an increased WTA L-rhamnosylation and AMP resistance. 
Faith et al. also observed a decreased bacterial burden of a serotype 4b Lm strain 
lacking the gtcA gene (Faith et al. 2009), a mutation that resulted in complete loss 
of galactose decoration of its WTAs (Promadej et al. 1999). Interestingly, gtcA is 
also present in Lm EGD-e, where it appears to be involved in WTA substitution 
with N-acetylglucosamine (Eugster et al. 2011), and was shown to contribute to 
the colonization of the mouse spleen, liver and brain (Autret et al. 2001). However 
the mechanism through which this occurs remains unclear. 
Virulence studies in mice lacking the CRAMP gene corroborated our in vitro 
susceptibility data and revealed the importance of WTA L-rhamnosylation-
promoted resistance to AMPs for Listeria virulence. In vivo data also provided a 
strong insight into the protective role of CRAMP against systemic infection by Lm, 
as had been previously observed with other bacterial pathogens (Nizet et al. 2001, 
Huang et al. 2007, Chromek et al. 2012). Our results on fecal shedding dynamics 
suggest that the contribution of CRAMP to the control of Lm during the intestinal 
phase of infection is minimal. A previous report showed a negligible enteric 
secretion of CRAMP in normal adult mice (Ménard et al. 2008), which may explain 
the similar shedding behavior of the wild type and ΔrmlACBD strains that were 
observed in both mouse strains. In this scenario, infection studies in newborn 
animals, whose enterocytes actively express CRAMP (Gallo et al. 1997, Ménard et 
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al. 2008), may provide conclusive information regarding the role of WTA L-
rhamnosylation in the Lm resistance to CRAMP during the intestinal phase of the 
infection. Notwithstanding, CRAMP is actively produced by phagocytes in adult 
mice (Rosenberger et al. 2004). As a major target for Lm colonization, the spleen 
is also an important reservoir of phagocytic cells. We can speculate that WTA L-
rhamnosylation is particularly important to increase the chances of Lm surviving 
CRAMP-mediated killing during spleen infection. Considering our data on the Lm 
susceptibility to LL-37, the human homolog of CRAMP, we can also envisage this 
scenario in the context of human infection. 
In conclusion, our work has unveiled for the first time a role for WTA 
glycosylation in bacterial resistance to AMPs. We propose that WTA L-
rhamnosylation reduces the cell wall permeability to AMPs, promoting a delay in 
the crossing of this barrier and in the disruption of the plasma membrane, thus 
favoring Lm survival and virulence in vivo. Our findings reveal a novel facet in the 
contribution of WTA modifications towards AMP resistance, reinforcing the crucial 
role of these Gram-positive surface glycopolymers in host defense evasion.
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I.6. Materials and Methods 
 
I.6.1. Bacterial strains and growth conditions 
 
Bacterial strains used in this study are listed in Table 1. Lm and E. coli 
strains were routinely cultured aerobically at 37 ºC in brain heart infusion (BHI, 
Difco) and Lysogeny Broth (LB) media, respectively, with shaking. For 
experiments involving the Lm ΔtagO1ΔtagO2 strain, bacteria were first cultured 
overnight at 30 ºC with shaking in the presence of 1 mM IPTG (isopropyl-β-D-
thiogalactopyranoside), washed and diluted (1:100) in fresh BHI and cultured 
overnight at 30 ºC with shaking (Eugster and Loessner 2012). When appropriate, 
the following antibiotics were included in culture media as selective agents: 
ampicilin (Amp), 100 μg/ml; chloramphenicol (Cm), 7 μg/ml (Lm) or 20 μg/ml (E. 
coli); erythromycin (Ery), 5 μg/ml. For genetic complementation purposes, colistin 
sulfate (Col) and nalidixic acid (Nax) were used at 10 and 50 μg/ml, respectively.  
 
I.6.2. Construction and complementation of mutant strains 
 
Lm mutant strains were constructed in the EGD-e background through a 
process of double homologous recombination mediated by the suicide plasmid 
pMAD (Arnaud et al. 2004). DNA fragments corresponding to the 5’- and 3’-
flanking regions of the rmlACBD locus (lmo1081–4) were amplified by PCR from 
Lm EGD-e chromosomal DNA with primers 1–2 and 3–4 (Table S2), and cloned 
between the SalI–MluI and MluI–BglII sites of pMAD, yielding pDC303. Similarly, 
DNA fragments corresponding to the 5’- and 3’-flanking regions of rmlT (lmo1080) 
were amplified with primers 15–16 and 17–18 (Table S2), and cloned between the 
SalI–EcoRI and EcoRI–BglII sites of pMAD, yielding pDC491. The plasmid 
constructs were introduced in Lm EGD-e by electroporation and transformants 
selected at 30 ºC in BHI–Ery. Positive clones were re-isolated in the same medium 
and grown overnight at 43 ºC. Integrant clones were inoculated in BHI broth and 
grown overnight at 30 ºC, after which the cultures were serially diluted, plated in 
BHI agar and incubated overnight at 37 ºC. Individual colonies were tested for 
growth in BHI–Ery at 30 ºC and antibiotic-sensitive clones were screened by PCR 
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for deletion of rmlACBD (primers 5–6, 7–8, 9–10 and 11–12) and rmlT (primers 
19–20) (Table S2). Genetic complementation of the deletion mutant strains was 
performed as described (Camejo et al. 2009). DNA fragments containing either the 
rmlACBD or rmlT loci were amplified from Lm EGD-e chromosomal DNA with 
primers 13–14 and 21–22 (Table S2), respectively, and cloned between the SalI–
PstI sites of the phage-derived integrative plasmid pPL2 (Lauer et al. 2002), 
generating pDC313 and pDC550. The plasmid constructs were introduced in the 
E. coli strain S17-1 and transferred, respectively, to the ΔrmlACBD and ΔrmlT 
strains by conjugation on BHI agar. Transconjugant clones were selected in BHI–
Cm/Col/Nax and chromosomal integration of the plasmids confirmed by PCR with 
primers 23 and 24 (Table S2). All plasmid constructs and gene deletions were 
confirmed by DNA sequencing. 
 
I.6.3. Gene expression analyses 
 
Total bacterial RNA was isolated from 10 ml of exponential cultures 
(OD600=0.6) by the phenol-chloroform extraction method, as previously described 
(Milohanic et al. 2003), and treated with DNase I (Turbo DNA-free, Ambion), as 
recommended by the manufacturer. Purified RNAs (1 μg) were reverse-
transcribed with random hexamers, using iScript cDNA Synthesis kit (Bio-Rad 
Laboratories). Quantitative real-time PCR (qPCR) was performed in 20-μl 
reactions containing 2 μl of cDNA, 10 μl of SYBR Green Supermix (Bio-Rad 
Laboratories) and 0.25 μM of forward and reverse primers (Table S2), using the 
following cycling protocol: 1 cycle at 95 ºC (3 min) and 40 cycles at 95 ºC (30 s), 
55 ºC (30 s) and 72 ºC (30 s). Each target gene was analyzed in triplicate and 
blank (water) and DNA contamination controls (unconverted DNase I-treated RNA) 
were included for each primer pair. Amplification data were analyzed by the 
comparative threshold (ΔΔCt) method, after normalization of the test and control 
sample expression values to a housekeeping gene (16S rRNA). For qualitative 
analysis, PCR was performed in 20-μl reactions containing 2 μl of cDNA, 10 μl of 
MangoMix 2× reaction mix (Bioline) and 0.5 μM of forward and reverse qPCR 
primers, using the following protocol: 1 cycle at 95 ºC (5 min), 25 cycles at 95 ºC 
(30 s), 55 ºC (30 s) and 72 ºC (20 s), and 1 cycle at 72 ºC (5 min). Amplification 
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products were resolved in 1% (w/v) agarose gel and analyzed in a GelDoc XR+ 
System (Bio-Rad Laboratories). 
 
I.6.4. WTA PAGE analysis 
 
Extraction and analysis of Lm WTAs by polyacrylamide gel electrophoresis 
was performed essentially as described (Carvalho et al. 2013), with the exception 
that WTAs extracts were obtained from exponential-phase cultures. Sedimented 
bacteria were washed (buffer 1: 50 mM MES buffer, pH 6.5) and boiled for 1 h 
(buffer 2: 4% SDS in buffer 1). After centrifugation, the pellet was serially washed 
with buffer 2, buffer 3 (2% NaCl in buffer 1) and buffer 1, before treatment with 20 
μg/ml proteinase K (20 mM Tris-HCl, pH 8; 0.5% SDS) at 50 ºC for 4 h. The 
digested samples were thoroughly washed with buffer 3 and distilled water and 
incubated overnight (16 h) with 0.1 M NaOH, under vigorous agitation. Cell wall 
debris were removed by centrifugation (10,000 rpm, 10 min) and the hydrolyzed 
WTAs present in the supernatant were directly analyzed by native PAGE in a Tris-
tricine buffer system. WTA extracts were resolved through a vertical (20 cm) 
polyacrylamide (20%) gel at 20 mA for 18 h (4 ºC). To visualize WTAs, the gel was 
stained in 0.1% Alcian blue (40% ethanol; 5% acetic acid) for 30 min and washed 
(40% ethanol; 10% acetic acid) until the background is fully cleared. Optionally, for 
increased contrasting, silver staining can be performed on top of the Alcian blue 
staining. 
 
I.6.5. Purification of cell wall components  
 
Cell walls of Lm strains were purified as described before (Filipe et al. 2005), 
with modifications. Overnight cultures were subcultured into 1–2 liters of BHI broth 
(initial OD600=0.005) and bacteria grown until exponential phase (OD600=1.0–1.5). 
Cultures were rapidly cooled in an ice/ethanol bath and bacteria harvested by 
centrifugation (7,500 rpm, 15 min, 4 °C). The pellet was resuspended in cold 
ultrapure water and boiled for 30 min with 4% SDS to kill bacteria and inactivate 
cell wall-modifying enzymes. The samples were cleared of SDS by successive 
cycles of centrifugation (12,000 rpm, 10 min) and washing with warm ultrapure 
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water until no detergent was detected (Hayashi 1975). SDS-free samples were 
resuspended in 2 ml of ultrapure water and cell walls disrupted with glass beads in 
a homogenizer (FastPrep, Thermo Savant). Fully broken cell walls were separated 
from glass beads by filtration (glass filters, pore size: 16-40 µm) and from 
unbroken cell walls and other debris by low-speed centrifugation (2,000 rpm, 
15 min). Nucleic acids were degraded after incubation (2 h) at 37 °C with DNase 
(10 µg/ml) and RNase (50 µg/ml) in a buffer containing 50 mM Tris-HCl, pH 7.0, 
and 20 mM MgSO4. Proteins were then digested overnight at 37 °C with trypsin 
(100 µg/ml) in the presence of 10 mM CaCl2. Nuclease and proteases were 
inactivated by boiling in 1% SDS, and samples were centrifuged (17,000 rpm, 
15 min) and washed twice with ultrapure water. Cell walls were resuspended and 
incubated (37 °C, 15 min) in 8 M LiCl and then in 100 mM EDTA, pH 7.0, after 
which they were washed twice with water. After resuspension in acetone and 
sonication (15 min), cell walls were washed and resuspended in ultrapure water 
before undergoing lyophilization.  
To obtain purified peptidoglycan, cell walls (20 mg) were incubated for 48 h 
with 4 ml of 46% hydrofluoric acid (HF), under agitation at 4 °C. Samples were 
washed with 100 mM Tris-HCl, pH 7.0, and centrifuged (17,000 rpm, 30 min, 4 °C) 
as many times as necessary to neutralize the pH. The pellet was finally washed 
twice with water prior to lyophilization. WTA extracts were obtained by incubating 
1 mg of cell wall with 300 µl of 46% HF (18 h, 4 °C). After centrifugation 
(13,200 rpm, 15 min, 4 °C), the supernatant was recovered and evaporated under 
a stream of compressed air. The dried WTA residue was resuspended in water 
and lyophilized.  
 
I.6.6. Extraction of bacterial cytoplasmic content 
 
The intracellular content of Lm strains was isolated according to a modified 
version of the protocol by Ornelas-Soares et al. (Ornelas-Soares et al. 1994). 
Bacterial cultures (200 ml) were grown until early exponential phase (OD600=0.3), 
and vancomycin was added at 7.5 µg/ml (5×MIC value (Blanot et al. 1999)) to 
induce the cytoplasmic accumulation of the peptidoglycan precursor UDP-
MurNAc-pentapeptide. Cultures were grown for another 45 min and chilled in an 
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ice-ethanol bath for 10 min. Bacteria were then harvested by centrifugation 
(12,000 rpm, 10 min, 4 ºC), washed with cold 0.9% NaCl, resuspended in 5 ml of 
cold 5% trichloroacetic acid (TCA) and incubated for 30 min on ice. Cells and other 
debris were separated by centrifugation (4,000 rpm, 15 min, 4 ºC) and the 
supernatant was extracted with 1-2 volumes of diethyl ether as many times as 
necessary to remove TCA (sample pH should rise to at least 6.0). The aqueous 
fraction containing the cytoplasmic material was lyophilized and the dried residue 
resuspended in ultrapure water.  
 
I.6.7. HPLC analyses 
 
To analyze their sugar composition, purified cell wall and peptidoglycan 
(200 µg each), as well as cytoplasmic (500 µg) and WTA extracts were hydrolyzed 
in 3 M HCl for 2 h at 95 °C. After vacuum evaporation, the samples were washed 
with water and lyophilized. The hydrolyzed material was then resuspended in 
150 µl of water and resolved by high-performance anion-exchange 
chromatography coupled with pulsed amperometric detection (HPAEC-PAD). Ten 
microliters were injected into a CarboPac PA10 column (Dionex, Thermo Fisher 
Scientific) and eluted at 1 ml/min (30 °C) with 18 mM NaOH, followed by a 
gradient of NaCH3COO: 0–20 mM (t=25–30 min), 20–80 mM (t=30–35 min), 80–
0 mM (t=40–45 min). Standards for glucosamine, muramic acid, L-rhamnose and 
ribitol (Sigma-Aldrich) were eluted under the same conditions to enable 
identification of chromatogram peaks. Data were acquired and analyzed with the 
Chromeleon software (Dionex, Thermo Fisher Scientific).  
Muropeptide samples were prepared and analyzed as described (de Jonge 
et al. 1992), with minor changes. Purified peptidoglycan was digested with 200 
µg/ml mutanolysin (Sigma-Aldrich) in 12.5 mM sodium phosphate, pH 5.5, for 16 h 
at 37 °C. Enzymatic activity was halted by heating at 100 °C for 5 min, after which 
the digested sample was reduced for 2 h with 2.5 mg/ml of sodium borohydride 
(NaBH4) in 0.25 M borate buffer, pH 9.0. The reaction was stopped by lowering the 
sample pH to 2 with ortho-phosphoric acid. After centrifugation, the supernatant 
was analyzed by reverse phase HPLC. Fifty microliters were injected into a 
Hypersil ODS (C18) column (Thermo Fisher Scientific) and muropeptide species 
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eluted (0.5 ml/min, 52 °C) in 0.1 M sodium phosphate, pH 2.0, with a gradient of 
5–30% methanol and detected at 206 nm. 
 
I.6.8. Intracellular multiplication 
 
Mouse macrophage-like J774A.1 cells (ATCC, TIB-67) were propagated in 
Dulbecco’s modified Eagle’s medium (DMEM) containing 10% fetal bovine serum 
and infection assays were performed as described (Camejo et al. 2009). Briefly, 
cells (~2×105/well) were infected for 45 min with exponential-phase bacteria at a 
multiplicity of infection of ~10 and treated afterwards with 20 μg/ml gentamicin for 
75 min. At several time-points post-infection, cells were washed with PBS and 
lysed in cold 0.2% Triton X-100 for quantification of viable intracellular bacteria in 
BHI agar. One experiment was performed with triplicates for each strain and time-
point. 
 
I.6.9. Resistance to salt stress and lysozyme 
 
Lm cultures grown overnight were appropriately diluted in BHI broth and their 
growth under the presence of stressful stimuli was monitored by optical density 
measurement at 600 nm (OD600). For comparative analysis of Lm resistance to 
salt stress, bacterial cultures were diluted 100-fold in BHI alone (control) or BHI 
containing 5% NaCl. To assess the Lm resistance to lysozyme, exponential-phase 
cultures (OD600 ≈ 1.0) were challenged with different doses of chicken egg white 
lysozyme (Sigma). A mutant Lm strain hypersensitive to lysozyme (ΔpgdA) was 
used as a positive control for susceptibility.  
 
I.6.10. AMP susceptibility 
 
Bacteria in the exponential phase of growth (OD600=0.7–0.8) were diluted 
(104 CFU/ml) in sterile PB medium (10 mM phosphate buffer, pH 7.4; 1% BHI) and 
mixed in a 96-well microplate with increasing concentrations of gallidermin (Santa 
Cruz Biotechnology), CRAMP or LL-37 (AnaSpec). Bacterial suspensions without 
AMPs were used as reference controls for optimal growth/survival. After incubation 
CHAPTER III – RESULTS 
 
 
 133 
for 2 h at 37 ºC, the mixtures were serially diluted in sterile PBS and plated in BHI 
agar for quantification of viable bacteria. Each condition was analyzed in duplicate 
in three independent assays. 
 
I.6.11. Cytochrome c binding 
 
Cytochrome c binding assays were performed as described (Vadyvaloo et al. 
2004). Bacteria from mid-exponential-phase cultures (OD600=0.6–0.7) were 
washed in 20 mM MOPS buffer, pH 7.0, and resuspended in ½ volume of 0.5 
mg/ml equine cytochrome c (Sigma-Aldrich) in 20 mM MOPS buffer, pH 7.0. After 
10 min of incubation, bacteria were pelleted and the supernatant collected for 
quantification of the absorbance at 530 nm. The mean absorbance values from 
replicate samples containing bacteria were subtracted to the mean value of a 
reference sample lacking bacteria, and the results were presented for each strain 
as percentage of unbound cytochrome c. 
 
I.6.12. Zeta potential measurements 
 
Bacteria (1 ml) from mid-exponential-phase cultures were washed twice with 
deionized water and diluted (107 CFU/ml) in 15 mM NaCl solutions adjusted to 
different pH values (1 to 7) with nitric acid. Bacterial suspensions (750 μl) were 
injected into a disposable capillary cell cuvette (DTS1061, Malvern Instruments) 
and the zeta potential was measured at 37 ºC in a ZetaSizer Nano ZS (Malvern 
Instruments), under an automated field voltage. Samples were measured in 
triplicate in three independent assays. 
 
I.6.13. Flow cytometry analyses 
 
Bacteria from 500 μl of mid-exponential-phase cultures were washed twice 
with PBS and treated for 5 min with 5 μg/ml CRAMP or PBS (untreated control). 
After centrifugation, the supernatant was removed and PBS-washed bacteria were 
incubated for 1 h with rabbit anti-CRAMP (1:100, Innovagen), followed by 1 h with 
Alexa Fluor 488-conjugated anti-rabbit IgG (1:200, Molecular Probes). Finally, 
CHAPTER III – RESULTS 
 
 
 134 
bacteria were fixed with 3% paraformaldehyde for 15 min, washed and 
resuspended in PBS. Alternatively, bacteria were similarly treated with an N-
terminally 5-FAM-labeled synthetic form of CRAMP (95% purity, Innovagen), 
washed and resuspended in PBS. Samples were acquired in a FACSCalibur flow 
cytometer equipped with CellQuest software (BD Biosciences) and data were 
analyzed with FlowJo (TreeStar Inc.). Green fluorescence was collected from at 
least 50,000 FSC/SSC-gated bacterial events in the FL1 channel (530 nm/20 nm 
bandpass filter). Fluorescence intensities were plotted in single-parameter 
histograms and results were presented as the average mean fluorescence 
intensity (MFI) value from three independent analyses.  
For bacterial membrane potential studies, the lipophilic fluorescent probe 
DiOC2(3) (3,3-diethyloxacarbocyanine, Santa Cruz Biotechnology) was used as a 
membrane potential indicator (Novo et al. 1999, Shapiro 2000). Mid-logarithmic 
phase bacteria were diluted (106 CFU/ml) in PBS with 30 μM DiOC2(3) and 
incubated for 15 min in the dark. CRAMP was added to a final concentration of 50 
μg/ml and the sample was immediately injected in the flow cytometer. Control 
samples treated with PBS or with 1.5 mM sodium azide (uncoupling agent) were 
analyzed to determine the fluorescence values corresponding to basal (100%) and 
null (0%) membrane potential (Fig. S6). Green and red (FL3, 670 nm/long 
bandpass filter) fluorescence emissions were continuously collected from 
FSC/SSC-gated bacteria for 30 min. After acquisition, a ratio of red over green 
fluorescence (R/G) was calculated per event and plotted in the y-axis versus time. 
A series of consecutive one-minute-wide gates was applied to the plot and the 
mean R/G value per gate was determined. The mean R/G values from uncoupler-
treated samples were deducted from the corresponding values from the untreated 
and CRAMP-treated samples, and the resulting values for each condition were 
normalized as percentage of the initial value (t=1 min). Finally, the temporal 
variation of the Lm membrane potential was represented graphically as the ratio of 
the normalized values from CRAMP-treated over untreated samples. 
 
I.6.14. SYTOX Green uptake 
 
Bacterial uptake of the cell-impermeable SYTOX Green dye was used to 
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study membrane permeabilization induced by CRAMP (Saar-Dover et al. 2012). 
Exponential-phase bacteria were washed and resuspended (107 CFU/ml) in sterile 
PBS containing 1 μM SYTOX Green (Molecular Probes). After 20 min of 
incubation in the dark, bacterial suspensions were mixed in PCR microplate wells 
with 50 μg/ml CRAMP or PBS (negative control) for a total volume of 100 μl. The 
mixtures were immediately placed at 37 ºC in a real-time PCR detection system 
(iQ™5, Bio-Rad Laboratories) and fluorescence emission at 530 nm was recorded 
every minute following excitation at 488 nm. 
 
I.6.15. Binding of AMP to purified cell walls 
 
One-hundred micrograms of purified cell wall were resuspended in 50 μl of 
5 μg/ml CRAMP or PBS (negative control) and gently shaken for 5 min. Samples 
were centrifuged (16,000 × g, 1 min), washed in PBS and in TM buffer (10 mM 
Tris-HCl, 10 mM MgCl2, pH 7.4) before overnight incubation at 37 °C with 
mutanolysin (400 U/ml) in TM buffer (50 μl). Supernatants were resolved by 
tricine-SDS-PAGE in a 16% gel, transferred onto nitrocellulose membrane and 
blotted with rabbit anti-CRAMP (1:1000) or mouse anti-InlA (L7.7; 1:1000), 
followed by HRP-conjugated goat anti-rabbit or anti-mouse IgG (1:2000, 
P.A.R.I.S). Immunolabeled bands were visualized using SuperSignal West Dura 
Extended Duration Substrate (Pierce) and digitally acquired in a ChemiDoc XRS+ 
system (Bio-Rad Laboratories). 
  
I.6.16. Immunoelectron microscopy 
 
Exponential-phase bacteria treated with 50 μg/ml CRAMP for 15 min at 37 ºC 
were fixed for 1 h at room temperature (4% paraformaldehyde, 2.5% 
glutaraldehyde, 0.1 M sodium cacodylate, pH 7.2), stained with 1% osmium 
tetroxide for 2 h and resuspended in 30% BSA (high-purity grade). Bacterial 
pellets obtained after centrifugation in microhematocrit tubes were fixed overnight 
in 1% glutaraldehyde, dehydrated in increasing ethanol concentrations, and 
embedded in Epon 812. Ultrathin sections (40–50 nm) were placed on 400-mesh 
Formvar-coated copper grids and treated with 4% sodium metaperiodate and 1% 
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periodic acid (10 min each) for antigen retrieval. For immunogold labeling of 
CRAMP, sections were blocked for 10 min with 1% BSA and incubated overnight 
(4 ºC) with rabbit anti-CRAMP (1:100 in 1% BSA). After extensive washing, 
sections were labeled with 10-nm gold complex-conjugated anti-rabbit IgG (1:200 
in 1% BSA) for 2 h, washed and contrasted with 4% uranyl acetate and 1% lead 
citrate. Images were acquired in a Jeol JEM-1400 transmission electron 
microscope equipped with a Gatan Orius SC1000 CCD camera and analyzed 
using ImageJ software. 
 
I.6.17. Animal infections 
 
Virulence studies were done in mouse models of the following strains: wild 
type BALB/c and 129/SvJ (Charles River Laboratories); and CRAMP-deficient 
(cramp-/-) 129/SvJ, which was bred in our facilities from a breeding pair provided 
by Dr. Richard L. Gallo (University of California, USA) (Nizet et al. 2001). 
Infections were performed in six-to-eight week-old specific-pathogen-free females 
as described (Cabanes et al. 2008). Briefly, for oral infections, 12-h starved 
animals were inoculated by gavage with 109 CFU in PBS containing 150 mg/ml 
CaCO3, while intravenous infections were performed through the tail vein with 
104 CFU in PBS. In both cases, the infection was carried out for 72 h, at which 
point the animals were euthanatized by general anesthesia. The spleen and liver 
were aseptically collected, homogenized in sterile PBS, and serial dilutions of the 
organ homogenates plated in BHI agar. For analysis of Lm fecal carriage, total 
feces produced by each infected animal (n=5 per strain) up to a given time-point 
were collected, homogenized in PBS and serial dilutions plated in Listeria selective 
media (Oxoid) for bacterial enumeration. Mice were maintained at the IBMC 
animal facilities, in high efficiency particulate air (HEPA) filter-bearing cages under 
12 h light cycles, and were given sterile chow and autoclaved water ad libitum. 
 
I.6.18. Ethics Statement 
 
All the animal procedures were in agreement with the guidelines of the 
European Commission for the handling of laboratory animals (directive 
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2010/63/EU), with the Portuguese legislation for the use of animals for scientific 
purposes (Decreto-Lei 113/2013), and were approved by the IBMC Animal Ethics 
Committee, as well as by the Direcção Geral de Veterinária, the Portuguese 
authority for animal protection, under license PTDC/SAU-MIC/111581/2009. 
 
I.6.19. Statistical analyses 
 
Statistical analyses were performed with Prism 6 (GraphPad Software). 
Unpaired two-tailed Student’s t-test was used to compare the means of two 
groups; one-way ANOVA was used with Tukey’s post-hoc test for pairwise 
comparison of means from more than two groups, or with Dunnett’s post-hoc test 
for comparison of means relative to the mean of a control group. Mean differences 
were considered statistically non-significant (ns) when p value was above 0.05. 
For statistically significant differences: *, p≤0.05; **, p≤0.01; ***, p≤0.001. 
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I.8. Tables 
 
Table 1. Plasmids and bacterial strains 
Plasmid or strain Code Relevant characteristics Source 
Plasmids 
pMAD  Gram-negative/Gram-positive shuttle 
vector; thermosensitive replication; 
Amp
r
 Ery
r
  
Arnaud et al. 
2004 
pPL2  L. monocytogenes phage-derived site-
specific integration vector; Cm
r
 
Lauer et al. 
2002 
pMAD(ΔrmlACBD) pDC303 pMAD with 5’- and 3’-flanking regions 
of rmlACBD locus; Amp
r
 Ery
r
 
This study 
pPL2(rmlACBD)  pDC313 pPL2 with rmlACBD locus and 5’- and 
3’-flanking regions; Cm
r
 
This study 
pMAD(ΔrmlT)   pDC491 pMAD with 5’- and 3’-flanking regions 
of rmlT; Amp
r
 Ery
r
 
This study 
pPL2(rmlT) pDC550 pPL2 with rmlT sequence and 5’- and 
3’-flanking regions; Cm
r
 
This study 
E. coli strains 
DH5α  Cloning host strain; F
-
 Φ80lacZΔM15 
Δ(lacZYA-argF) U169 recA1 endA1 
hsdR17(rk
-
, mk
+
) phoA supE44 thi-1 
gyrA96 relA1 λ
-
 
Life 
Technologies 
S17-1  Conjugative donor strain; recA pro 
hsdR RP4-2-Tc::Mu-Km::Tn7 
Simon et al. 
1983 
L. monocytogenes strains 
EGD-e  wild type; serotype 1/2a Glaser et al. 
2001 
EGD-e ΔpgdA  EGD-e pgdA (lmo0415) deletion 
mutant 
Boneca et al. 
2007 
EGD-e ΔrmlACBD  DC307 EGD-e rmlACBD (lmo1081–4) 
deletion mutant 
This study 
EGD-e ΔrmlACBD::pPL2(rmlACBD)  DC367 EGD-e rmlACBD (lmo1081–4) 
deletion mutant complemented with 
pPL2(rmlACBD) (pDC313); Cm
r
 
This study 
EGD-e ΔrmlT  DC492 EGD-e rmlT (lmo1080) deletion 
mutant 
This study 
EGD-e ΔrmlT::pPL2(rmlT) DC553 EGD-e rmlT (lmo1080) deletion 
mutant complemented with 
pPL2(rmlT) (pDC550); Cm
r
 
This study 
EGD-e ΔtagO1ΔtagO2::pLIV2(tagO1)  EGD-e tagO1 (lmo0959) and tagO2 
(lmo2519) double deletion mutant 
complemented with pLIV2(tagO1), 
expressing tagO1 under the control 
of an IPTG-inducible promoter; Cm
r
 
Eugster and 
Loessner 2012 
EGD BUG600 wild type; serotype 1/2a Murray et al. 
1926 
EGD ΔdltA BUG2182 EGD dltA (LMON_0982) deletion 
mutant 
Mandin et al. 
2005 
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I.9. Supplementary information 
 
 
 
Fig. S1. Proteins involved in Lm WTA L-rhamnosylation. (A) Schematic diagram of the L-rhamnose 
biosynthesis pathway (adapted from (Giraud and Naismith 2000, Li et al. 2006)). Each of the RmlACBD 
proteins catalyzes one of the four reaction steps that convert glucose-1-phosphate into nucleotide-linked L-
rhamnose. dTTP, thymidine triphosphate; PPi, pyrophosphate; NADP, nicotinamide adenine dinucleotide 
phosphate. (B) Alignment of the amino acid sequences of B. subtilis 168 GgaB (GenBank: AAA73513.1) and 
Lm RmlT (GenBank: NP_464605.1). Boxed sequences correspond to the GT-A glycosyltransferase fold 
domain, as predicted by the NCBI Conserved Domain Search. The GT-A family signature DxD motif is 
highlighted in dark gray. The numbers indicate the position of the last amino acid in each line. Protein 
sequence alignments were obtained with ClustalW2 and edited with UCSF Chimera. 
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Fig. S2. Genetic characterization of Lm strains used in this study. (A) Genotypes and gene expression of 
the constructed Lm strains were confirmed by PCR and RT-PCR. (B) Comparison of the rmlACBD 
transcription levels in ΔrmlT versus wild type Lm strains by quantitative real-time PCR. Data represent the 
mean±SD of three independent analyses. *, p≤0.05.  
 
 
 
 
Fig. S3. HPLC analyses of the cell wall sugar and muropeptide composition from Lm strains. (A) 
HPAEC-PAD analysis of the sugar composition of cell wall purified from Lm strains. Samples were hydrolyzed 
in 3 M HCl (2 h, 95 ºC), diluted with water and lyophilized before injection into the HPLC equipment. 
Standards for ribitol (Rib), L-rhamnose (Rha), glucosamine (GlcN), and muramic acid (Mur) were eluted under 
identical conditions to allow peak identification. (B) Reverse-phase HPLC analysis of the muropeptide 
composition from different Lm strains, following overnight digestion of purified peptidoglycan samples with 
mutanolysin and reduction with NaBH4. Muropeptide species (monomeric, dimeric, trimeric, etc.) were eluted 
with a 5–30% methanol gradient and detected by UV absorption at 206 nm. 
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Fig. S4. Dose-dependent survival response of Lm strains to different AMPs. Quantification of viable 
bacteria after treatment of mid-exponential-phase Lm strains (2 h, 37 ºC) with increasing concentrations of 
gallidermin, CRAMP or LL-37. The average replicate values from AMP-treated samples were expressed as 
percentage of surviving bacteria relative to the values of the respective untreated control samples (set at 100). 
Data represent mean±SD of three independent experiments. Asterisks indicate statistical significance 
between wild type and mutant strains (*, p≤0.05; ***, p≤0.001), while hashes indicate statistical significance 
between mutant and respective complemented strains (#, p≤0.05; ###, p≤0.001). 
 
 
 
 
Fig. S5. Zeta potential profile of wild type and WTA L-rhamnosylation mutant Lm strains. 
 
 
 
Fig. S6. Determination of the Lm membrane potential magnitude by flow cytometry. The membrane 
potential of untreated and sodium azide (1.5 mM)-treated suspensions of DiOC2(3)-stained wild type EGD-e 
suspensions was analyzed (see Materials and Methods) to determine the red/green fluorescence ratio values 
corresponding, respectively, to a basal (100%) and null (0%) membrane potential. 
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Fig. S7. SYTOX Green uptake kinetics of Lm strains in response to CRAMP-mediated membrane 
permeabilization. Exponential-phase bacteria were incubated (37 ºC) with PBS (white symbols) or 50 μg/ml 
CRAMP (black symbols), in the presence of 1 μM SYTOX Green, and the increase in green fluorescence 
emission was recorded over 115 min. 
 
 
 
 
Fig. S8. Growth of Lm strains in broth and inside eukaryotic host cells. (A) Stationary-phase cultures 
were diluted 100-fold in BHI broth and incubated at 37 °C in aerobic and shaking conditions. Optical density 
values at 600 nm (OD600) from each culture were measured every hour. (B) Intracellular multiplication in 
J774A.1 murine macrophages. Cells (2×10
5
/well) were infected (45 min) with Lm, treated with 20 μg/ml 
gentamicin (75 min) and lysed at 2, 5, 7 and 20 h post-infection for quantification of intracellular viable bacteria 
in BHI agar. 
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Table S1. Homology between the RmlACBD proteins of Lm EGD-e and other strains and species
a
 
Species
b
 / Strain Serovar RmlA RmlB RmlC RmlD 
Lmo 10403S 1/2a 100 100 100 100 
Lmo SLCC2755 1/2b 100 99 99.5 99.3 
Lmo SLCC2372 1/2c 100 100 100 100 
Lmo SLCC2479 3c 100 100 100 100 
Lmo SLCC2482 7 100 98.7 99.5 99.3 
Lse SLCC3954 1/2b 97.2 95.1 98.4 92.0 
Smu UA159  74.6 45.7 28.6 51.6 
Mtu H37Rv  58.3 46.7 33.5 34.3 
Sen LT2  68.4 51.8 46.4 34.8 
Sfl 2457T  70.8 51.5 48.0 35.9 
Pae PAO1  69.1 52.4 47.2 32.2 
a 
Values in percentage of amino acid identity as determined by protein-protein BLAST analysis.
 
b 
Lmo, Listeria monocytogenes; Lse, Listeria seeligeri; Smu, Streptococcus mutans; Mtu, Mycobacterium 
tuberculosis; Sen, Salmonella enterica serovar Typhimurium; Sfl, Shigella flexneri; Pae, Pseudomonas 
aeruginosa 
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Table S2. Primers 
# Name Sequence (5’ to 3’)
a
 
Construction of plasmids and screening of clones 
1 rmlA-A TACGTCGACTGCTCAAATCGATGCTGG 
2 rmlA-B CGACGCGTCATTCTTTTCTCTCC 
3 rmlD-C ATACGCGTTTGGCAAGATGCTTTAGTTCG 
4 rmlD-D ATTAGATCTTAGTGGTCTCCACCAAGC 
5 rmlA-F GGCTACCACGTGAATGATCC 
6 rmlA-R AACTCACCACGTTCAGATGG 
7 rmlB-F GCAGCAGAATCTCATGTAGACC 
8 rmlB-R CCAGTTTCTCCAAGTGAACC 
9 rmlC-F ACATACGGTGAGTGGGAAGG 
10 rmlC-R AATCCGGATCATCGTAGGC 
11 rmlD-F TGGGAAGTAAACGTGGATGG 
12 rmlD-R CCAAACACCCATGAAGTACG 
13 rmlA-G ATACTATGCGGCCGCTTCATGTGTTTGGTGAAAGC 
14 rmlD-H GCGGTCGACACAATTATACGAATGCATCG 
15 rmlT-A ATAGTCGACCCTAAAGTTAATGGCAAAGCTCCTGC 
16 rmlT-B CGAATTCCATTATATCCTCCTAAAATAGATTAACAG 
17 rmlT-C CGAATTCTAAGAATGGAGAGAAAAGAATGAAAGG 
18 rmlT-D ACTAGATCTCAATTTCCATTAGTACGCCTCACTC 
19 rmlT-F TATTGCCACACGCTTTACCG 
20 rmlT-R CTTCCACGATTGAACGAACG 
21 rmlT-G TATCTGCAGGAGGGAAAACGTTAGGTAGC 
22 rmlT-H GCGGTCGACCTAGTTCCACTTCCTCCTGC 
23 PL95 ACATAATCAGTCCAAAGTAGATGC 
24 PL102 TATCAGACCTAACCCAAACCTTCC 
Quantitative real-time PCR 
25 qPCR-rmlA-F TTCTTGAAGCGTCTACCT 
26 qPCR-rmlA-R GCAGCCTCATCAATATACC 
27 qPCR-rmlB-F GTAGACCGTAGTATTATCAATCC 
28 qPCR-rmlB-R TCTCCAAGTGAACCATACA 
29 qPCR-rmlC-F TATTCAAGATAACCACTC 
30 qPCR-rmlC-R TCAACAACTACATCATAA 
31 qPCR-rmlD-F AGATTCTGTAGATATTGTGGAT 
32 qPCR-rmlD-R CATCTTCTGCTGCTTCTA 
32 qPCR-16S-F GCGTAGATATGTGGAGGAAC 
33 qPCR-16S-R CAGGCGGAGTGCTTAATG 
a
 Restriction sites underlined 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PART II 
 
 
L-Rhamnosylation of Listeria monocytogenes wall teichoic acids 
is required for efficient surface anchoring of GW proteins 
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II.1. Introduction 
 
In Gram-positive bacteria, a large portion of surface proteins associate non-
covalently with cell envelope components through interactions that are commonly 
mediated by protein domains containing repeated sequences. Interestingly, many 
of these proteins appear to be associated with autolytic functions (Scott and 
Barnett 2006, Bierne and Cossart 2007), indicating that this type of labile, 
reversible cell surface association provides some sort of positional flexibility for 
bacterial cell wall-degrading enzymes that is key for their optimal activity. Repeat 
domains like the LysM domain anchor proteins directly to the peptidoglycan (Buist 
et al. 2008), while others have affinity for secondary cell wall polymers, such as 
TAs. For instance, the pneumococcal virulence-promoting PspA adhesin and LytA 
amidase have similar C-terminal choline-binding repeats, which are necessary and 
sufficient for their attachment to the S. pneumoniae choline-decorated LTAs 
(Holtje and Tomasz 1975, Yother and White 1994). Similarly, proteins carrying GW 
repeat domains were shown or at least strongly suggested to interact with LTAs, 
as observed in the cases of the S. aureus autolysin Atl (Yamada et al. 1996), and 
the Lm invasin InlB and autolysin Ami (Jonquières et al. 1999). 
WTAs also dictate the localization and control the activity of autolytic proteins 
at the bacterial surface (Brown et al. 2013). Characterization of S. aureus WTA 
mutants revealed anomalies in autolysis levels and in the ability to properly form 
septa and/or complete cell division (Vergara-Irigaray et al. 2008, Schlag et al. 
2010, Biswas et al. 2012, Qamar and Golemi-Kotra 2012). Moreover, the particular 
contribution of WTA substituents to S. aureus autolysis was contrasting: whereas 
D-alanylation is essential for proper autolytic activity (Peschel et al. 2000), the 
impairment of WTA glycosylation with GlcNAc did not perturb this process (Brown 
et al. 2012), indicating that sugar substituents are not involved in WTA-mediated 
regulation of autolysis. In Lm, LTA D-alanylation is required for cell adhesion and 
virulence in vivo (Abachin et al. 2002), however its role in autolysis was never 
addressed. Likewise, information regarding the contribution of Lm WTAs – and of 
their glycosidic substituents – to this process is currently nonexistent. Therefore, 
we decided to study the involvement of this particular WTA tailoring mechanism in 
the spatial and functional regulation of Lm autolysis.  
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We showed that an Lm mutant strain lacking L-rhamnosylated WTAs 
(ΔrmlACBD) displays a reduced autolysis rate in comparison with a wild type 
strain. This phenotype appears to be linked to a prominent decrease of the Lm cell 
surface-associated levels of the autolysin Ami. Moreover, we observed that this 
decrease is concurrent with secretion of Ami to culture supernatants, suggesting 
that WTA L-rhamnosylation is necessary for efficient association of Ami to the Lm 
cell surface. To determine if other Lm GW proteins were similarly affected, we 
screened for WTA L-rhamnosylation-dependent variations in the surface 
association of the remaining eight GW repeat-containing proteins encoded in the 
Lm genome (Cabanes et al. 2002). Besides Ami, only InlB showed an anchoring 
mechanism dependent on the Lm WTA L-rhamnosylation status, albeit to a lesser 
degree. This shift in the relative distribution of this major Lm invasin may be 
responsible for the impaired entry of the ΔrmlACBD strain in different epithelial cell 
lines. These data reveal novel roles for WTA L-rhamnosylation in Lm biology, such 
as supporting autolytic processes and promoting host cell invasion, via its 
contribution to the efficient anchoring of a particular group of surface proteins. 
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II.2. Results 
 
II.2.1. WTA L-rhamnosylation-deficient Lm is less autolytic due to deficient 
surface anchoring of the autolysin Ami 
 
To assess the contribution of WTA L-rhamnosylation to autolytic processes in 
Lm, we performed an in vitro autolysis assay through which we compared the lysis 
kinetics of wild type and WTA L-rhamnosylation-deficient (ΔrmlACBD) Lm strains 
shaken at 37 ºC in a neutral pH buffer. We observed that bacterial suspensions 
containing the ΔrmlACBD strain clarified at a slower pace than the ones containing 
the wild type strain (Fig. 25A), indicating that autolysis was decreased in Lm 
populations lacking L-rhamnosylated WTAs. This WTA L-rhamnosylation 
dependence for normal autolytic activity was corroborated by the lysis profile of the 
complemented ΔrmlACBD strain (ΔrmlACBD+rmlACBD) in the same conditions, 
which showed reversion (albeit partial) of the mutant phenotype towards a wild 
type-like autolytic phenotype (Fig. 25A). 
 The reduced autolytic levels observed in WTA L-rhamnosylation mutant 
bacteria could be the result of a decrease in the surface localization and/or activity 
of autolytic enzymes. To determine which of these hypotheses was true we 
analyzed the surface proteomes – in particular, non-covalently cell wall-attached 
proteins, which include most autolysins – of wild type and ΔrmlACBD bacteria, in 
search of significant protein content changes between both strains. After SDS-
mediated retrieval of surface proteins from mid-exponential-phase bacteria, 
extracts were resolved by SDS-PAGE and proteins visualized by Coomassie 
staining. We observed a striking reduction in the amount of an abundant 75–100 
kDa protein in the ΔrmlACBD sample relative to the same band present in the wild 
type extract (Fig. 25B). Moreover, this decrease is dependent on the presence of 
L-rhamnosylated WTAs, since the amount of this protein in ΔrmlACBD+rmlACBD 
bacteria increased to levels similar to those observed in wild type extracts 
(Fig. 25B). Through peptide mass fingerprinting, this protein was identified 
(confidence index of 100%) as the Lm virulence-associated autolytic amidase Ami 
(McLaughlan and Foster 1998, Milohanic et al. 2001). This decrease in the amount 
of surface-associated Ami in ΔrmlACBD bacteria agrees with the lower levels of 
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autolysis observed in this strain, indicating that WTA L-rhamnosylation is required 
to maintain a certain amount of Ami at the Lm cell surface and thus support a 
physiological level of autolytic activity. 
Taking into account that Ami is a member of the GW protein family in Lm 
(Cabanes et al. 2002) and that TAs are important surface anchors of proteins 
bearing this class of cell wall-binding repeat domains (Yamada et al. 1996, 
Jonquières et al. 1999), we investigated if the diminished levels of Ami at the cell 
surface of WTA L-rhamnosylation mutant bacteria were a consequence of a defect 
 
Fig. 25. WTA L-rhamnosylation-deficient Lm is less autolytic due to deficient surface anchoring of the 
autolysin Ami. (A) Lm strains grown to the exponential phase (OD600 1.0) were washed and resuspended in 
1 volume of 50 mM glycine buffer (pH 8.0). Bacterial suspensions were incubated at 37 ºC with shaking and 
autolysis was measured at different time points as the decrease in OD600 relative to the initial value, set as 
100%. (B) Non-covalently associated surface proteins were extracted from mid-exponential-phase Lm strains 
with 2% SDS (37 ºC, 30 min), concentrated, resolved by SDS-PAGE and stained with Coomassie Brilliant 
blue. Black arrow indicates a protein with strain-dependent quantity changes that was identified by peptide 
mass fingerprinting as Ami. Mw, molecular weight ladder (standard band weight indicated in kDa). (C) Non-
covalently associated surface proteins (obtained as in B) and secreted proteins (recovered from culture 
supernatant) from Lm strains were analyzed by Western blot to detect the levels of Ami. The listerial GAPDH 
(GAPDHLm) protein was used as loading control. Blots are representative of two independent experiments. (D) 
Ami is highly secreted to the surrounding environment in the absence of L-rhamnosylated WTAs. Data from a 
comparative secretomic analysis of wild type (EGD-e) and ΔrmlACBD strains shows an increase in the 
number of Ami-derived peptides detected in the ΔrmlACBD culture supernatant sample. 
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in the cell wall association of this protein. To do this, we performed a Western blot 
analysis of the (SDS-extractable) surface protein and the secreted protein 
fractions from both wild type and ΔrmlACBD strains, using an anti-Ami antiserum 
to detect this protein. Immunoblot results confirmed the SDS-PAGE results 
(Fig. 25B), showing the same drop of surface-associated Ami levels in mutant 
bacteria as compared to wild type bacteria (Fig. 25C). Conversely, a significantly 
higher amount of Ami was detected in the secreted protein fraction of the 
ΔrmlACBD strain (Fig. 25C). Mutant complementation restored the protein levels 
in each fraction to those observed in samples obtained from wild type bacteria 
(Fig. 25C). Further validation of these results was achieved with a comparative 
analysis of the secretomes of wild type and ΔrmlACBD strains, performed in 
collaboration with the group of Francisco García-del Portillo (CNB-CSIC, Madrid), 
which revealed a significant increase in the amount of Ami-derived peptides 
detected in ΔrmlACBD samples, relative to those in wild type samples (Fig. 25D).  
Altogether, these results definitively confirm that, in the absence of WTA L-
rhamnosylation, Ami protein molecules are not properly affixed to the Lm cell 
surface and, as a result, end up being secreted into the surrounding environment. 
This supports the hypothesis that the decoration of Lm WTAs with L-rhamnose 
controls the surface-associated levels of Ami, and concomitantly Ami-dependent 
autolytic events, by promoting their efficient attachment to the cell envelope. 
 
II.2.2. Study of the WTA L-rhamnosylation-dependent surface localization of 
Lm GW proteins 
 
To determine if WTA L-rhamnosylation is also important for the correct 
surface anchoring of other Lm GW proteins, we screened the surface-associated 
and secreted protein fractions from wild type and ΔrmlACBD strains expressing 
tagged variants of all nine GW proteins encoded in the Lm genome (Cabanes et 
al. 2002) in order to detect strain-dependent differences in the partition of each 
protein. To do this, we first generated a plasmid construct based on the listerial 
site-specific integrative pPL2 (Lauer et al. 2002), which enabled the expression of 
N-terminally FLAG-tagged sequences under the control of the native ami promoter 
(Fig. 26A). Nine plasmid constructs were derived from this one by cloning 
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individually the GW repeat domain-encoding sequence of each GW protein – Ami 
(Lmo2558), Auto (Lmo1076), InlB (Lmo0434), Lmo1215, Lmo1216, Lmo1521, 
Lmo2203, Lmo2591 and Lmo2713 – downstream the FLAG tag sequence. Finally, 
each plasmid was introduced and stably integrated into the chromosome of wild 
type and ΔrmlACBD bacteria, giving rise to 18 new strains.   
Following the fractionation of mid-exponential-phase cultures to obtain 
extracts of secreted and (non-covalently) surface-associated proteins, samples 
were analyzed by Western blot to detect FLAG-tagged proteins. Using an anti-
FLAG probe, we were able to visualize bands with the correct molecular weights 
from every strain (Fig. 26B), indicating that all plasmid constructs were functional 
and that bacteria were successfully expressing the tagged GW protein truncates. 
When comparing protein distribution between strains in each fraction, we observed 
different situations. Concerning the GW domain of Ami (AmiGW), the largest of all 
Lm GW proteins, with eight repeats, we confirmed the previous observations that 
showed a sharp reduction of surface-associated protein levels and a concomitant 
rise in Ami secretion in ΔrmlACBD bacteria (Fig. 26B). A similar outcome (i.e. 
lower surface association/increased secretion) was verified with InlBGW, although 
the difference was not as large as with AmiGW. As previously reported (Lingnau et 
al. 1995, Jonquières et al. 1999), FLAG-tagged InlBGW was also found in both 
fractions, showing the dual character of InlB. In contrast, the similarly sized AutoGW 
and Lmo2591GW showed no variation in their respective protein levels between 
strains. However, while the former protein was exclusively detected in the surface-
associated fraction, the latter was only present in the secreted protein extracts 
(Fig. 26B). The remaining (and smallest) GW protein truncates (Lmo1215GW, 
Lmo1216GW, Lmo1521GW, Lmo2203GW and Lmo2713GW), were all detected solely 
in the secreted fractions of both strains, like Lmo2591GW (Fig. 26B).  
These results indicate that other Lm GW proteins besides Ami rely on WTA 
L-rhamnosylation for proper attachment to the bacterial surface. Moreover, they 
suggest that whereas proteins with large-sized GW repeat domains display a WTA 
L-rhamnosylation-dependent mechanism of Lm cell surface association, this 
dependence seems to be lost in proteins with increasingly smaller GW domains, 
as such proteins are frequently found to be fully secreted. 
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A 
 
B 
 
Fig. 26. Study of the WTA L-rhamnosylation-dependent surface localization of Lm GW proteins. (A) 
Map of the plasmid template used to enable ami promoter (Pami, white boxed sequence)-dependent 
expression of N-terminally FLAG-tagged proteins targeted for secretion by the Ami signal peptide (gray boxed 
sequence). The vector backbone is derived from pPL2 plasmid (Lauer et al. 2002). Other sequence elements, 
such as the -35 and -10 promoter boxes, the transcription start site (+), the ribosome-binding site (RBS), and 
unique restriction enzyme sites are underlined. (B) Mid-exponential-phase cultures of wild type and 
ΔrmlACBD bacteria expressing FLAG-tagged proteins corresponding to the GW repeat domains of each of 
the nine Lm GW proteins were processed for the recovery of secreted proteins and non-covalently associated 
surface proteins. Proteins extracts were concentrated and analyzed by Western blot, using an anti-FLAG tag 
antibody to detect GW domain proteins and compare their levels between strains and fractions. The listerial 
GAPDH protein was used as loading control. IB, immunoblotting antibody. 
pDC426 
(6368 bp) 
PSA integrase 
Piap 
CmR (Gram+) 
CmR (Gram-) 
p15A ori 
RP4 oriT 
PSA  
attPP’ 
SalI        PstI 
FLAG Pami Ami (1−30 aa = signal peptide) 
TTG (Start codon) 
   | 
 Sal I                                                  -35                   -10        + 
GTCGACTTTACAGAAAAAAACATACGTAAATAGGTTCATTGTTACCAATATCCATTGACTACAACCAGACGTGTTGTCATAATTAGAAATAGAATACTT 
 
 
                              RBS 
TTATTTAATATAAAAAGTAGTGCAGTTAGGAGAGGATTTAAACT TTGAAAAAATTAGTAAAATCGGCGGTTGTTTTTGCAAGCCTTGTTTTTATTGGC 
                                             MetArgArgLeuValArgCysAlaValValPheAlaCysLeuValPheIleGly 
 
                                             FLAG             Pst I 
ACCTCCGCTACTATGATTACAGAAAAAGCAAGTGCTGATTACAAGGATGACGATGACAAGGCTGCAG  
ThrCysAlaThrMetIleThrGluArgAlaCysAlaAspTyr Ar gAspAspAspAspAr gAlaAla 
137 bp 90 bp 25 bp 
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II.2.3. WTA L-rhamnosylation is required for host cell invasion  
 
The previous results showed that only two members of the Lm family of GW 
proteins were differentially anchored to the bacterial surface in a WTA L-
rhamnosylation-dependent fashion: the autolysin Ami and the host cell invasion-
promoting protein InlB. We proposed a link between the reduced amount of 
surface-associated Ami and the lower levels of autolysis observed in ΔrmlACBD 
bacteria, so we sought to investigate the effect of the decreased bacteria-
associated InlB levels in the ability of Lm to interact with and enter into host cells.   
Having confirmed the increased secretion of the native, full-length InlB 
protein in ΔrmlACBD bacteria by Western blot, using an InlB-specific antibody 
(Fig. 27A), we began this study by testing the cell-adhesive potential of Lm lacking 
 
Fig. 27. WTA L-rhamnosylation is required for host cell invasion but not adhesion. (A) Non-covalently 
associated surface and secreted protein fractions from Lm strains were analyzed by Western blot to detect 
the InlB. The listerial GAPDH (GAPDHLm) protein was used as loading control. Blots are representative of two 
independent experiments. (B, C) Caco-2 and HeLa cell monolayers were used to evaluate the host cell 
adhesion and invasion capacity of wild type (EGD-e) and WTA L-rhamnosylation-deficient (ΔrmlACBD) Lm 
strains. For adhesion assays (B), cells were infected (MOI 50) for 30 min (37 ºC, 7% CO2), washed thoroughly 
and lysed in cold 0.2% Triton X-100 for CFU quantification of cell-associated bacteria. For invasion assays 
(C), cells were infected (MOI 50) for 1 h (37 ºC, 7% CO2), treated with 20 μg/ml gentamicin for 1.5 h (37 ºC, 
7% CO2), washed thoroughly and lysed in cold 0.2% Triton X-100 for CFU quantification of intracellular 
bacteria. Data are represent as mean±SD (n=3) and presented as percentage relative to the wild type value, 
set at 100. Statistical analyses were performed using an unpaired, two-tailed t-test (ns, not significant; ***, 
p<0,001). 
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L-rhamnose-decorated WTAs. For this, human epithelial cell lines (Caco-2 and 
HeLa) were briefly incubated with either wild type or ΔrmlACBD Lm strains and 
after several washes the number of cell-associated bacteria was quantified. 
Mutant bacteria evidenced a cell-binding ability comparable to that of their wild 
type congeners, indicating that the surface depletion of Ami and InlB does not 
interfere with the attachment efficiency of WTA L-rhamnosylation-deprived Lm 
(Fig. 27B). Next, we compared the invasiveness of these strains using the same 
eukaryotic cell lines. Unlike their wild type-like adhesive properties, ΔrmlACBD 
bacteria displayed a significant reduction of their intracellular levels in both Caco-2 
and HeLa cells (<40% of wild type) after 2.5 hours of infection (Fig. 27C), 
revealing a strong impairment of Lm-induced uptake by target cells in the absence 
of L-rhamnosylated WTAs. This attenuated phenotype correlates with the 
decrease in Lm surface levels of InlB observed in the ΔrmlACBD strain, as 
Lm ΔinlB mutants were previously shown to be weakly to non-invasive in these 
cell lines (Dramsi et al. 1995, Ireton et al. 1996).  
Importantly, these results unveil a novel link between WTA L-rhamnosylation 
and Lm virulence via its contribution towards the maintenance of optimal levels of 
the surface-associated invasin InlB. 
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II.3. Discussion 
 
The Gram-positive cell envelope is host to a vast array of proteins whose 
diversity of structural and functional roles is extremely important not only for cell 
surface maintenance and metabolism but also for overall bacterial physiology and 
viability (Navarre and Schneewind 1999). Several proteins interact with the 
bacterial surface in a non-covalent manner that is often based in the affinity 
between protein repeat-containing domains and specific cell envelope components 
(Desvaux et al. 2006). Interestingly, a considerable number of proteins using this 
mechanism of surface association is known or predicted to have autolytic (i.e. cell 
wall-degrading) functions (Desvaux et al. 2006, Scott and Barnett 2006, Bierne 
and Cossart 2007). TAs have been either identified or presumed to perform cell 
envelope protein-anchoring functions in different species (Holtje and Tomasz 
1975, Yother and White 1994, Yamada et al. 1996, Jonquières et al. 1999). In 
some cases, this role was found to be determined by TA substituents, such as 
choline in streptococci (Holtje and Tomasz 1975) and D-alanine in S. aureus 
(Peschel et al. 2000).  
In the case of Lm, there are no evidences regarding TA-mediated anchoring 
of autolysins, although it has been suggested (Asano et al. 2012) that the 
virulence-associated amidase Ami (Milohanic et al. 2001) may bind to LTAs via its 
GW repeat domain, in a process similar to that of InlB (Jonquières et al. 1999). 
The lack of information concerning the particular involvement of Lm WTAs and 
their substituents in the surface positioning and activity of autolysins prompted us 
to address this question. This work confirmed the existence of a link between Lm 
WTA L-rhamnosylation and autolytic activity. It specifically showed that this 
tailoring mechanism is required to support basal levels of autolysis through the 
efficient attachment of Ami to the Lm cell surface. In addition, it revealed that InlB, 
a major cell invasion-promoting factor that contains a GW repeat domain similar to 
Ami, is also less associated with the surface of Lm lacking L-rhamnosylated WTAs. 
Importantly, this finding is consistent with a significant impairment of host cell 
invasion levels observed in these mutant bacteria. 
To answer the question of whether L-rhamnosylation of Lm WTAs contributes 
to the mechanisms of bacterial self-degradation, a simple in vitro autolysis assay 
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revealed that the rate of self-induced lysis was diminished in bacteria devoid of 
this WTA glycosylation mechanism, and that its reintroduction was sufficient to 
restore normal levels of autolysis. A similar observation was made with S. aureus 
dltA mutants, unable to perform D-alanylation of TAs (Peschel et al. 2000). In this 
case, it was suggested that the strongly anionic D-alanine ester-free TAs bind 
avidly the positively charged autolysins (Fischer et al. 1981), inhibiting their action 
through entrapment. However, a parallel study using a dltC mutant in another 
S. aureus strain background and slightly different experimental conditions provided 
an opposite phenotype, i.e. enhanced cell lysis (Nakao et al. 2000). This was also 
reported in D-alanylation mutant strains of L. lactis and L. plantarum (Steen et al. 
2005, Palumbo et al. 2006). In both situations, unrestrained activity of a major 
autolysin is pointed as the reason for the mutant phenotypes. In the L. lactis 
mutant, this was attributed in part to a reduced HtrA-mediated degradation of the 
AcmA autolysin (Steen et al. 2005), while the LTA polymers of the L. plantarum 
dltA mutant were longer and heavily glucosylated (Palumbo et al. 2006). The 
conflicting behaviors observed in different bacterial species deficient in the same 
mechanism highlight the complexity of the mechanisms linking TAs and autolysin 
activity. 
Reduced surface levels of autolytic proteins can explain the decline in the 
levels of autolysis observed in WTA L-rhamnosylation-deprived Lm. Our data from 
an SDS-PAGE analysis of non-covalently associated surface protein extracts from 
WTA L-rhamnosylation mutant Lm revealed a striking drop in the amount of a high-
molecular weight protein (~100 kDa) in comparison with its levels in wild type 
bacterial extracts. We identified this protein as Ami, a 99-kDa autolytic N-
acetylmuramoyl-L-alanine amidase (McLaughlan and Foster 1998), whose 
immature precursor weighs 102 kDa before signal peptide cleavage. Ami is the 
biggest of nine Lm surface proteins containing a domain with GW module repeats 
(Cabanes et al. 2002). Its considerable length (917-aa precursor) is conferred by 
an extensive C-terminal domain with eight (or four pairs of) GW module repeats 
(McLaughlan and Foster 1998, Milohanic et al. 2001, Cabanes et al. 2002). InlB, 
another Lm GW protein, is reversibly attached to the cell envelope via interaction 
with LTAs (Jonquières et al. 1999). As mentioned before, it is suggested that Ami 
also associates with the Lm cell surface by binding to LTAs (Braun et al. 1997, 
CHAPTER III – RESULTS 
 
 
 163 
Jonquières et al. 1999, Asano et al. 2012), although this still requires direct 
experimental confirmation.  
Considering the reduction of the surface levels of Ami in Lm cells lacking L-
rhamnosylated WTAs and previous studies supporting the participation of TAs in 
the non-covalent anchoring of surface proteins bearing repeat domains, we 
investigated the potential involvement of WTAs – and in particular the contribution 
of their decoration with L-rhamnose – in the interaction of Ami with the Lm surface. 
Our data from immunoblot analysis of the Lm surface protein and secreted protein 
fractions, complemented with a high-throughput secretomic study of the wild type 
and mutant strains, demonstrated that the absence of WTA L-rhamnosylation 
results in significant oversecretion of Ami, which explains the fate of the missing 
surface-associated protein. Although it would be interesting to verify if there are 
changes in the total levels of Ami expression in both strains, it seems clear that 
there is a shift in the spatial distribution of Ami, from a predominant Lm surface 
localization to a chiefly secreted form. This finding uncovers a rather preeminent 
role for WTA L-rhamnosylation in the mechanisms of surface protein anchoring, 
since to our knowledge there was no prior evidence of WTA glycosidic 
substituents having such a significant influence, either direct or indirect, on surface 
protein binding levels. In this context, it would be important to confirm the role of 
LTAs as prime surface anchors for Ami and investigate if L-rhamnosylated WTAs 
can act as some sort of secondary structures that help stabilize the Ami-LTA 
interaction. For the latter hypothesis, surface-associated Ami protein levels could 
be quantified in an Lm WTA mutant strain, although the severe growth and 
morphological defects characteristic of this strain should be taken into account 
(Eugster and Loessner 2012). Interestingly, one report characterizing Ami 
orthologues produced by Lm strains of serotypes 1/2a and 4b showed that (i) each 
protein only bound efficiently to the surface of bacteria from its own serotype, and 
that (ii) the GW domain sequences are homologous within serotypes with similar 
WTA structures (Milohanic et al. 2004). This highlights a clear role for WTAs and 
its sugar substituents in the anchoring of Ami and potentially of other GW proteins. 
Besides Ami and InlB, Lm encodes seven other GW proteins (Cabanes et al. 
2002). Among these, only one, Auto (Lmo1076), has been characterized as an 
autolysin (Cabanes et al. 2004) that, unlike Ami, possesses NAGase activity 
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(Bublitz et al. 2009). We attempted to evaluate a potential WTA L-rhamnosylation 
dependence in the cell surface anchoring mechanism of Lm GW proteins other 
than Ami. In our approach, each protein was represented solely by its GW repeat 
domain for two reasons: (i) to assess its specific contribution in full-length protein 
binding, and (ii) to prevent toxicity/lethality during the cloning stages, as the 
catalytic domains of all but two GW proteins (InlB and Lmo2713) are predicted to 
have bacteriolytic activities (Bierne and Cossart 2007). Indeed, previous studies 
were troubled by unsuccessful attempts to clone either the full-length or the N-
terminal fragments of Ami (Braun et al. 1997, McLaughlan and Foster 1998). 
Recently, Asano and colleagues were successful in cloning and expressing 
recombinant Ami forms containing the amidase domain (Asano et al. 2012), 
showing that it is possible to express heterologously the full-length form of this 
autolysin.  
Our results show that the effect observed with native Ami was reproduced 
with only its GW domain (AmiGW), indicating that this repeat-rich region is entirely 
responsible for Lm surface anchoring of full-length Ami and strengthening the 
supportive role of L-rhamnosylated WTAs in this process. In addition, they 
revealed that, besides AmiGW, only InlBGW displayed increased secretion in the 
absence of WTA L-rhamnosylation. This effect was also observed with the native 
full-length InlB protein. However, the extent of this oversecretion is not as big as 
the one observed with AmiGW, which is not surprising considering that InlB is 
already found in both bacterium-associated and secreted forms in wild type 
conditions (Braun et al. 1997, Jonquières et al. 1999). While none of the remaining 
seven GW domains showed strain-dependent variations of their protein levels, 
they were exclusively detected either in the Lm surface (AutoGW) or in the secreted 
protein fraction (all others). It is interesting to observe GW domains of different 
proteins (Auto and Lmo2591), but with similar molecular weights and equal 
number of repeats, displaying totally opposite localizations. This strongly suggests 
that other sequence elements besides the number of GW module repeats (Braun 
et al. 1997) may also determine the spatial localization of these proteins.  
Immunoblot detection of the FLAG-tagged GW domains became increasingly 
difficult with decreasing molecular weight, indicating that smaller proteins are not 
as well expressed as the larger ones or that they are not as easily recovered from 
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culture supernatants during precipitation. Since all GW domains were expressed 
under the control of the same promoter (ami), the second hypothesis seems more 
plausible. Although this analysis requires further confirmation, its results provide 
significant insights into the anchoring mechanisms of each Lm GW protein. 
As a major determinant of Lm internalization into different types of host cells 
(Dramsi et al. 1995, Lingnau et al. 1995, Ireton et al. 1996, Parida et al. 1998), we 
further investigated the potential effects of enhanced InlB secretion regarding this 
process. Our data demonstrated that a WTA L-rhamnosylation Lm mutant strain is 
not affected in its ability to adhere to epithelial cell monolayers but is significantly 
attenuated in its self-induced cellular uptake levels. Functional characterization of 
Ami demonstrated its contribution towards Lm adhesion to target cells (Milohanic 
et al. 2001). However, this role appears to be secondary as it only becomes 
relevant in a ΔinlAB background, and varies in a cell type-dependent manner 
(Milohanic et al. 2001). In this context, we could expect decreased host cell 
adhesion levels in Lm WTA L-rhamnosylation mutants, since Ami levels are 
critically reduced at their surface and InlB is also partially depleted. However, it is 
likely that the remaining amount of anchored InlB, together with InlA, are sufficient 
to maintain optimal levels of eukaryotic cell association. Although InlB occurs 
normally in both surface-attached and secreted forms, the bacterium-bound form 
is more preponderant at triggering host cell internalization of Lm (Braun et al. 
1998), which could explain the attenuated phenotype of the WTA L-rhamnosylation 
mutant strain. Moreover, InlB is known to interact with other eukaryotic cell surface 
components to further promote bacterial invasion (Braun et al. 2000, Jonquières et 
al. 2001). In the case of GAGs, this interaction takes place through the GW 
domain (Jonquières et al. 2001). We can speculate that excessive amounts of 
soluble InlB close to the site of Lm association with the host cell surface may 
saturate these InlB-binding eukaryotic partners to a point where it hinders Lm 
internalization.  
Caco-2 and HeLa cell lines have been extensively used for the study of Lm 
internalization mechanisms primarily dependent on the engagement of either InlA 
(Caco-2) or InlB (HeLa). Although Caco-2 cells also express the InlB receptor c-
Met (Pizarro-Cerdá et al. 2012), our results showed a cell type-independent 
invasion defect, suggesting that the bacterial aspect of the InlA-mediated 
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internalization pathway may also be affected in the absence of WTA L-
rhamnosylation.  
In conclusion, this work has demonstrated the contribution of WTA L-
rhamnosylation to important physiological and virulence processes (invasion of 
host cells) in Lm, through a newly identified role in the anchoring and stabilization 
of non-covalently bound surface proteins sharing a common cell surface-binding 
repeat domain.  
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II.4. Materials and methods 
 
II.4.1. Bacterial strains and growth conditions 
 
Bacterial strains used in this study are listed in Table 1. Lm and E. coli 
strains were routinely cultured aerobically at 37 ºC in brain heart infusion (BHI, 
Difco) and lysogeny broth (LB) media, respectively, with shaking. When 
appropriate, the following antibiotics were added as selective agents: ampicilin 
(Amp), 100 μg/ml; chloramphenicol (Cm), 7 μg/ml (Lm) or 20 μg/ml (E. coli); 
erythromycin (Ery), 5 μg/ml. For the selection of pPL2 integrants following 
conjugation with S17-1, colistin sulfate (Col) and nalidixic acid (Nax) were used at 
10 and 50 μg/ml, respectively.  
 
II.4.2. Construction of strains expressing FLAG-tagged cell wall-binding 
domains of GW proteins 
 
A master plasmid vector derived from pPL2 (Lauer et al. 2002) was 
constructed to allow the expression and secretion of N-terminally FLAG-tagged 
proteins in Lm strains from chromosome-integrated single-copy genes. A 270-bp 
DNA fragment comprising the ami promoter (Pami) and Ami signal peptide 
(residues 1–30) sequences followed by a FLAG tag sequence was produced by 
PCR using Lm EGD-e genomic DNA as template and primers 1–2 (Table 2). After 
purification, the PCR fragment was digested and cloned between the SalI and PstI 
sites of pPL2, yielding pDC426 (Fig. 2A). This plasmid was then used to generate 
derivative constructs, each containing the GW repeat domain of one of the nine 
GW proteins encoded in the Lm genome (Cabanes et al. 2002). PCR fragments 
comprising the GW repeat domain of InlB (InlBGW, 721 bp), Auto (AutoGW, 1012 
bp), Lmo1215 (Lmo1215GW, 256 bp), Lmo1216 (Lmo1216GW, 445 bp), Lmo1521 
(Lmo1521GW, 607 bp), Lmo2203 (Lmo2203GW, 523 bp), Ami (AmiGW, 1993 bp), 
Lmo2591 (Lmo2591GW, 979 bp) and Lmo2713 (Lmo2713GW, 253 bp) were 
produced from Lm EGD-e genomic DNA using, respectively, the primer pairs 3–4, 
5–6, 7–8, 9–10, 11–12, 13–14, 15–16, 17–18 and 19–20 (Table 2). After 
purification, fragments were digested with the appropriate restriction enzymes 
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(Roche Applied Sciences) and cloned between the PstI and NotI sites of pDC426, 
to yield pDC481, pDC459, pDC460, pDC461, pDC480, pDC462, pDC440, 
pDC463 and pDC464. Each of the nine plasmid constructs were introduced into 
E. coli S17-1 and transferred to both wild-type EGD-e and ΔrmlACBD strains by 
conjugation on BHI agar. Transconjugant clones were selected in BHI–
Cm/Col/Nax and chromosomal integration of the plasmids confirmed by PCR with 
primers 21 and 22 (Table 2). Plasmid constructs were confirmed by both PCR and 
DNA sequencing. 
 
II.4.3. Autolysis assay 
 
The autolytic activity of Lm strains was monitored in vitro. Bacterial cultures 
grown to the exponential phase (OD600=1.0) were centrifuged and the pelleted 
cells were washed with ice-cold bi-distilled water and resuspended in 50 mM 
glycine buffer (pH 8.0) to a final OD600 value of 1.0. Bacterial suspensions were 
incubated at 37 ºC with shaking and the autolytic activity was measured 
throughout time as the percentage of OD600 decrease relative to the initial value. 
For each time point, values were presented as mean ± standard deviation of three 
independent experiments. 
 
II.4.4. Analysis of Lm surface and secreted protein extracts 
 
Extraction of non-covalently surface-associated and secreted Lm proteins 
was performed as described (Braun et al. 1997, Cabanes et al. 2004), with minor 
changes. Twenty-milliliter samples of Lm cultures grown to the exponential phase 
(OD600=0.8) were centrifuged (4,500 rpm, 15 min, 4 ºC) and the bacterial pellet 
and culture supernatant recovered for further processing. Bacteria were washed 
with ice-cold PBS, resuspended in 1.5 ml of a 2% SDS solution in PBS and 
incubated for 30 min at 37 ºC, to allow the extraction of non-covalently associated 
surface proteins. After centrifugation (15,000 rpm, 1 min), the recovered 
supernatant was filtered (0.22 µm) inactivated concentrated/dialysed against PBS 
in Vivaspin 4 (10-kDa cutoff) concentrators (Sartorius Stedim). Culture 
supernatants were filtered (0.22 µm) and treated with a protease inhibitor cocktail 
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mix (cOmplete, Roche Applied Sciences) before precipitation of proteins with the 
sequential addition of 0.2 mg/ml of sodium deoxycholate (30 min, 4 ºC) and 6% 
(v/v) TCA (overnight, 4 ºC). Proteins were collected by centrifugation (12,000 rpm, 
15 min, 4 ºC) and washed twice with cold acetone. The pellet was air-dried and 
resuspended in 20 mM Tris-HCl buffer (pH 7.4) to a final volume of 200 μl. 
Proteins extracts were quantified (A280) in a NanoDrop 1000 spectrophotometer 
(Thermo Scientific). 
Protein extracts were analyzed by SDS-PAGE in an 10% (v/v) 
polyacrylamide gel and stained with Coomassie Brilliant Blue or transferred 
(Trans-Blot Turbo Transfer System, Bio-Rad Laboratories) onto a nitrocellulose 
membrane and probed with mouse monoclonal anti-FLAG (clone M2, Sigma-
Aldrich), diluted 1:1000 (for surface protein extracts) or 1:250 (for secreted protein 
extracts); mouse monoclonal anti-InlB (H15.1, Braun et al. 1999), diluted 1:1000; 
rabbit polyclonal anti-Ami antiserum (R5, kind gift from Pascale Cossart), diluted 
1:2000; rabbit polyclonal anti-Lm GAPDH (GAPDHLm, Abgent), diluted 1:2000 (for 
surface protein extracts) or 1:1000 (for secreted protein extracts); and then with 
anti-mouse or anti-rabbit HRP-conjugated secondary antibodies (P.A.R.I.S 
Biotech), diluted 1:2000. Immunolabeled proteins were detected by 
chemiluminescence using Western Blotting Substrate kit (Pierce).  
 
II.4.5. Cell line infection assays 
 
Human colorectal adenocarcinoma Caco-2 (ATCC HTB-37™) and cervix 
adenocarcinoma HeLa (ATCC CCL-2™) cell lines were propagated at 37 ºC (7% 
CO2) in Eagle’s Minimum Essential Medium (EMEM) supplemented with 20% fetal 
bovine serum (FBS), 1% sodium pyruvate and 1% non-essential amino acids, and 
in Dulbecco’s Modified Eagle Medium (DMEM) supplemented with 10% FBS 
(Lonza). To assess bacterial adhesion to host cells, confluent cell monolayers 
(~2×105/well) were inoculated for 30 min at 37 ºC (7% CO2) with exponential-
phase bacteria (OD600 0.6) at a multiplicity of infection (MOI) of 75 bacteria/cell in 
cell culture medium. After removing the inoculum, cells were washed three times 
with warm medium to remove weakly associated bacteria and lysed with 1 ml of 
cold 0.2% Triton X-100. Ten-fold serial dilutions were plated in BHI agar and 
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incubated overnight at 37 ºC to allow quantification of cell-adhering bacteria. To 
assess bacterial invasion of host cells, confluent monolayers were inoculated for 1 
hour at 37 ºC (7% CO2) with exponential-phase bacteria (OD600 0.6) at a MOI 75. 
After removing the inoculum, cells were incubated for 1.5 hours at 37 ºC (7% CO2) 
with 20 μg/ml gentamicin, to kill extracellular bacteria. Cells were then treated as 
before for quantification of intracellular viable bacteria. Each condition was 
assayed in triplicate in at least three independent assays.  
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II.5. Tables 
 
Table 1. Plasmids and bacterial strains 
Plasmid or strain Code Relevant characteristics Source 
Plasmids 
pPL2  L. monocytogenes phage-derived site-
specific integration vector; Cm
r
 
Lauer et al. 
2002 
pPL2(Pami-AmiSP-FLAG)  pDC426 pPL2 carrying a DNA fragment 
containing the ami promoter and Ami 
signal peptide (SP, residues 1–30)-
encoding sequences, followed by a 
FLAG tag (DYKDDDDK)-encoding 
sequence; Cm
r
 
This study 
pDC426(InlBGW) pDC481 pDC426 carrying a DNA fragment 
encoding the InlB GW repeat domain 
(residues 399–630); Cm
r
 
This study 
pDC426(AutoGW) pDC459 pDC426 carrying a DNA fragment 
encoding the Auto GW repeat 
domain (residues 244–572); Cm
r
 
This study 
pDC426(Lmo1215GW) pDC460 pDC426 carrying a DNA fragment 
encoding the Lmo1215 GW repeat 
domain (residues 213–283); Cm
r
 
This study 
pDC426(Lmo1216GW) pDC461 pDC426 carrying a DNA fragment 
encoding the Lmo1216 GW repeat 
domain (residues 189–265); Cm
r
 
This study 
pDC426(Lmo1521GW) pDC480 pDC426 carrying a DNA fragment 
encoding the Lmo1521 GW repeat 
domain (residues 37–231); Cm
r
 
This study 
pDC426(Lmo2203GW) pDC462 pDC426 carrying a DNA fragment 
encoding the Lmo2203 GW repeat 
domain (residues 210–375); Cm
r
 
This study 
pDC426(AmiGW) pDC440 pDC426 carrying a DNA fragment 
encoding the Ami GW repeat domain 
(residues 262–917); Cm
r
 
This study 
pDC426(Lmo2591GW) pDC463 pDC426 carrying a DNA fragment 
encoding the Ami GW repeat domain 
(residues 191–508); Cm
r
 
This study 
pDC426(Lmo2713GW) pDC464 pDC426 carrying a DNA fragment 
encoding the Ami GW repeat domain 
(residues 33–109); Cm
r
 
This study 
E. coli strains 
DH5α  Cloning host strain; F
-
 Φ80lacZΔM15 
Δ(lacZYA-argF) U169 recA1 endA1 
hsdR17(rk
-
, mk
+
) phoA supE44 thi-1 
gyrA96 relA1 λ
-
 
Life 
Technologies 
S17-1  Conjugative donor strain; recA pro 
hsdR RP4-2-Tc::Mu-Km::Tn7 
Simon et al. 
1983 
L. monocytogenes strains 
EGD-e  wild type; serotype 1/2a Glaser et al. 
2001 
EGD-e ΔrmlACBD  DC307 EGD-e rmlACBD (lmo1081–4) 
deletion mutant 
Carvalho et al. 
2015  
EGD-e ΔrmlACBD::pPL2(rmlACBD)  DC367 EGD-e rmlACBD (lmo1081–4) 
deletion mutant complemented with 
pPL2(rmlACBD) (pDC313); Cm
r
 
Carvalho et al. 
2015  
EGD-e::pDC426(InlBGW) DC484 EGD-e carrying pDC426(InlBGW) 
(pDC481); Cm
r
 
This study 
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(Continued from previous page) 
Plasmid or strain Code Relevant characteristics Source 
L. monocytogenes strains 
EGD-e ΔrmlACBD::pDC426(InlBGW)  EGD-e rmlACBD (lmo1081–4) 
deletion mutant carrying 
pDC426(InlBGW) (pDC481); Cm
r
 
This study 
EGD-e::pDC426(AutoGW) DC475 EGD-e carrying pDC426(AutoGW) 
(pDC459); Cm
r
 
This study 
EGD-e ΔrmlACBD::pDC426(AutoGW) DC467 EGD-e rmlACBD (lmo1081–4) 
deletion mutant carrying 
pDC426(AutoGW) (pDC459); Cm
r
 
This study 
EGD-e::pDC426(Lmo1215GW) DC476 EGD-e carrying pDC426(Lmo1215GW) 
(pDC460); Cm
r
 
This study 
EGD-e 
ΔrmlACBD::pDC426(Lmo1215GW) 
DC468 EGD-e rmlACBD (lmo1081–4) 
deletion mutant carrying 
pDC426(Lmo1215GW) (pDC460); 
Cm
r
 
This study 
EGD-e::pDC426(Lmo1216GW) DC477 EGD-e carrying pDC426(Lmo1216GW) 
(pDC461); Cm
r
 
This study 
EGD-e 
ΔrmlACBD::pDC426(Lmo1216GW) 
DC469 EGD-e rmlACBD (lmo1081–4) 
deletion mutant carrying 
pDC426(Lmo1216GW) (pDC461); 
Cm
r
 
This study 
EGD-e::pDC426(Lmo1521GW) DC482 EGD-e carrying pDC426(Lmo1521GW) 
(pDC480); Cm
r
 
This study 
EGD-e 
ΔrmlACBD::pDC426(Lmo1521GW) 
DC483 EGD-e rmlACBD (lmo1081–4) 
deletion mutant carrying 
pDC426(Lmo1521GW) (pDC480); 
Cm
r
 
This study 
EGD-e::pDC426(Lmo2203GW) DC478 EGD-e carrying pDC426(Lmo2203GW) 
(pDC462); Cm
r
 
This study 
EGD-e 
ΔrmlACBD::pDC426(Lmo2203GW) 
DC470 EGD-e rmlACBD (lmo1081–4) 
deletion mutant carrying 
pDC426(Lmo2203GW) (pDC462); 
Cm
r
 
This study 
EGD-e::pDC426(AmiGW) DC445 EGD-e carrying pDC426(AmiGW) 
(pDC440); Cm
r
 
This study 
EGD-e ΔrmlACBD::pDC426(AmiGW) DC446 EGD-e rmlACBD (lmo1081–4) 
deletion mutant carrying 
pDC426(AmiGW) (pDC440); Cm
r
 
This study 
EGD-e::pDC426(Lmo2591GW) DC479 EGD-e carrying pDC426(Lmo2591GW) 
(pDC463); Cm
r
 
This study 
EGD-e 
ΔrmlACBD::pDC426(Lmo2591GW) 
DC471 EGD-e rmlACBD (lmo1081–4) 
deletion mutant carrying 
pDC426(Lmo2591GW) (pDC463); 
Cm
r
 
This study 
EGD-e::pDC426(Lmo2713GW) DC485 EGD-e carrying pDC426(Lmo2713GW) 
(pDC464); Cm
r
 
This study 
EGD-e 
ΔrmlACBD::pDC426(Lmo2713GW) 
DC472 EGD-e rmlACBD (lmo1081–4) 
deletion mutant carrying 
pDC426(Lmo2713GW) (pDC464); 
Cm
r
 
This study 
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Table 2. Primers 
# Name Sequence (5’ to 3’)
a
 
1 Pami-SalI-F AGCGTCGACTTTACAGAAAAAAACATACG 
2 AmiSP-FLAG-PstI-R ATTCTGCAGCCTTGTCATCGTCATCCTTGTAATCAGCACTTGCTTTTTCT 
GTAATCATAGTAGCGGAGG 
3 InlBGW-PstI-F ATCCTGCAGGCTTAACCCGCTATGTCAAATATATTCG 
4 InlBGW-NotI-R AGAGCGGCCGCTTATTTCTGTGCCCTTAAATTAGCTGC 
5 AutoGW-NsiI-F ATCATGCATGCACTCTGTACGATACGATTAAACAAC 
6 AutoGW-NotI-R AGAGCGGCCGCTTAATATTTAAATGCTTTTTTGTCCATCC 
7 Lmo1215GW-NsiI-F ATCATGCATGCTATGATACAAAATCAACTGGC 
8 Lmo1215GW-NotI-R AGAGCGGCCGCCTACTTTTTATCGATTAATTCTTGTTTCAC 
9 Lmo1216GW-PstI-F ATCCTGCAGGCTCAGATAAAGCAATTAAGGCTACTGG 
10 Lmo1216GW-NotI-R AGAGCGGCCGCTTACCAGATGATGGATTGAACGTTC 
11 Lmo1521GW-PstI-F ATCCTGCAGGCGAAGTCTTAAATGTCCGTAGCGGTCC 
12 Lmo1521GW-NotI-R AGAGCGGCCGCTTAATCGACTACCCAGTTAGCTACATAACC 
13 Lmo2203GW-PstI-F ATCCTGCAGGCTCAACAGAAAACCAATTAGCATACG 
14 Lmo2203GW-NotI-R AGAGCGGCCGCTTATTTTACTTCTAACGCTTTATTAGG 
15 AmiGW-PstI-F ATCCTGCAGGTTTGATTAACGAAAAATATAAAGCAATGC 
16 AmiGW-NotI-R TTTGCGGCCGCTTATTGCTTTTTAGCACTTAGG 
17 Lmo2591GW-PstI-F ATCCTGCAGGCTCTAATCAATCCTTAGCAGCAATTGG 
18 Lmo2591GW-NotI-R AGAGCGGCCGCTTAACTATTGATGTCGATAGCTTTAATCC 
19 Lmo2713GW-NsiI-F ATCATGCATGCTATGACAAAGCAGTTAATCTAAAAGG 
20 Lmo2713GW-NotI-R AGAGCGGCCGCTTATGTAAAGGCACGTGAGTCAATCC 
21 PL95 ACATAATCAGTCCAAAGTAGATGC 
22 PL102 TATCAGACCTAACCCAAACCTTCC 
a
 Restriction sites underlined. FLAG tag nucleotide sequence in bolded and italicized letters. 
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The results presented in this thesis contributed to an improved understanding 
of the importance of WTAs and WTA glycosylation mechanisms in processes 
relevant for bacterial physiology, virulence and immune evasion. In particular, we 
have characterized the role of WTA decoration with L-rhamnose in different 
aspects of Lm biology (Fig. 28). We showed that WTA L-rhamnosylation in this 
organism is encoded in a single chromosomal operon containing genes for the 
enzymatic biosynthesis and appendage of L-rhamnose to nascent WTA polymers. 
We revealed that this modification is required to promote resistance and favor 
bacterial survival when challenged by cationic AMPs. Supported by biochemical 
and microscopic data, we proposed a mechanism that links AMP resistance to a 
WTA L-rhamnosylation-promoted reduction of the Lm cell wall permeability to this 
type of molecules. In addition, we demonstrated that WTA L-rhamnosylation 
ensures physiological levels of autolytic activity and supports host cell invasion. 
Importantly, we revealed that these contributions appear to be accomplished 
indirectly through the role of L-rhamnosylated WTAs in the efficient surface 
anchoring of GW proteins that do have an active part in these processes. Finally, 
we firmly established the dependence of Lm pathogenesis on this particular WTA 
tailoring mechanism. 
Lm strains are distributed across several serotypes, each represented by 
unique cell surface antigens (Seeliger and Höhne 1979, Seeliger and Langer 
1989, Gorski 2008). Among these, WTAs are prominent serotype markers due to 
the highly diverse nature and organization of their backbone structure and 
substituent groups (Kamisango et al. 1983, Fiedler et al. 1984, Fujii et al. 1985, 
Uchikawa et al. 1986a). Serogroup 1/2 strains are the only ones to display L-
rhamnose as a side-chain group. Although strains from serogroups 3 and 7 also 
possess the biosynthetic rmlABCD genes, internal point mutations have rendered 
the pathway non-functional (Eugster et al. 2015). In addition to the serogroup-
specific substituent L-rhamnose, serogroup 1/2 WTAs are decorated with GlcNAc 
(Kamisango et al. 1983), which is present in other serotypes (Fiedler et al. 1988). 
In this work, however, we have only addressed specifically the role of WTA L-
rhamnosylation in different biological processes of Lm. Many, if not all, of these 
processes are extensive to other Lm serotypes, which contain differentially 
structured and/or substituted WTA backbones. Therefore, a transversal study 
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aimed at evaluating and comparing the biological contributions of glycosyl 
substituents in the many Lm serotypes should provide a more comprehensive 
perspective on the overall role of WTA substitution in Lm biology.  
 
Fig. 28. Schematic representation of the proposed impact of WTA L-rhamnosylation in different 
aspects of Lm biology. This work has shown that this WTA modification promotes Lm resistance to AMPs 
by turning the cell wall less permeable to their penetration, thus delaying their contact with the plasma 
membrane. In addition, L-rhamnosylated WTAs contribute to the surface anchoring of some GW proteins, 
such as Ami and InlB, which are required to ensure optimal levels of autolysis and invasion of host cells. For 
simplicity, WTAs are represented only with L-rhamnose as substituent group, while only the LTA backbone is 
shown. Gray arrowheads represent the intensity of Ami/InlB secretion in each condition. 
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While characterizing the Lm rmlACBD locus, we came across rmlT 
(lmo1080), a gene located in the same operon and that encodes a protein with 
predicted glycosyltransferase activity. Biochemical analyses of the WTAs from an 
Lm mutant strain where this gene was inactivated confirmed the requirement of 
RmlT for the transfer of L-rhamnose from its cytoplasmic pool to the WTA 
backbone. Bioinformatic prediction of its subcellular location indicates RmlT as a 
cytoplasmic protein, which is in agreement with studies indicating that WTA 
glycosylation, unlike D-alanylation, occurs in this compartment prior to WTA export 
(Brown et al. 2013). Nevertheless, functional characterization of RmlT is 
necessary to definitively validate its WTA L-rhamnosyltransferase activity and 
localization. Such studies would include, for instance, in vitro activity and 
specificity assays, using purified recombinant RmlT variants in the presence of L-
rhamnose or other glycosyl donor substrates and WTAs or similar acceptor 
molecules.  
Bacterial autolysis was another physiological process for which we 
determined a dependence on Lm WTA L-rhamnosylation. We showed that in its 
absence, Lm displayed a lower rate of self-degradation. Further investigation 
revealed that the proportion of the autolytic enzyme Ami associated with the Lm 
surface was sharply diminished because the protein was not being properly 
anchored to the bacterial cell envelope. We postulated that these two findings are 
correlated, but this requires confirmation. For instance, we should not discard 
variations in the levels of other autolytic proteins that were not perceivable from 
the SDS-PAGE gel containing surface protein extracts. Also, zymographic analysis 
of these extracts should be able to expose WTA L-rhamnosylation-dependent 
changes in the activity of autolysins whose total protein levels remained 
unaffected. The autolytic profile of an Lm Δami strain should provide indications 
regarding the weight of the contribution of surface-associated Ami towards the 
overall autolytic process, enabling us to draw a more accurate conclusion about a 
link between reduced surface-associated Ami levels and reduced bacterial lysis. 
Alternatively, considering that our results showed that the GW domain of Auto 
(AutoGW) is stably anchored to the Lm surface regardless of the WTA L-
rhamnosylation status, we could analyze the autolytic profile of a WTA L-
rhamnosylation-deficient strain mutated in the ami locus so as to express a 
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chimera protein containing the N-terminal catalytic domain of Ami and AutoGW in 
the C-terminus. We would expect this strain to be able to properly attach Ami to its 
cell surface and thus behave like a wild type Lm. 
Our study of the GW domain- and WTA L-rhamnosylation-dependent surface 
anchoring of Lm GW proteins was the first to provide some information about 
many of these proteins. Indeed, apart from InlB, Ami and Auto (Lingnau et al. 
1995, Braun et al. 1997, Cabanes et al. 2004), nothing was known about the 
localization of the remaining GW proteins. Interestingly, while AmiGW appears to be 
completely displaced from the bacterial surface in the absence of L-rhamnosylated 
WTAs, the native full-length protein still preserves some surface-associated levels, 
as analyzed by SDS-PAGE. This suggests that the N-terminal catalytic domain of 
Ami may partly contribute to surface attachment. Braun and colleagues showed 
that the strength of the interaction between GW proteins and the Lm surface was 
correlated with the number of GW repeats (Braun et al. 1997). Our results in wild 
type bacteria agree with this observation: the longest GW domains – AmiGW (8 
repeats) and AutoGW (~4 repeats) – are exclusively surface-associated, while 
smaller ones – InlB (~3 repeats) > Lmo1521GW/Lmo2203GW/Lmo2713GW (2 
repeats) > Lmo1215GW/Lmo1216GW (1 repeat) – are increasingly delocalized to the 
secreted fraction. However, this trend changes in the absence of WTA L-
rhamnosylation, with AmiGW being completely secreted whereas AutoGW remains at 
the surface. A striking case is observed with Lmo2591GW, which is fully secreted 
irrespective of the WTA L-rhamnosylation status. However, Lmo2591GW is also 
similar in molecular size and number of GW repeats to AutoGW, which is 
exclusively found at the surface in both strains. These antagonistic behaviors 
suggest that surface anchoring properties may also be modulated by the amino 
acid sequence of GW modules, particularly by the non-conserved regions specific 
to each GW protein (Braun et al. 1997, Cabanes et al. 2002, Marino et al. 2002). 
Structural studies involving these apparently similar GW domains ought to provide 
elucidating data regarding the veracity of this hypothesis. 
As Ami, the surface levels of InlB were shown to decrease in bacteria lacking 
L-rhamnosylated WTAs, due to inefficient protein anchoring. This perturbation in 
the surface localization of a key Lm invasin prompted us to assess the cell 
invasive properties of these mutant bacteria. Our results showed a significant drop 
CHAPTER IV – GENERAL DISCUSSION 
 
 
 181 
in intracellular Lm numbers, confirming a defect in the invasion of epithelial cells. It 
would be interesting to verify if this attenuated phenotype is also observed in other 
cell types, such as parenchymal (e.g. hepatocytes) or endothelial cells. To try to 
confirm whether the decreased levels of the surface-associated InlB form are 
responsible for the attenuated invasion phenotype, a similar chimera protein 
strategy could be also employed. In this case, a WTA L-rhamnosylation mutant 
strain would express the N-terminal functional domain of InlB, containing the c-
Met-binding LRR region (Shen et al. 2000), fused to the AutoGW. This fusion would 
hypothetically keep InlB activity segregated to the Lm surface. However, in normal 
conditions, InlB is partly secreted (Braun et al. 1997) and this soluble form was 
reported to contribute to the optimization of InlB-mediated Lm internalization by 
host cells (Jonquières et al. 2001). Still, a chimeric protein containing the LRR and 
inter-repeat regions of InlB fused to the C-terminal region of the staphylococcal 
protein A (SPA) – which mediates a stable covalent association with the cell wall – 
was able to greatly potentiate (100-fold) the invasion of Vero cells by non-invasive 
L. innocua (Braun et al. 1999). 
In part I of the results, the requirement of WTA L-rhamnosylation for optimal 
Lm virulence levels was demonstrated in a mouse infection model. Although these 
infection assays suggest that a major part of the in vivo attenuation of Lm WTA L-
rhamnosylation mutants is due to the impaired capacity to resist to host-produced 
AMPs, it cannot be ruled out that a part of this attenuated phenotype is a reflection 
of the undermined ability of these bacteria to invade cells, as shown in part II of 
the results. A way to address this possibility would be to perform infection assays 
on wild-type mice with a WTA L-rhamnosylation mutant strain expressing InlB 
solely as a chimera with AutoGW or the C-terminal region SPA (to dissociate its 
anchoring mechanism from the WTA L-rhamnosylation status) and observe 
whether virulence levels are increased relative to an isogenic strain expressing 
native InlB or even comparable to those of a wild type Lm. 
In conclusion, our findings have expanded the current knowledge on WTAs, 
but most importantly, have raised the status and influence of WTA glycosylation 
mechanisms in overall bacterial biology to a previously unrecognized level. 
Particularly significant – and the base of all these newly identified contributions – is 
the newfound role of WTA L-rhamnosyl substituents in assisting the non-covalent 
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binding of bacterial surface proteins with common anchoring motif domains. 
Further work will be necessary to determine if this supporting mechanism is 
exclusively dependent on WTA L-rhamnosylation or if it is broadly guided by WTA 
glycosyl substituents in general. Most importantly, additional investigation should 
focus on understanding the molecular details governing these WTA glycosylation-
dependent protein interactions with the bacterial cell envelope. 
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